<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06482912-20021119-C00001.CDX SYSTEM "US06482912-20021119-C00001.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00001.MOL SYSTEM "US06482912-20021119-C00001.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00001.TIF SYSTEM "US06482912-20021119-C00001.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00002.CDX SYSTEM "US06482912-20021119-C00002.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00002.MOL SYSTEM "US06482912-20021119-C00002.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00002.TIF SYSTEM "US06482912-20021119-C00002.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00003.CDX SYSTEM "US06482912-20021119-C00003.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00003.MOL SYSTEM "US06482912-20021119-C00003.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00003.TIF SYSTEM "US06482912-20021119-C00003.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00004.CDX SYSTEM "US06482912-20021119-C00004.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00004.MOL SYSTEM "US06482912-20021119-C00004.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00004.TIF SYSTEM "US06482912-20021119-C00004.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00005.CDX SYSTEM "US06482912-20021119-C00005.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00005.MOL SYSTEM "US06482912-20021119-C00005.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00005.TIF SYSTEM "US06482912-20021119-C00005.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00006.CDX SYSTEM "US06482912-20021119-C00006.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00006.MOL SYSTEM "US06482912-20021119-C00006.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00006.TIF SYSTEM "US06482912-20021119-C00006.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00007.CDX SYSTEM "US06482912-20021119-C00007.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00007.MOL SYSTEM "US06482912-20021119-C00007.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00007.TIF SYSTEM "US06482912-20021119-C00007.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00008.CDX SYSTEM "US06482912-20021119-C00008.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00008.MOL SYSTEM "US06482912-20021119-C00008.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00008.TIF SYSTEM "US06482912-20021119-C00008.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00009.CDX SYSTEM "US06482912-20021119-C00009.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00009.MOL SYSTEM "US06482912-20021119-C00009.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00009.TIF SYSTEM "US06482912-20021119-C00009.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00010.CDX SYSTEM "US06482912-20021119-C00010.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00010.MOL SYSTEM "US06482912-20021119-C00010.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00010.TIF SYSTEM "US06482912-20021119-C00010.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00011.CDX SYSTEM "US06482912-20021119-C00011.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00011.MOL SYSTEM "US06482912-20021119-C00011.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00011.TIF SYSTEM "US06482912-20021119-C00011.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00012.CDX SYSTEM "US06482912-20021119-C00012.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00012.MOL SYSTEM "US06482912-20021119-C00012.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00012.TIF SYSTEM "US06482912-20021119-C00012.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00013.CDX SYSTEM "US06482912-20021119-C00013.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00013.MOL SYSTEM "US06482912-20021119-C00013.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00013.TIF SYSTEM "US06482912-20021119-C00013.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00014.CDX SYSTEM "US06482912-20021119-C00014.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00014.MOL SYSTEM "US06482912-20021119-C00014.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00014.TIF SYSTEM "US06482912-20021119-C00014.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00015.CDX SYSTEM "US06482912-20021119-C00015.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00015.MOL SYSTEM "US06482912-20021119-C00015.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00015.TIF SYSTEM "US06482912-20021119-C00015.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00016.CDX SYSTEM "US06482912-20021119-C00016.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00016.MOL SYSTEM "US06482912-20021119-C00016.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00016.TIF SYSTEM "US06482912-20021119-C00016.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00017.CDX SYSTEM "US06482912-20021119-C00017.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00017.MOL SYSTEM "US06482912-20021119-C00017.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00017.TIF SYSTEM "US06482912-20021119-C00017.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00018.CDX SYSTEM "US06482912-20021119-C00018.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00018.MOL SYSTEM "US06482912-20021119-C00018.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00018.TIF SYSTEM "US06482912-20021119-C00018.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00019.CDX SYSTEM "US06482912-20021119-C00019.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00019.MOL SYSTEM "US06482912-20021119-C00019.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00019.TIF SYSTEM "US06482912-20021119-C00019.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00020.CDX SYSTEM "US06482912-20021119-C00020.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00020.MOL SYSTEM "US06482912-20021119-C00020.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00020.TIF SYSTEM "US06482912-20021119-C00020.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00021.CDX SYSTEM "US06482912-20021119-C00021.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00021.MOL SYSTEM "US06482912-20021119-C00021.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00021.TIF SYSTEM "US06482912-20021119-C00021.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00022.CDX SYSTEM "US06482912-20021119-C00022.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00022.MOL SYSTEM "US06482912-20021119-C00022.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00022.TIF SYSTEM "US06482912-20021119-C00022.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00023.CDX SYSTEM "US06482912-20021119-C00023.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00023.MOL SYSTEM "US06482912-20021119-C00023.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00023.TIF SYSTEM "US06482912-20021119-C00023.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00024.CDX SYSTEM "US06482912-20021119-C00024.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00024.MOL SYSTEM "US06482912-20021119-C00024.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00024.TIF SYSTEM "US06482912-20021119-C00024.TIF" NDATA TIF>
<!ENTITY US06482912-20021119-C00025.CDX SYSTEM "US06482912-20021119-C00025.CDX" NDATA CDX>
<!ENTITY US06482912-20021119-C00025.MOL SYSTEM "US06482912-20021119-C00025.MOL" NDATA MOL>
<!ENTITY US06482912-20021119-C00025.TIF SYSTEM "US06482912-20021119-C00025.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06482912</PDAT></DNUM></B110>
<B130><PDAT>B2</PDAT></B130>
<B140><DATE><PDAT>20021119</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09771921</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20010129</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C08G 7708</PDAT></B511>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>528 15</PDAT></B521>
<B522><PDAT>528 31</PDAT></B522>
<B522><PDAT>528 28</PDAT></B522>
<B522><PDAT>528 29</PDAT></B522>
<B522><PDAT>556407</PDAT></B522>
<B522><PDAT>556425</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Method of preparing aminofunctional alkoxy polysiloxanes</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4059581</PDAT></DNUM>
<DATE><PDAT>19771100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Prokai</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>544 69</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4570010</PDAT></DNUM>
<DATE><PDAT>19860200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Stuber et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556475</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4952715</PDAT></DNUM>
<DATE><PDAT>19900800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Blum et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556409</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5051458</PDAT></DNUM>
<DATE><PDAT>19910900</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Costanzi et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>524 99</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5128494</PDAT></DNUM>
<DATE><PDAT>19920700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Blum</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556457</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5162136</PDAT></DNUM>
<DATE><PDAT>19921100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Blum et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>427226</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5405655</PDAT></DNUM>
<DATE><PDAT>19950400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Blum et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>427387</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5639844</PDAT></DNUM>
<DATE><PDAT>19970600</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Blum et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>528 15</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5925779</PDAT></DNUM>
<DATE><PDAT>19990700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Cray et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556425</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>6258968</PDAT></DNUM>
<DATE><PDAT>20010700</PDAT></DATE>
<KIND><PDAT>B1</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Eversheim et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556425</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B562><NCIT><STEXT><PDAT>P. Boudjouk, et al., &ldquo;Nickel Catalyzed Silane Reductions of &agr;, &bgr;&mdash;Unsaturated Ketones and Nitriles,&rdquo; </PDAT><HIL><ITALIC><PDAT>Tetrahedron Letters </PDAT></ITALIC></HIL><PDAT>39, pp. 3951-3952 (1998), Elsevier Science Ltd., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>M. Chauhan, et al., &ldquo;A New Catalyst for Exclusive &bgr;-Hydrosilylation of Acrylonitrile,&rdquo; </PDAT><HIL><ITALIC><PDAT>Tetrahedron Letters </PDAT></ITALIC></HIL><PDAT>40, pp. 4127-4128 (1999), Elsevier Science Ltd., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>L. Sommer, et al., &ldquo;Group VIII Metal Catalyzed Reactions of Organosilicon Hydrides with Amines, Hydrogen Halides, and Hydrogen Sulfide,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Org. Chem. </PDAT></ITALIC></HIL><PDAT>32, pp. 2470-2472 (1967), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>R. Corriu, et al., &ldquo;Selective Catalytic Route to Bifunctional Silanes. Catalysis by Rhodium and Ruthenium Complexes of the Alcoholysis of Diarylsilanes and the Hydrosilylation of Carbonyl Compounds,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.; Chem. Comm. </PDAT></ITALIC></HIL><PDAT>1, pp. 38-39 (1973), The Chemical Society, Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Aylett, et al., &ldquo;Silicon-Transition-metal Compounds. Part I. Silyltetracarbonylcobalt and Related Compounds,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.</PDAT></ITALIC></HIL><PDAT>, pp. 1910-1916 (1969), Inorg. Phys. Theor., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Aylett, et al., &ldquo;Silicon-Transition Metal Compounds. Part II. Preparation and Properties of Silylpentacarbonylmanganese,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.</PDAT></ITALIC></HIL><PDAT>, pp. 1916-1920 (1969), Inorg. Phys. Theor., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Aylett, et al., &ldquo;Silicon-Transition Metal Compounds. Part III. Reactions of Silytetracarbonylcobalt and Silypentacarbonylmanganese with Lewis Bases of Nitrogen and Phosphorous,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.; Chem. Comm.</PDAT></ITALIC></HIL><PDAT>, pp. 1920-1924 (1969), Inorg. Phys. Theor., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Sternbach, et al., &ldquo;The Preparation of Methoxysilanes by the Interaction of Monosilane and Methanol,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Amer. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>81, pp. 5109-5110 (1959), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Aylett, et al., &ldquo;A Volatile Silicon-Transition-metal Compound,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.; Chem. Comm.</PDAT></ITALIC></HIL><PDAT>, p. 217 (1965), The Chemical Society, Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Y. Baay, et al., &ldquo;Trimethyl- and Trichlorosilylcobalt Tetracarbonyls and the Hydrosilation of Ethylene,&rdquo; </PDAT><HIL><ITALIC><PDAT>Inorg. Chem. </PDAT></ITALIC></HIL><PDAT>8 (4), pp. 986-994 (1969), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>A. Chalk, &ldquo;Group IV-Cobalt Complexes as Catalysis for Silylation and Cyclic Ether Polymerization,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.; Chem. Comm.</PDAT></ITALIC></HIL><PDAT>, pp. 847-848 (1970), The Chemical Society, Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>P. Rakita, et al., &ldquo;Reductive Solvolysis of Dimethylindenylsilane: Evidence for a Two-step Mechanism,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.; Chem. Comm.</PDAT></ITALIC></HIL><PDAT>, pp. 533-534 (1973), The Chemical Society, Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>P. Reddy, et al., &ldquo;Palladium-Catalyzed Dehydrogenative Polymerization between Hydrosilanes and Quinones of Hydroquinone,&rdquo; </PDAT><HIL><ITALIC><PDAT>Chemistry Letters</PDAT></ITALIC></HIL><PDAT>, pp. 250-251 (2000), The Chemical Society of Japan, Japan. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Y. Baay, et al., &ldquo;Synthesis And Properties Of Trimethylsiyl Cobalt Tetracarbonyl And Related Compounds,&rdquo; </PDAT><HIL><ITALIC><PDAT>Inorg. Nucl. Chem. Letters </PDAT></ITALIC></HIL><PDAT>3, pp. 159-161 (1967), Pergamon Press Ltd., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>R. Corriu, et al., &ldquo;Alcoolyse Selective D&apos;Organosilanes Catalysees Par Un Complexe Du Rhodium,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Organomet. Chem. </PDAT></ITALIC></HIL><PDAT>114, pp. 135-144 (1976), Elsevier Science S.A., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>R. Corriu, et al., &ldquo;Reactions D&apos;Organosilanes Catalyses Par Des Complexes Du Rhodium; Synthese D&apos;Organosilanes Polyfonctionnels,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Organomet. Chem. </PDAT></ITALIC></HIL><PDAT>127, pp. 7-17 (1977), Elsevier Science S.A., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>H. Ito, et al., &ldquo;Highly stereoselective metathesis reaction between optically active hdyrosilane and copper(I) salt in 1,3-dimethyl-2-imidazolidinone,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Organomet. Chem. </PDAT></ITALIC></HIL><PDAT>574, pp. 102-106 (1999), Elsevier Science S.A., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>J. Wang, et al., &ldquo;Dehydrocoupling reactions of amines with silanes catalyzed by &lsqb;Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>U&rsqb;&lsqb;BPh</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&rsqb;,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Organomet. Chem. </PDAT></ITALIC></HIL><PDAT>610, pp. 49-57 (2000), Elsevier Science S.A., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Y. Li, et al., &ldquo;Efficient Synthesis of Poly(silyl ether)s by Pd/C and RhC1(PPh</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-Catalyzed Cross-Dehydrocoupling Polymerization of Bis(hydrosilane)s with Diols,&rdquo; </PDAT><HIL><ITALIC><PDAT>Macromolecules </PDAT></ITALIC></HIL><PDAT>32, pp. 6871-6873 (1999), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>R. Zhang, &ldquo;Dehydrocoupling Polymerization of Bis-silanes and Disilanols to Poly(silphenylenesiloxane) As Catalyzed by Rhodium Complexes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Macromolecules </PDAT></ITALIC></HIL><PDAT>33, pp. 3508-3510 (2000), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Y. Blum, et al., &ldquo;Modifications of hydrosiloxane polymers for coating applications,&rdquo; </PDAT><HIL><ITALIC><PDAT>Surface Coatings International Part B: Coatings Transactions 84 </PDAT></ITALIC></HIL><PDAT>(</PDAT><HIL><ITALIC><PDAT>1</PDAT></ITALIC></HIL><PDAT>), pp. 27-33 (2001), OCCA, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>M. Chauhan, et al., &ldquo;An Efficient Pd-Catalyzed Route to Silyl Esters,&rdquo; </PDAT><HIL><ITALIC><PDAT>Organic Letters</PDAT></ITALIC></HIL><PDAT>. 2 (8), pp. 1027-1029 (2000), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>A. Arruda, et al., &ldquo;New organosilicon polymer for the extraction and luminescence analysis of uranyl in environmental samples,&rdquo; </PDAT><HIL><ITALIC><PDAT>Anal. Chim. Acta </PDAT></ITALIC></HIL><PDAT>396, pp. 263-272 (1999), Elsevier Sience B.V., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Chauhan, et al., &ldquo;Dehydrogenative condensation of SiH and SH bonds. A metal-catalyzed protocol to stable thiopolysiloxanes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Tetrahedron Letters </PDAT></ITALIC></HIL><PDAT>41, pp. 1127-1130 (2000), Elsevier Science Ltd., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Q. Fan, et al., &ldquo;Synthesis and Properties of Polyurethane Modified with Aminoethylaminopropyl Poly(dimethyl siloxane),&rdquo; </PDAT><HIL><ITALIC><PDAT>J. App. Polymer Sci. </PDAT></ITALIC></HIL><PDAT>74, pp. 2552-2558 (1999), John Wiley &amp; Sons, Inc., U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Chauhan, et al., &ldquo;New Neutral Carrier-type Ion Sensors. Crown Ether Derivatives of Poly(methylhydrosiloxane),&rdquo; </PDAT><HIL><ITALIC><PDAT>Tetrahedron Letters </PDAT></ITALIC></HIL><PDAT>40, pp. 4123-4126 (1999), Elsevier Science Ltd., The Netherlands. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Y. Cai, et al., &ldquo;Surface properties of silicone-containing block-graft copolymer/polystyrene systems,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Adhesion Sci. Technol. </PDAT></ITALIC></HIL><PDAT>13 (9), pp. 1017-1027 (1999), VSP, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Chauhan, et al., &ldquo;A Catalytic Route to Grafted Silicones,&rdquo; </PDAT><HIL><ITALIC><PDAT>Organometallics </PDAT></ITALIC></HIL><PDAT>20, pp. 2725-2729 (2001), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>L. Lestel, et al., &ldquo;Crosslinking of polyether networks by hydrosilylation and related side reactions,&rdquo; </PDAT><HIL><ITALIC><PDAT>Polymer </PDAT></ITALIC></HIL><PDAT>31, pp. 1154-1158 (1990), Butterworth-Heinemann Ltd., Great Britain. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>S. Yun, et al., &ldquo;Synthesis and Ionic Conductivity of Supramolecular Layered Silicate Hybrids of Phosphotungstates and Poly(ethylene glycol) Dicarboxylates,&rdquo; </PDAT><HIL><ITALIC><PDAT>Chemistry of Materials </PDAT></ITALIC></HIL><PDAT>11 (7), pp. 1644-1647 (1999), American Chemical Society, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>T. Ready, et al., &ldquo;Functionalized Polysiloxanes as Primer Components in Coating Systems,&rdquo; Power Point Slides from Presentation and Abstracts of Presentations, 32</PDAT><HIL><SP><PDAT>nd </PDAT></SP></HIL><PDAT>Great Lakes 2000 Regional Meeting, American Chemical Society, 28 pp. (2000), Fargo, North Dakota, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>T. Ready, et al., &ldquo;New High Performance Polysiloxane Primers for Aluminum,&rdquo; Abstract and Power Point Slides from Presentation to Air Force Office of Scientific Research, 2000 AFOSR Corrosion Review, 26 pp. (2000), Duck Key, Florida, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>C. Howie, et al., &ldquo;Proton Inventory of the Transition State for Hydride Expulsion from Silicon,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Amer. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>95 (16), pp. 5286-5288 (1973), American Chemical Society, Book and Journals Division, U.S.A. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>P. Boudjouk, et al., &ldquo;Hydrosilylation Catalysed by Activated Nickel,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc.; Chem. Comm.</PDAT></ITALIC></HIL><PDAT>, pp. 1424-1425 (1991), The Chemical Society, Great Britain.</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>63</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>528 15</PDAT></B582>
<B582><PDAT>528 31</PDAT></B582>
<B582><PDAT>528 28</PDAT></B582>
<B582><PDAT>528 29</PDAT></B582>
<B582><PDAT>556407</PDAT></B582>
<B582><PDAT>556425</PDAT></B582>
</B580>
<B590><B595><PDAT>0</PDAT></B595><B596><PDAT>0</PDAT></B596></B590>
</B500>
<B600>
<B690US>
<DOC>
<DNUM><PDAT>20020156223</PDAT></DNUM>
<DATE><PDAT>20021024</PDAT></DATE>
<CTRY><PDAT>US</PDAT></CTRY>
<KIND><PDAT>A1</PDAT></KIND>
</DOC>
</B690US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Philip</PDAT></FNM><SNM><STEXT><PDAT>Boudjouk</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Fargo</PDAT></CITY>
<STATE><PDAT>ND</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Thomas E.</PDAT></FNM><SNM><STEXT><PDAT>Ready</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Page</PDAT></CITY>
<STATE><PDAT>ND</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Bhanu P. S.</PDAT></FNM><SNM><STEXT><PDAT>Chauhan</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Silver Spring</PDAT></CITY>
<STATE><PDAT>MD</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>NDSU Research Foundation</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Fargo</PDAT></CITY><STATE><PDAT>ND</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Foley &amp; Lardner</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
<B741>
<PARTY-US>
<NAM><FNM><PDAT>Charles G.</PDAT></FNM><SNM><STEXT><PDAT>Carter</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B741>
<B741>
<PARTY-US>
<NAM><FNM><PDAT>Jason E.</PDAT></FNM><SNM><STEXT><PDAT>Pauls</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Margaret G.</PDAT></FNM><SNM><STEXT><PDAT>Moore</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1712</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>A method of preparing a aminofunctional alkoxy polysiloxane is disclosed. The method includes reacting a polyhydrosiloxane with an alcohol reactant containing an aminoalcohol to form the aminofunctional alkoxy polysiloxane. Linear and cyclic aminofunctional alkoxy polysiloxane are also disclosed. A coating composition comprising an aminofunctional alkoxy polysiloxane is also provided.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>The U.S. Government has a paid-up license in the present invention and the right (in limited circumstances) to require the patent owner to license others on reasonable terms as provided for by the terms of Grant Nos. F49620-96-1-0360 and F49620-99-0283 awarded by the Air Force Office of Scientific Research and Grant No. 9874802 awarded by the National Science Foundation.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>Synthetic routes to functionalized polysiloxanes often suffer from complex methodologies, low yields, side reactions (e.g. involving rearrangements and/or degradation), or minimal characterization of the product(s). It generally known to synthesize alkoxysilanes under mild and neutral reaction conditions using metal-catalyzed oxidation reactions of monomeric hydrosilanes. The reported methods can suffer from the disadvantage of the non-selective modification of Si&mdash;H bonds, which leads to susceptibility of the Si&mdash;H bonds toward side reactions including dehydrocoupling, rearrangement and/or backbone degradation reactions. The formation of mixtures of &agr; and &bgr;-isomers, insoluble materials and rearrangement products are common drawbacks of reported methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>Accordingly, it would be advantageous to provide a method of preparing a poly((aminofunctional alkoxy)-alkylsiloxane) using a relatively simple method under relatively mild reaction conditions. It would also be advantageous to provide a method of preparing a poly((aminofunctional alkoxy)-alkylsiloxane) that allowed for the selective alcoholysis of Si&mdash;H bonds without significant degradation of the siloxane backbone. It would also be advantageous to provide a method of preparing a poly((aminofunctional alkoxy)-alkylsiloxane) that allowed for monitoring of the reaction progress (e.g. by NMR). It would also be advantageous to provide a poly((aminofunctional alkoxy)-alkylsiloxane) product in a relatively high yield. It would be desirable to provide a method of preparing a poly((aminofunctional alkoxy)-alkylsiloxane) having one or more of these or other advantageous features.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>The present invention relates to a method of preparing aminofunctional polysiloxanes. More particularly, the present invention relates to a method of preparing aminofunctional alkoxy polysiloxanes. The method includes reacting a polyhydrosiloxane with an alcohol reactant including an aminoalcohol to form the aminofunctional alkoxy polysiloxane. The reaction is typically carried out in the presence of a catalyst, e.g., a dehydrogenative coupling catalyst which includes a rhodium compound.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>The present application also provides a coating composition which includes an aminofunctional alkoxy polysiloxane. The coating composition is particularly suitable as an adhesive or primer for coupling a topcoat to a substrate. The aminofunctional alkoxy polysiloxane may serve as the primary resin in the coating composition or in other embodiments, an aminofunctional alkoxy polysiloxane may act as a crosslinking agent and/or curing accelerator, e.g., in epoxy-based coating compositions.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>The present aminofunctional alkoxy polysiloxane compound can be a linear and/or cyclic alkoxy polysiloxane. As used herein, the term &ldquo;aminofunctional alkoxy polysiloxane compound&rdquo; refers to an alkoxy substituted polysiloxane compound which includes one or more aminofunctional alkoxy groups. For the purposes of this application, the term aminofunctional alkoxy group refers to groups which include at least one basic nitrogen atom and encompasses groups resulting from the removal of a hydroxyl hydrogen atom from an amino functional alkanol (e.g., &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), an amino functional cycloalkanol, and/or an amino functional hydroxy-substituted aryl compound (e.g., &mdash;O&mdash;C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>). As employed herein, the term &ldquo;aryl&rdquo; refers to both hydrocarbon aromatic groups and heteroatom-containing aromatic groups. For example, the aminofunctional alkoxy group may be an aminofunctional pyridyloxy group (i.e., a group resulting from the removal of the hydroxyl hydrogen atom from an aminofunctional hydroxypyridine).</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>Amino groups are organic functional groups which contain a basic nitrogen atom. Examples of amino groups include aliphatic amino groups, such as mono-, di- and trialkylamino groups; cycloaliphatic amino groups, such a piperidinyl and piperazinyl groups; aromatic amino groups (i.e, where the basic nitrogen atom is part of an aromatic ring), such as pyridyl groups, pyrimidyl groups and pyrazinyl groups; and amino-substituted aromatic groups (i.e., where the basic nitrogen atom is directly bonded to an aromatic group), such as aminophenyl groups (e.g., &mdash;NH&mdash;C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and &mdash;C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) and aminopyridyl groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>As employed herein, the term &ldquo;alkoxy group&rdquo; encompasses functional groups which include an alkyl-OH, cycloalkyl-OH or aryl-OH functional group whether or not the overall group includes an amino functional group, i.e., an aminofunctional alkoxy groups constitute one type of alkoxy group but not all alkoxy groups necessarily include a basic nitrogen atom.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>As illustrated in formula (I) below, the siloxane subunits may not all contain an aminofunctional alkoxy group. Typically, at least a majority and, in many instances, all of the siloxane subunits of the polymer include an aminofunctional alkoxy group. Polysiloxanes where not all of the siloxane subunits of the include the same substituents polymer (with the exception of the terminal subunits) are referred to herein as &ldquo;polysiloxane copolymers.&rdquo; As used herein, such &ldquo;copolymers&rdquo; can have two or more different siloxane subunits. Polysiloxane copolymers can be formed by reacting a mixture of two alcohols, e.g., a mixture of 2-aminoethanol and ethanol, with a polyhydrosiloxane. Generally, the different siloxane subunits are randomly distributed in a polysiloxane copolymer (a &ldquo;random copolymer&rdquo;). However, by using appropriate synthetic methods known to those of skill in the art, polysiloxane copolymers in which the different siloxane subunits are present in &ldquo;blocks&rdquo; of two or more identical adjacent subunits can also be produced (&ldquo;block copolymers&rdquo;). The present polysiloxane copolymers typically have a ratio of siloxane subunits containing an aminofunctional alkoxy group to subunits which do not include an aminofunctional alkoxy group of about 20:1 to 1:20.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>Throughout this disclosure, the text refers to various embodiments of the aminofunctional alkoxy polysiloxane compounds and methods of preparing and using the compounds. The various embodiments described are meant to provide illustrative examples and should not necessarily be construed as descriptions of alternative species. Rather it should be noted that the descriptions of various embodiments provided in this disclosure may be of overlapping scope. The embodiments discussed in this disclosure are merely illustrative and are not meant to limit the scope of the present invention.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION</PDAT></STEXT></H>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>A aminofunctional alkoxy polysiloxane compound can be formed by reacting a linear or cyclic polyhydrosiloxane and an alcohol reactant which includes an aminoalcohol (i.e. an amino functional compound which includes an alkyl-OH, cycloalkyl-OH or aryl-OH functional group) in the presence of a metal catalyst. The reaction of the polyhydrosiloxane and the aminoalcohol is typically carried out in the presence of a dehydrogenative coupling catalyst, such as those catalysts known to be useful for the dehydrogenative coupling of silanes. Suitable dehydrogenative coupling catalysts include catalysts which have been employed in metal catalyzed dehydrogenative coupling of silanes and alcohols, such as those including Cr, Cu, Ir, Mn, Ni, Pd, Pt, Rh, Ru, Ti and Zn species. The dehydrogenative coupling catalysts may be a mixed metal catalyst that includes more than one metal species.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>As used in this disclosure, the term &ldquo;aminofunctional alkoxy polysiloxane&rdquo; refers to a alkoxy polysiloxane compound which includes one or more aminofunctional alkoxy groups. For the purposes of this application, the term &ldquo;polyaminofunctional alkoxy group&rdquo; refers to groups which include two or more amino groups and encompasses groups resulting from the removal of a hydroxyl hydrogen atom from a polyamino functional alkanol (e.g., &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), a polyamino functional cycloalkanol, a polyamino functional hydroxy-substituted aryl compounds (e.g., &mdash;O&mdash;C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NHCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>The method of preparing the aminofunctional alkoxy polysiloxane compound provides for the selective alcoholysis of Si&mdash;H bonds with aminoalcohol compounds, without significant degradation of the siloxane backbone or aminolysis of the Si&mdash;H bonds (i.e., dehydrogenative coupling of the hydrosilane occurs relatively exclusively with the hydroxyl moiety of the aminoalcohol). Without intending to be limited to any particular theory, it is believed that the formation of the aminofunctional alkoxy polysiloxane is accomplished by the dehydrogenative alcoholysis coupling between the selectively activated Si&mdash;H bond of the polyhydrosiloxane and the aminoalcohol.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>I. REACTIONS</PDAT></STEXT></H>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>The formation of the aminofunctional alkoxy polysiloxane can be derived from a &ldquo;linear&rdquo; polyhydrosiloxane or a &ldquo;cyclic&rdquo; polyhydrosiloxane. An exemplary reaction for the formation of a linear poly((aminofunctional alkoxy)-alkylsiloxane) from a linear polyhydrosiloxane is shown in the following scheme: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00001">
<CHEMCDX ID="CHEMCDX-00001" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00001.CDX"/>
<CHEMMOL ID="CHEMMOL-00001" ALT="chemistry mol file" FILE="US06482912-20021119-C00001.MOL"/>
<EMI ID="EMI-C00001" ALT="embedded image" HE="246.7584" WI="216.027" FILE="US06482912-20021119-C00001.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>An exemplary reaction for the formation of a cyclic poly((aminofunctional alkoxy)-alkylsiloxane) from a cyclic polyhydrosiloxane is shown in the following scheme: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00002">
<CHEMCDX ID="CHEMCDX-00002" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00002.CDX"/>
<CHEMMOL ID="CHEMMOL-00002" ALT="chemistry mol file" FILE="US06482912-20021119-C00002.MOL"/>
<EMI ID="EMI-C00002" ALT="embedded image" HE="243.6399" WI="216.027" FILE="US06482912-20021119-C00002.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>In general, the reaction may be conducted by introducing relatively equimolar amounts of the polyhydrosiloxane and the aminoalcohol (and the catalyst and the optional solvent) into a reaction vessel, and mixing or stirring the components. The reaction between the polyhydrosiloxane and the aminoalcohol is commonly carried out under relatively anhydrous and deoxygenated conditions. This may be conveniently achieved by degassing the reaction mixture and carrying the reaction out under an inert gas atmosphere (e.g. under a dry nitrogen or argon atmosphere). The reaction is typically conducted at a temperature of about 0-200&deg; C. The use of reaction temperatures of less than about 100&deg; C., suitably 60-90&deg; C., is quite common. The reaction mixture may initially become yellow in color and emit gas (presumably H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), and may later became red/orange as the gas emission subsides. The reaction may be conducted for about 1-48 hours, suitably 1-30 hours, suitably 2-12 hours. NMR and IR analysis of the reaction mixture may establish the point at which relatively complete reaction of the Si&mdash;H functionalities are achieved. (The reaction progress could be monitored by the residual Si&mdash;H and O&mdash;H stretches that fall in a convenient window of the IR spectrum, and incorporation ratios of the alcohol can also be determined by integration of the NMR signals assigned to specific components.)</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>Purification of the product may be achieved by passing the polyalkoxysiloxane product through neutral silica gel. In some instances, it may be advantageous to place a layer of anhydrous magnesium sulfate on top of a silica gel plug used to purify the reaction product. In another embodiment, the catalyst may be precipitated, (e.g., by allowing a benzene solution of the product to stand at ambient temperature for about 24-48 hours) and then removed by filtration.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>II. POLY(HYDROSILOXANE)</PDAT></STEXT></H>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>Exemplary polyhydrosiloxanes which can be used as starting materials in the present method include polyhydrosiloxane (linear and/or cyclic) with one or two Si&mdash;H bonds in each siloxane subunit. The polyhydrosiloxane may be an alkyl, aryl and/or aralkyl substituted polysiloxane. Particularly suitable compounds are polyalkylhydrosiloxanes substituted with lower alkyl groups (i.e. C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl groups), such as methyl and/or ethyl groups. Other suitable polyhydrosiloxanes may be substituted with alkyl, cycloalkyl, phenyl and/or benzyl groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>Examples of suitable linear polyhydrosiloxane for use in the present method include compounds having the formula (I): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00003">
<CHEMCDX ID="CHEMCDX-00003" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00003.CDX"/>
<CHEMMOL ID="CHEMMOL-00003" ALT="chemistry mol file" FILE="US06482912-20021119-C00003.MOL"/>
<EMI ID="EMI-C00003" ALT="embedded image" HE="43.68735" WI="149.54625" FILE="US06482912-20021119-C00003.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00021" LVL="7"><PTEXT><PDAT>wherein n is an integer from 2 to 1,000 and m is an integer from 0 to 1,000;</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, or phenyl;</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is hydrogen;</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, or phenyl; and</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, or phenyl.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>In one common embodiment, R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl, R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is a methyl group, and R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>are independently hydrogen or methyl. In polyhydrosiloxanes of this type, individual siloxane subunits are typically substituted with a random distribution of (a) a hydrogen and an alkyl group; (b) two alkyl groups; and (c) two hydrogen atoms. The polyalkoxysiloxane products formed from such a polyhydrosiloxane will generally have a corresponding random distribution of substituents where some or all (depending on the stoichiometry of the reactants) of the hydrogen atoms of the polyhydrosiloxane have been replaced by an alkoxy group. Specific examples of suitable linear polyalkysiloxane compounds include such compounds where R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are methyl groups and n and m are integers from 2 to about 100.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>Examples of suitable cyclic polyhydrosiloxane compounds for use in the present method include compounds having the following formula (II): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00004">
<CHEMCDX ID="CHEMCDX-00004" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00004.CDX"/>
<CHEMMOL ID="CHEMMOL-00004" ALT="chemistry mol file" FILE="US06482912-20021119-C00004.MOL"/>
<EMI ID="EMI-C00004" ALT="embedded image" HE="78.246" WI="57.6072" FILE="US06482912-20021119-C00004.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00029" LVL="7"><PTEXT><PDAT>wherein q is an integer from 1 to 12; z is an integer from 0 to 11; and q&plus;z&equals;an integer from 3 to 12;</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, or phenyl;</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is hydrogen;</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, or phenyl; and</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, or phenyl.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>Specific examples of suitable cyclic polyalkoxysiloxane compounds include compounds where z is 0 and R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is methyl, such as cyclotetra(methylhydro)-siloxane (&ldquo;D4H&rdquo;; n&equals;4) and cyclodeca(methylhydro)-siloxane (&ldquo;D10H&rdquo;; n&equals;10).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>III. AMINOALCOHOL</PDAT></STEXT></H>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>The alcohol reactant employed in the present method includes an aminoalcohol or a polyaminoalcohol. Depending on the desired product, the alcohol reactant may only include aminoalcohol or may be a mixture of aminoalcohol and an alcohol compound lacking an amino functional group. For example, the alcohol reactant may be a mixture of 3-aminopropanol and ethanol.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>The aminoalcohol includes at least one amino group, which is an organic functional group including a basic nitrogen atom. The amino group may be a primary, secondary or tertiary amino group. Examples of suitable amino groups include aliphatic amino groups (e.g. mono-, di- and trialkyl amino groups), cycloaliphatic amino groups (e.g. piperidinyl and piperazinyl groups), heterocyclic amino groups (e.g. pyridyl groups, pyrimidyl groups and pyrazinyl groups), and aromatic amino groups (e.g. anilino groups and aminophenyl groups). As used in this disclosure, the term &ldquo;aminoalcohol&rdquo; includes amino functional hydroxy substituted alkyl, cycloalkyl, aralkyl and aryl compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The aminoalcohol is suitably an aminofunctional alkoxy alcohol, which provides an aminofunctional alkoxy group to the poly((aminofunctional alkoxy)-alkylsiloxane). Specific examples of suitable aminoalcohols include 3-amino-1-propanol, 1,3-(N,N-dimethylamino)-2-propanol, 2,5-dimethoxybenzyl alcohol, 3-(2-pyridyl)-1-propanol, 3-(4-pyridyl)-1-propanol, 4-hydroxy-N-methylpiperidine, 4-aminophenol, and 9-phenanthrolinemethanol. The amino functional group may be &ldquo;pendant&rdquo; on the alkoxy group (i.e. not in the backbone chain of the alkoxy group) and/or present as part of the backbone chain of the alkoxy group.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>As discussed above, the alcohol may be a mixture of an aminoalcohol and plain alcohol (i.e., an alcohol compound lacking an amino functional group). Specific examples of the suitable mixture of the aminoalcohol and plain alcohol include a 50:50 mixture of HO&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&mdash;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and ethanol (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>OH). Without intending to be limited to any particular theory, it is believed that using a mixture of the aminoalcohol and plain alcohol would result in a suitable poly((aminofunctional alkoxy)-alkylsiloxane) compound, and the number of amino groups present relative to the number of siloxane subunits would be less than typically achieved with only an aminoalcohol. According to a preferred embodiment, the alcohol is a primary alcohol. According to an alternative embodiment the alcohol may be relatively hindered (e.g. tert-butyl alcohol).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>IV. CATALYST</PDAT></STEXT></H>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>The reaction of the polyhydrosiloxane and the alcohol reactant is typically carried out in the presence of a catalyst. The catalyst may be provided in an amount of less than about 5 mole %, suitably less than about 0.1 mole %, suitably less than about 0.01 mole %. The amount of catalyst employed can be determined by those of skill in the art and will be based on a variety of factors such as desired reaction time, type of metal species in the catalyst, the presence or absence of solvent in the reaction mixture, the particular reactants involved, the configuration of the reaction vessel and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>The reaction of the polyhydrosiloxane and the aminoalcohol is typically carried out in the presence of a dehydrogenative coupling catalyst, such as those catalysts known to be useful for the dehydrogenative coupling of silanes. Suitable dehydrogenative coupling catalysts include catalysts which have been employed in metal catalyzed dehydrogenative coupling of silanes and alcohols, such as those including Pd, Cu, Mn, Ni, Rh and/or Ru species. Other suitable dehydrogenative coupling catalysts may include Pt, Zn, Ir, Cr, and/or Ti species. The dehydrogenative coupling catalysts may be a mixed metal catalyst that includes more than one metal species.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>Particularly suitable catalysts include rhodium catalysts and, more desirably, catalysts which include rhodium(I) species, such as phosphine-containing rhodium(I) catalysts. Suitable examples of phosphine-containing rhodium(I) catalysts include tris-phosphino rhodium(I) salts, such as RhCl(P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(known as &ldquo;Wilkinson&apos;s catalyst&rdquo;), RhCl(P(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CF</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n&equals;6-8</PDAT></SB></HIL><PDAT>CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and RhCl(P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. Examples of additional suit rhodium catalysts include the compounds shown in Table 1:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="offset" colwidth="14pt" align="left"/>
<colspec colname="1" colwidth="105pt" align="left"/>
<colspec colname="2" colwidth="98pt" align="left"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" rowsep="1"><PTEXT><PDAT>TABLE 1</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>(&eegr;</PDAT><HIL><SP><PDAT>6</PDAT></SP></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>B(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)Rh(cod)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Rh(CO)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(acac)</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>((C</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>14</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>RhCl</PDAT><HIL><SB><PDAT>)</PDAT></SB></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Rh(cod)B(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>(&lcub;RhCl(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&boxH;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rcub;</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Rh(C</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>BF</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>/P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>(RhCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CO)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Rh</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CO)</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>5% Rh/C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Rh</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>(CO)</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Rh</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CO)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Rh</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>(CO)</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>/NEt</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Rh/Al</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Co</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>Rh(CO)</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Rh/C</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>Other suitable catalysts include those catalysts useful for metal catalyzed dehydrogenative coupling of silanes and alcohols including Pd, Cu(0), Cu(I), Cu(II), Mn, Pd(0), Ni and Ru metal species. Specific examples of such catalysts for catalyzed dehydrogenative coupling of silanes and aminoalcohols include compounds having the formula as shown in Table 2:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00002">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="1" colwidth="154pt" align="left"/>
<colspec colname="2" colwidth="63pt" align="left"/>
<thead>
<row>
<entry namest="1" nameend="2" rowsep="1"><PTEXT><PDAT>TABLE 2</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>10% Pd/C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>SiMn(CO)</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Cu(O) metal</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Mn</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(Co)</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>CuCl/LiO(t-C</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Pd/C</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>CuClCN/LiO(t-C</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>PdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>CUO(t-C</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>)/(C</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>NCl</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Raney Ni</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>RUCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tris(dibenzylideneacetone)dipalladium(0)-chloroform</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Still other suitable catalysts include those catalysts useful for the dehydrogenative coupling of silanes, specifically those including U, Mn, Pd, Pt, Ni and Ru metal secies. Specific examples of suitable catalysts for dehydrogenative coupling of silanes include compounds having the formula as shown in Table 3:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00003">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="offset" colwidth="28pt" align="left"/>
<colspec colname="1" colwidth="105pt" align="left"/>
<colspec colname="2" colwidth="84pt" align="left"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" rowsep="1"><PTEXT><PDAT>TABLE 3</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>((Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>U)(B(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Pd/C</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>SiMn(CO)</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Pd(OCOCH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Pd/Al</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>PdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>((C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Raney Ni</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Pt/C</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Ru/C</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>Still other suitable catalysts include those catalysts having Mn, Pt, Ir, Ti, Ni, Au, Cr, Fe, Pd, Ir, Mo, Ru, Y, Zn and Ru metal species shown in Table 4 below:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00004">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="1" colwidth="140pt" align="left"/>
<colspec colname="2" colwidth="77pt" align="left"/>
<thead>
<row>
<entry namest="1" nameend="2" rowsep="1"><PTEXT><PDAT>TABLE 4</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>(CO)</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>MnC(O)(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>IrCl(CO)((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>(CO)</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>MnC(O)CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>IrCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>(CO)</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>MnSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PtCl</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Ir(CO)Cl</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Mn</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CO)</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PtCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>MO(CO)</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)P)(CO)</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>MnBr</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Ni(cod)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)P)(CO)</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>MnC(O)CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>NiCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PtCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>NiCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)SH</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((cyclohexyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)Pt(ethene)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>NiCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>S</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>(&mgr;-OTi(salen))</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>NiCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/CS</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((t-butyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)Pt(divinyldimethoxysilane)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>NiI</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/Li</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>((t-butyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)Pt(norbornene)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>NiI</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/Li</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>AuCl(P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Pd/C</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Bis(benzene)chromium(0)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>PdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(PEt</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ethylenebis(tetrahydroindenyl) TiF</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Pt/C</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Zn(Zn(C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/diamine</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Pt(acac)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>&plus; Pd/C</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Pt-black</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PtCl</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>*6H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>RUCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Zn(2-ethylhexanoate)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/NaBH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>RuCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ycl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>RuCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>*nH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O/CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Fe(CO)</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>RuHCl(CO)(i-C</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>7</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00045" LVL="2"><PTEXT><PDAT>Ethylene-bis(indenyl)Ti(1,1&prime;-binapth-2,2&prime;-diolate)</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="2"><PTEXT><PDAT>Ethylene-bis(indenyl)Ti(1,1&prime;-binapth-2,2&prime;-diolate)</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="2"><PTEXT><PDAT>Y(2,2&prime;-bis-(tert-butyldimethylsilylamido)-6,6&prime;-dimethylbiphenyl)(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(THF)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00048" LVL="2"><PTEXT><PDAT>(Ni&lcub;&eegr;-CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CHSiMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O&rcub;</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&lcub;&mgr;-(&eegr;-CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;SiMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O&rcub;)</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>V. SOLVENT</PDAT></STEXT></H>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>Depending on the choice of starting materials, the reaction may be &ldquo;neat&rdquo; (i.e. without added solvent) or in the presence of a solvent. In cases where the starting poly(alkylhydrosiloxane) is somewhat viscous, it is typically advantageous to include a solvent in the reaction mixture. The solvent is desirably chosen so that it does not react with other components of the reaction mixture and, preferably, does not strongly interact with the catalyst (if one is present). Exemplary solvents include relatively inert solvents that are capable of solublizing the reactants, such as hydrocarbon solvents, halogenated hydrocarbon solvents, and ethers. Suitable solvents include, without limitation, aromatic solvents (e.g. benzene, toluene, xylene, chlorobenzene and the like), hydrocarbon solvents (e.g. hexanes, heptanes, octanes, petroleum fractions), halogenated alkanes (e.g. CCl</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, chlorinated ethanes, and the like), ethers (e.g. dialkyl ethers, glymes, THF, and the like).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>VI. AMINOFUNCTIONAL ALKOXY POLYSILOXANES</PDAT></STEXT></H>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>A aminofunctional alkoxy polysiloxane may be formed from a polyhydrosiloxane and an aminoalcohol. The aminofunctional alkoxy polysiloxane may be linear or cyclic, depending on the nature of the polyhydrosiloxane selected.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>Examples of suitable linear aminofunctional alkoxy polysiloxane compounds that may be produced by the method include compounds having the formula (III): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00005">
<CHEMCDX ID="CHEMCDX-00005" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00005.CDX"/>
<CHEMMOL ID="CHEMMOL-00005" ALT="chemistry mol file" FILE="US06482912-20021119-C00005.MOL"/>
<EMI ID="EMI-C00005" ALT="embedded image" HE="43.68735" WI="149.54625" FILE="US06482912-20021119-C00005.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>wherein n is an integer from 2 to 1,000 and m is an integer from 0 to 1,000;</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group;</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is an aminofunctional alkoxy group;</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>More commonly, R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl and, preferably, methyl groups, and R</PDAT><HIL><SP><PDAT>4</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>are independently hydrogen, phenyl or methyl. Specific examples of suitable linear poly((aminofunctional alkoxy)-alkylsiloxane) compounds that may be produced by the present method include compounds having the formula (IV): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00006">
<CHEMCDX ID="CHEMCDX-00006" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00006.CDX"/>
<CHEMMOL ID="CHEMMOL-00006" ALT="chemistry mol file" FILE="US06482912-20021119-C00006.MOL"/>
<EMI ID="EMI-C00006" ALT="embedded image" HE="282.28095" WI="215.31825" FILE="US06482912-20021119-C00006.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>Examples of suitable cyclic aminofunctional alkoxy polysiloxane compounds that may be produced by the method include compounds having the formula (V): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00007">
<CHEMCDX ID="CHEMCDX-00007" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00007.CDX"/>
<CHEMMOL ID="CHEMMOL-00007" ALT="chemistry mol file" FILE="US06482912-20021119-C00007.MOL"/>
<EMI ID="EMI-C00007" ALT="embedded image" HE="78.246" WI="57.6072" FILE="US06482912-20021119-C00007.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00060" LVL="7"><PTEXT><PDAT>wherein q is an integer from 1 to 12; z is an integer from 0 to 11; and q&plus;z&equals;an integer from 3 to 12;</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group;</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is an aminofunctional alkoxy group;</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>Specific examples of suitable cyclic poly(aminofunctional alkoxy)-alkylsiloxane) compounds that may be produced by the method include compounds having the formula (VI): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00008">
<CHEMCDX ID="CHEMCDX-00008" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00008.CDX"/>
<CHEMMOL ID="CHEMMOL-00008" ALT="chemistry mol file" FILE="US06482912-20021119-C00008.MOL"/>
<EMI ID="EMI-C00008" ALT="embedded image" HE="83.5191" WI="198.02475" FILE="US06482912-20021119-C00008.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00066" LVL="7"><PTEXT><PDAT>where R&mdash; is an aminofunctional alkyl group, e.g., compounds having the formula (VI) where R is: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00009">
<CHEMCDX ID="CHEMCDX-00009" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00009.CDX"/>
<CHEMMOL ID="CHEMMOL-00009" ALT="chemistry mol file" FILE="US06482912-20021119-C00009.MOL"/>
<EMI ID="EMI-C00009" ALT="embedded image" HE="174.0123" WI="198.02475" FILE="US06482912-20021119-C00009.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>Suitable aminofunctional alkoxy polysiloxane compounds may be derived by selecting the appropriate aminoalcohol (i.e. the aminoalcohol selected corresponds to the alkoxy group of the aminofunctional alkoxy polysiloxane compound).</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>The amino group of the aminofunctional alkoxy polysiloxane compounds may be aliphatic or cycloaliphatic. Specific examples of suitable alkoxy groups of the aminofunctional alkoxy polysiloxane compound include groups corresponding to an aliphatic aminoalcohol represented by the formulas: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00010">
<CHEMCDX ID="CHEMCDX-00010" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00010.CDX"/>
<CHEMMOL ID="CHEMMOL-00010" ALT="chemistry mol file" FILE="US06482912-20021119-C00010.MOL"/>
<EMI ID="EMI-C00010" ALT="embedded image" HE="141.38145" WI="69.1173" FILE="US06482912-20021119-C00010.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>The aminofunctional group of the aminofunctional alkoxy polysiloxane compounds may include a piperidinyl group, a piperazinyl group and a pyrrolidinyl group. The aminofunctional group of the aminofunctional alkoxy polysiloxane compounds may include an aromatic amino group. Examples of suitable aromatic amino groups of the aminofunctional alkoxy polysiloxane compounds can include a pyridyl group, a pyrimidyl group and/or a pyrazinyl group. The aminofunctional group of the aminofunctional alkoxy polysiloxane compounds may include an amino-substituted aromatic group such as anilino groups and aminophenyl groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>The aminofunctional group of the aminofunctional alkoxy polysiloxane compounds may include diaminofunctional alkoxy groups. The diaminofunctional groups may be a 1,2-diaminofunctional alkoxy group and a 1,3-diaminofunctional alkoxy group. Suitable examples of diaminofunctional alkoxy groups include 1,3-diaminofunctional alkoxy groups having the formula (VII): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00011">
<CHEMCDX ID="CHEMCDX-00011" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00011.CDX"/>
<CHEMMOL ID="CHEMMOL-00011" ALT="chemistry mol file" FILE="US06482912-20021119-C00011.MOL"/>
<EMI ID="EMI-C00011" ALT="embedded image" HE="42.72345" WI="198.02475" FILE="US06482912-20021119-C00011.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00071" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SP><PDAT>6</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>7</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>are independently hydrogen or C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl, or R</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>7 </PDAT></SP></HIL><PDAT>form a C</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>cyclic group or R</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>form a C</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>cyclic group. Specific examples of such 1,3-diaminofunctional alkoxy groups include </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00012">
<CHEMCDX ID="CHEMCDX-00012" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00012.CDX"/>
<CHEMMOL ID="CHEMMOL-00012" ALT="chemistry mol file" FILE="US06482912-20021119-C00012.MOL"/>
<EMI ID="EMI-C00012" ALT="embedded image" HE="34.8138" WI="177.8679" FILE="US06482912-20021119-C00012.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>Specific examples of suitable alkoxy groups of the aminofunctional alkoxy polysiloxane compound corresponding to a diaminofunctional include groups having the formula (VIII):</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NR</PDAT><HIL><SP><PDAT>7</PDAT></SP></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>q</PDAT></SB></HIL><PDAT>NR</PDAT><HIL><SP><PDAT>8</PDAT></SP></HIL><PDAT>R</PDAT><HIL><SP><PDAT>9</PDAT></SP></HIL><PDAT>&emsp;&emsp;(VIII)</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00074" LVL="7"><PTEXT><PDAT>where q is 2 or 3; and R</PDAT><HIL><SP><PDAT>7</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>are independently hydrogen or C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>alkyl, or R</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>form a C</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>cyclic group. Specific examples of such diaminofunctional groups include groups represented by the formulas:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00005">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="1" colwidth="133pt" align="left"/>
<colspec colname="2" colwidth="140pt" align="left"/>
<thead>
<row>
<entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>(1) &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NHCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(4) &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NHCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>(2) &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NMeCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(5) &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NMeCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>(3) &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NHCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(6) &mdash;O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NHCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>The amino functional substituent that may be present in the aminofunctional alkoxy polysiloxane compounds could include heteroatoms in the backbone of the substituent itself according to suitable embodiments. Suitable examples of such heteroatoms in the backbone of the amino functional alkoxy substituent include compounds represented by the formulas:</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;(O&mdash;CHR&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&emsp;&emsp;(1)</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;(O&mdash;CHR&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;NHR&emsp;&emsp;(2)</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><F><PTEXT><PDAT>&mdash;(O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&emsp;&emsp;(3)</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>The poly((aminofunctional alkoxy)-alkylsiloxane) compounds are typically a liquid at room temperature, and have a viscosity less than about the viscosity of water. The poly((aminofunctional alkoxy)-alkylsiloxane) compounds are generally transparent and colorless.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>The poly((aminofunctional alkoxy)-alkylsiloxane) compounds generally have relatively good stability. For example, the poly((aminofunctional alkoxy)-alkylsiloxane) compounds are commonly stable for about five weeks at ambient temperature under an inert atmosphere (e.g. gas), and stable for about one day at ambient temperature and pressure. Stability of at least about several months may be achieved for the poly((aminofunctional alkoxy)-alkylsiloxane) compounds by storage under refrigeration (e.g. temperature less than about 10&deg; C.).</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>The aminofunctional alkoxy group typically includes no more than about 30 carbon atoms. The poly((aminofunctional alkoxy)-alkylsiloxane) compounds typically have a relatively high solubility in common organic solvents (which facilitates characterization by NMR, IR and UV), and relatively good solubility in water. The poly((aminofunctional alkoxy)-alkylsiloxane) may be a homopolymer, a blend, or a stoichiometric copolymer according to alternative embodiments.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>VII. UTILITY</PDAT></STEXT></H>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>Poly((aminofunctional alkoxy)-alkylsiloxane) compounds can have a variety of uses. For example, such compounds may be useful as a component of a coating composition. Depending on the particular application, a poly((aminofunctional alkoxy)-alkylsiloxane) compound may be used by itself to form a coating or may be formulated with other components known to those of skill in the art to form the coating composition. For example, a poly((aminofunctional alkoxy)-alkylsiloxane) may act as a crosslinking agent and/or curing accelerator in a coating composition, e.g., in an epoxy-based coating composition.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>In another embodiment, a poly((aminofunctional alkoxy)-alkylsiloxane) compound may be used as a &ldquo;primer&rdquo; component in a coating system (e.g. to adhere a topcoat to a substrate). The primer containing the poly ((aminofunctional alkoxy)-alkylsiloxane) and a topcoat (e.g. polyurethane may be applied to a substrate according to the following exemplary method. A substrate (e.g. aluminum 2024-T3) may be treated by cleaning its surface with a solvent (e.g. acetone). The primer may be applied to the substrate &ldquo;neat&rdquo; with an applicator such as a &ldquo;draw down&rdquo; bar. The primer may be dried at ambient temperature for about one day, and cured at about 45 C for about five hours. The topcoat may be applied to the primer with an applicator such as a &ldquo;draw down&rdquo; bar. The topcoat may be dried at ambient temperature for about one day, and subsequently cured at an elevated temperature (e.g. at about 45-50 C for a period of hours).</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>Other uses for the poly((aminofunctional alkoxy)-alkylsiloxane) compounds include applications in the production of adhesives, catalyst supports, ionically conductive materials, liquid crystals, crosslinking agents, conductive and electroluminescent polymers, electrochemical sensing devices, and nonlinear optical chromophores.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>VIII. EXAMPLES</PDAT></STEXT></H>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>In Examples 1-6, a poly((aminofunctional alkoxy)-alkylsiloxane) was formed by reacting a poly(alkylhydrosiloxane) and an aminoalcohol in deuterobenzene in the presence of a Rh(I) catalyst (((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>RhCl). Two methods were used to remove the spent catalyst. According to the first method (&ldquo;Method A&rdquo;), the reaction mixture was flushed through a ml syringe having a &ldquo;Kimwipe&rdquo; plug at the bottom, followed by a 3 ml silica gel plug (i.e. neutral, dried under vacuum and subsequently saturated with either benzene or toluene). On the occasions that excess aminoalcohol was present in the product mixture, it was removed by flushing the product mixture through a silica-gel plug (1 in.&times;1 cm diameter, with toluene solvent) where the aminoalcohol could be isolated as a secondary eluent. According to the second method (&ldquo;Method B&rdquo;), the reaction mixture was allowed to sit for about two days at ambient temperature, after which the catalyst precipitated out of solution as a red solid. The supernate was then removed from the solid with a syringe.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>For Examples 1-6, all operations were carried out under inert atmosphere (unless otherwise stated). Deuterated benzene (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) was purchased from Cambridge Isotope Laboratories, Inc. of Andover, Mass. and distilled over sodium under inert atmosphere prior to use. All other reagents were purchased from Sigma Aldrich Chemical Co., Inc. of Milwaukee, Wis. and used without further purification. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H and </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were obtained on a Varian Inova 400 MHz NMR commercially available from Varian, Inc. of Palo Alto, Calif. </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were obtained on a Varian Mercury 300 MHz NMR commercially available from Varian, Inc. of Palo Alto, Calif. NMR chemical shifts were referenced to a tetramethylsilane &dgr;&equals;0.00 ppm) external standard. Infrared analysis were performed using liquid cells on a Mattson 2020 series FT-Infrared Spectrometer commercially available from Mattson Instruments of Madison, Wis.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 1</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>bis-(Trimethylsiloxy)-1,3-dimethyl-1,3-(3-amino-1-propoxy)siloxane</PDAT></STEXT></H>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00013">
<CHEMCDX ID="CHEMCDX-00013" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00013.CDX"/>
<CHEMMOL ID="CHEMMOL-00013" ALT="chemistry mol file" FILE="US06482912-20021119-C00013.MOL"/>
<EMI ID="EMI-C00013" ALT="embedded image" HE="94.8024" WI="141.8634" FILE="US06482912-20021119-C00013.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>Deuterobenzene (1 ml), 3-amino-1-propanol (1.51 ml, 0.02 mol), and ((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>RhCl (0.162 g, 0.0002 mol) were introduced into a 25 ml &ldquo;Schlenk&rdquo; tube containing a magnetic stirring bar and sealed with a rubber septum. These components were degassed via 5 freeze/pump/thaw cycles and infused with argon. 1,3-Bis(trimethyl-siloxy)-1,3-dimethylsiloxane (3.30 ml, 0.02 mol) was injected into the reaction tube via a syringe while the other reactants were still frozen (to minimize autocatalization by the amine moieties) and 5 additional freeze/pump/thaw cycles were performed in order to further de-gas the reaction mixture.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>At this time, the reaction tube was submerged in a silicon oil bath preheated to 80&deg; C. As all of the reactants became homogenous, the reaction mixture became bright yellow in color and vigorous gas evolution (presumably H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) was observed. The reaction tube was kept under positive argon pressure during the entire course of the reaction in order to flush the H</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>gas from the reaction mixture. After approximately 1 hour, the reaction mixture became red/orange and the gas evolution subsided, the solution was stirred at 80&deg; C. for an additional hour to ensure substantially complete conversion. NMR and IR samples were extracted via a syringe and indicated complete conversion.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>After using Method A or Method B, the catalyst could not be detected by NMR in the product solution (catalyst arene substituent </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;7.17 m, 7.65 m; </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;128.92, 129.08, 132.14, 132.60, 132.723). The solvent was removed via reduced pressure. The isolated yield of the product using Method A was 72%, while the isolated yield of the product from Method B was 95%.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;0.104 (s, 1H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 0.08 (s, 3H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 0.78 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 1.52 (p, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, J</PDAT><HIL><SB><PDAT>2-1</PDAT></SB></HIL><PDAT>&equals;6.35 Hz, J</PDAT><HIL><SB><PDAT>2-3</PDAT></SB></HIL><PDAT>&equals;6.61 Hz), 2.63 (t, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, J</PDAT><HIL><SB><PDAT>2-3</PDAT></SB></HIL><PDAT>&equals;6.61 Hz), 3.74 (t, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, J</PDAT><HIL><SB><PDAT>1-2</PDAT></SB></HIL><PDAT>&equals;6.35 Hz).</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;&minus;4.14 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 1.43 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 36.31 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 38.85 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 59.88 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si &dgr;&equals;&minus;57.74 &amp; &minus;57.77 (rac &amp; meso diads &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 8.65 and 8.62 (rac and meso diads, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>The FT-Infrared spectra (in C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) for the product were as follows: &mdash;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>absorbances at 3391 cm</PDAT><HIL><SP><PDAT>&minus;1 </PDAT></SP></HIL><PDAT>and 3310 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 2</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT></PDAT></STEXT></H>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>Poly((3-amino-1-propoxy)methylsiloxane)</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>In a 25 ml &ldquo;Schlenk&rdquo; tube, 3-amino-1-propanol (1.51 ml, 0.02 mol) and ((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>RhCl (0.162 g, 0.0002 mol) were mixed in deuterobenzene (1 ml) and sealed with a rubber septum. These components were degassed via 5 freeze/pump/thaw cycles and infused with argon. Poly(methylhydro)siloxane (1.21 ml, 0.02 mol) was injected into the reaction tube via a syringe, while the other reactants were still frozen and 5 additional freeze/pump/thaw cycles were performed in order to further de-gas the reaction mixture.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>At this time, the reaction tube was submerged in a silicon oil bath preheated to 80&deg; C. As all of the reactants became homogenous, the reaction mixture became bright yellow in color and vigorous gas evolution (presumably H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) was observed. The reaction tube was kept under positive argon pressure during the entire course of the reaction in order to flush the H</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>gas from the reaction mixture. After approximately 1 hour, the reaction mixture became red/orange, and the gas evolution subsided. The solution was stirred at 80&deg; C. for an additional hour (e.g. for substantially complete conversion). NMR and IR samples were extracted via a syringe and indicated substantially complete conversion of Si&mdash;OH and OH bonds.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>The reaction mixture was allowed to sit for about two days at ambient temperature, after which the catalysts had precipitated out of solution as a red solid. The supernate was removed from the solid with a syringe (isolated yield of the product was 94%).</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;0.09 (bs, 3H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 0.22 (bs, approx. 1H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 0.87 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 1.58 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 2.67 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 3.81 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;&minus;2.50 to &minus;5.70 (multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 1.61 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 35.50 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 38.99 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 60.36 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si &dgr;&equals;&minus;57.4 to &minus;58.4 (multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 8.88 to 9.05 (multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>The FT-Infrared spectra (in C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) for the product were as follows: &mdash;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>absorbances at 3391 cm</PDAT><HIL><SP><PDAT>&minus;1 </PDAT></SP></HIL><PDAT>and 3310 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 3</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>bis-(Trimethylsiloxy)-1,3-dimethyl-1,3-(1,3-N,N-dimethylamino)-2-propoxy)siloxane</PDAT></STEXT></H>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00014">
<CHEMCDX ID="CHEMCDX-00014" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00014.CDX"/>
<CHEMMOL ID="CHEMMOL-00014" ALT="chemistry mol file" FILE="US06482912-20021119-C00014.MOL"/>
<EMI ID="EMI-C00014" ALT="embedded image" HE="87.85665" WI="210.49875" FILE="US06482912-20021119-C00014.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>Bis(trimethylsiloxy)-1,2-dimethyl-1,2-(1,3-(N,N-dimethylamino)-2-propoxy)siloxane was synthesized according to the method described in Example 2, except that N,N-1,3-dimethylamino,2-propanol (3.26 ml, 0.02 mol) was used instead of 3-amino-1-propanol. Method B was used to isolate the product in 97% yield.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;0.22 (s, 24H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 0.26 (s, 6H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 2.22 (s, 12H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 2.44 (dm, 4H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3)</PDAT></SB></HIL><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 4.15 (p, 1H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;&minus;2.53 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 1.87 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 46.55 ((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 64.32 ((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 69.99 ((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si &dgr;&equals;&minus;59.34 and &minus;58.40 (rac and meso diads, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 7.99 &amp; 7.74 (rac and meso diads, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 4</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Poly((1,3&mdash;N,N-dimethylamino-2-propoxy)methylsiloxane)</PDAT></STEXT></H>
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>Poly((1,3-N,N-dimethylamino-2-propoxy)methylsiloxane was synthesized according to the method described in Example 2, except that 1,3-N,N-dimethylamino-2-propanol (3.26 ml, 0.02 mol) was used instead of 3-amino-1-propanol. Method B was used to isolate the product in 97% yield.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;0.25 (s, 24H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 0.38 (s, 6H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 2.22 (s, 12H, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 2.44 (dm, 4H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 4.42 (p, 1H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;&minus;2.72 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 1.87 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 46.73 ((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 64.59 ((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 70.02 ((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si &dgr;&equals;&minus;58.0 to &minus;61.0 (multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 9.21 to 8.92 multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 5</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Cyclotetra(3-amino-1-propoxy)methylsiloxane</PDAT></STEXT></H>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>Cyclotetra(3-amino-1-propoxy)methylsiloxane was synthesized according to the method described in Example 2 except that cyclotetra(methylhydro)siloxane (7) (1.21 ml, 0.02 mol) was used in place of 1,3-bis(trimethylsiloxy)-1,3-dimethylsiloxane and 3-amino-1-propanol was used as the amino alcohol. Method B was used to isolate the product in 94% yield.</PDAT></PTEXT></PARA>
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;0.17 (bs, 3H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 0.80 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 1.65 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 2.75 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 3.91 (bs, 2H, &mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;&minus;3.00 to &minus;7.00 (multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 36.94 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 39.51 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 60.87 (&mdash;OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si &dgr;&equals;&minus;57.4 to &minus;59.5 (multiple peaks, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;).</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>FT-Infrared spectra for the product were as follows: IR in C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>: &mdash;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>absorbances at 3391 cm</PDAT><HIL><SP><PDAT>&minus;1 </PDAT></SP></HIL><PDAT>and 3310 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 6</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Cyclotetra(1,3-(N,N-dimethylamino)-2-propoxy)methylsiloxane</PDAT></STEXT></H>
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00015">
<CHEMCDX ID="CHEMCDX-00015" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00015.CDX"/>
<CHEMMOL ID="CHEMMOL-00015" ALT="chemistry mol file" FILE="US06482912-20021119-C00015.MOL"/>
<EMI ID="EMI-C00015" ALT="embedded image" HE="242.19405" WI="216.027" FILE="US06482912-20021119-C00015.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>Cyclotetra(1,3-(N,N-dimethylamino)-2-propoxy)methylsiloxane was prepared according to the method described in Example 2, except that cyclotetra(methylhydro)siloxane (1.21 ml, 0.02 mol) was used in place of 1,3-bis(trimethylsiloxy)-1,3-dimethylsiloxane, and 1,3-(N,N-dimethylamino)-2-propanol (3.26 ml, 0.02 mol) was used as the amino alcohol. Method B was used to isolate the product in 98% yield.</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H &dgr;&equals;0.42 (s, 6H, &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 2.22 (s, 12H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 2.47 (dm, 4H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 4.22 (p, 1H, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C &dgr;&equals;&minus;2.37 (&mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>13</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;), 46.98 (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 64.92 (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 70.65 (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si &dgr;&equals;&minus;58.0 to &minus;60.60 (multiple peaks &mdash;OSi(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)((CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH(&mdash;O)CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)O&mdash;).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>IX. Examples 7-10</PDAT></STEXT></H>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>In Examples 7-10, an aminofunctional alkoxy siloxane was formed by reacting a poly(methylhydro)siloxane (PMHS) with the corresponding amino alcohol in the presence of a rhodium catalyst. The reactions were monitored by multinuclear NMR. In a typical experiment, RhCl(PPh</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(0.04 mmol) was dissolved in benzene-d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, (0.5 mL) in a NMR tube, followed by the addition of benzyl alcohol (0.216 mL, 2 mmol) and (0.120 mL, 2 mmol). This mixture was degassed by 3-4 freeze pump-thaw cycles and heated in an oil bath at 78 C, just below the refluxing temperature, under a constant flow of argon. During the course of the reaction, evolution of a gas (presumably H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) was observed.</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>For Examples 7-10, all reactions were carried out under an atmosphere of argon. Air sensitive products and reagents were handled by standard &ldquo;Schlenk&rdquo; techniques. All solvents were dried and distilled from purple solutions of sodium/benzophenone or P</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>, and glassware was dried in an oven at 110-120&deg; C. prior to use. Poly(methylhydro)siloxane Me</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>Si&mdash;(O&mdash;SiMeH&mdash;)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;O&mdash;SiMe</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>&tilde;2000; n&equals;33-35) and RhCl(PPh3)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(99.99%) were obtained from Sigma Aldrich Chemical Co., Inc. of Milwaukee, Wis. and used as received. Commercially available alcohols were used without any further purification, except benzyl alcohol and 2,5-dimethoxybenzyl alcohol, which were distilled prior to use.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="0"><PTEXT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si, </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C, </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra were recorded on JEOL GSX270 and GSX400 spectrometers commercially available from JEOL USA, Inc. of Peabody, Mass. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H and </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C chemical shifts were measured against Me</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>Si using solvent resonances as standard locks. </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si chemical shifts were referenced to external Me</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>Si in the same solvent. Molecular weight of the polymers was determined by a Waters gel permeation chromatograph (GPC), commercially available from Waters Corporation of Milford, Mass. with polystyrene as the standard and THF as the solvent. IR spectra were recorded on a Matheson Instruments 2020 Galaxy Series spectrometer (commercially available from Matheson Instruments) as KBr pellets or solutions in CaF</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>cells. Elemental analyses were carried out by Galbraith Laboratories Inc. of Knoxville, Tenn.</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>The following method was used for EXAMPLES 7-10. In a &ldquo;Schlenk&rdquo; tube, RhCl(PPh</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(&tilde;36 mg, 0.04 mmol) was suspended in dry benzene (0.8 mL), followed by the addition of benzylalcohol (0.22 mL, 2 mmol) and PMHS (0.12 mL, 2 mmol). This mixture was degassed by 3-4 freeze pump-thaw cycles and heated in an oil bath at 78 C, under a constant flow of argon. The red color of the catalyst disappeared within about 15 minutes of heating and the reaction mixture turned yellow and homogeneous. During substantially the entire course of the reaction, evolution of H</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>was observed. After 24 hours, the mixture was cooled to room temperature, and passed through a dry silica gel pad and eluted with pentane/benzene (20/80). For gram scale preparations (4-7 gm) of these polymers, longer reaction times (48-72 h) were employed.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 7</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Poly(3-(2-pyridyl)-1-propoxy)methysiloxane)</PDAT></STEXT></H>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>A poly(3-(2-pyridyl)-1-propoxy)methysiloxane) product was made according to the following scheme by reacting poly(methylhydro)siloxane (n&equals;33-35) with 3-(2-pyridyl)-1-propanol: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00016">
<CHEMCDX ID="CHEMCDX-00016" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00016.CDX"/>
<CHEMMOL ID="CHEMMOL-00016" ALT="chemistry mol file" FILE="US06482912-20021119-C00016.MOL"/>
<EMI ID="EMI-C00016" ALT="embedded image" HE="230.4288" WI="309.15675" FILE="US06482912-20021119-C00016.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00127" LVL="0"><PTEXT><PDAT>Color changes during the course of the reaction provided an indication of the reaction progress. As the reaction proceeded, the yellow color turned orange and returned to light red after about 24 hours when the reaction was substantially completed. Solvent evaporation under reduced pressure provided the product to be recovered in a yield of 97%.</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR showed the absence of Si&mdash;H signals and Si&mdash;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>/O&mdash;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Ph resonances in a ratio consistent with the proposed structure. The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 0.13 (s, OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 0.30 (s, broad, SiMe); 4.84-4.90 (s, broad, OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); 7.14, 7.32 (broad, aromatics).</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 1.55 (OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); &minus;4.12 (broad, SiMe); 64.35 (broad, OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); 126.53, 127.14, 128.30, 140.44 (broad, aromatics).</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>After about 24 hours, the </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si spectrum displayed the formation of the product in essentially quantitative yield. The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &minus;56.63, &minus;56.7 (very small); &minus;57.26; &minus;57.34; &minus;57.41 (SiMe); &plus;9.62 (terminal OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>). Analysis calculated for C</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Si: C 57.83, H 6.02, Si 16.86; Found: C 57.85, H 6.00, Si 16.88.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>The molecular weight (M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>) determined by gel permeation chromatography (GPC) was 5600 (M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>/M</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&equals;1.19) relative to polystyrene standard, which was found in relative agreement with calculated values (M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>&tilde;5445-5775 for n&equals;32-35) indicating total substitution of Si&mdash;H bonds with backbone preservation. GPC(THF/polystyrene): M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>&equals;5600 (M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>/M</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&equals;1.19).</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>In order to access the stability of these polymers towards hydrolysis, the product was dissolved in benzene-D</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>and treated with 3-fold excess of D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O. Polymer degradation was monitored by NMR. After 3 hours at RT&lt;10%, conversion of SiOCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Ph bonds to SiOH/SiOSi bonds was observed. After 2.5 hours of heating at 78 C, only 25% of the SiOCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Ph bonds were cleaved.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 8</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Poly(3-(4-pyridyl)-1-propoxy)methysiloxane)</PDAT></STEXT></H>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>A poly(3-(4-pyridyl)-1-propoxy)methysiloxane) product was made according to the following scheme by reacting poly(methylhydro)siloxane (n&equals;33-35) with 3-(4-pyridyl)-1-propanol: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00017">
<CHEMCDX ID="CHEMCDX-00017" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00017.CDX"/>
<CHEMMOL ID="CHEMMOL-00017" ALT="chemistry mol file" FILE="US06482912-20021119-C00017.MOL"/>
<EMI ID="EMI-C00017" ALT="embedded image" HE="230.4288" WI="343.23345" FILE="US06482912-20021119-C00017.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>The product was recovered in a yield of 93%.</PDAT></PTEXT></PARA>
<PARA ID="P-00135" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 0.14 (s, OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 0.34 (s, broad, SiMe); 1.22 (t, broad, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 1.88 (m, broad, CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); 4.01 (t, broad, OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 1.42 (OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); &minus;0.5 (SiMe); 10.60 (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 24.70 (CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); 62.91 (OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &minus;57.94 (SiMe); &plus;8.51 (terminal OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 9</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Poly((N-methyl-4-piperidyloxy)methysiloxane)</PDAT></STEXT></H>
<PARA ID="P-00138" LVL="0"><PTEXT><PDAT>A poly((N-methyl-4-piperidyloxy)methysiloxane) product was made according to the following scheme by reacting poly(methylhydro)siloxane (n&equals;33-35) with N-methyl-4-piperidinol: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00018">
<CHEMCDX ID="CHEMCDX-00018" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00018.CDX"/>
<CHEMMOL ID="CHEMMOL-00018" ALT="chemistry mol file" FILE="US06482912-20021119-C00018.MOL"/>
<EMI ID="EMI-C00018" ALT="embedded image" HE="230.4288" WI="354.51675" FILE="US06482912-20021119-C00018.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>The product was recovered in a yield of 95%.</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 0.15 (s, OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); &minus;0.014 (s, broad, SiMe); 1.11 (d, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 4.12 (q, broad, OCH).</PDAT></PTEXT></PARA>
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 1.72 (OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); &minus;3.02 (SiMe); 15.69 (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 64.60 (OCH).</PDAT></PTEXT></PARA>
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &minus;60.01 (broad, SiMe); &plus;7.95 (terminal OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 10</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Poly(4-(N,N-dimethylamino)-phenoxy)methysiloxane)</PDAT></STEXT></H>
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>A poly(4-(N,N-dimethylamino)-phenoxy)methysiloxane) product was made according to the following scheme by reacting poly(methylhydro)siloxane (n&equals;33-35) with 4-(N,N-dimethylamino)-phenol: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00019">
<CHEMCDX ID="CHEMCDX-00019" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00019.CDX"/>
<CHEMMOL ID="CHEMMOL-00019" ALT="chemistry mol file" FILE="US06482912-20021119-C00019.MOL"/>
<EMI ID="EMI-C00019" ALT="embedded image" HE="230.4288" WI="392.44905" FILE="US06482912-20021119-C00019.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>The product was recovered in a yield of 91%.</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; 0.13 (s, OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); 0.32 (s, broad, SiMe); 2.12 (m, broad, CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); 2.91 (t, broad, CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); 3.92 (t, broad, OCH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>); &lcub;6.69 (t, broad), 6.94 (d, broad), 7.18 (m, broad), 8.43 (broad) aromatics&rcub;.</PDAT></PTEXT></PARA>
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si NMR spectra for the product were as follows: </PDAT><HIL><SP><PDAT>29</PDAT></SP></HIL><PDAT>Si-NMR (C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, 25&deg; C.); &dgr; &minus;57.20, &minus;57.95, &minus;58.06, &minus;58.16 (SiMe); &plus;9.08 (terminal OSiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>). Analysis calculated for C</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>13</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>NSi: C 55.38, H 6.66, N 7.17; Found: C 55.39, H 6.67, N 7.19.</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>GPC(THF/polystyrene): M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>&equals;6538 (M</PDAT><HIL><SB><PDAT>w</PDAT></SB></HIL><PDAT>/M</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&equals;1.12).</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="0"><PTEXT><PDAT>It is important to note that the construction and arrangement of the elements of the poly((aminofunctional alkoxy)-alkylsiloxane) compounds as shown and described in the various embodiments is illustrative only. Although only a few embodiments of the present inventions have been described in detail in this disclosure, those skilled in the art who review this disclosure will readily appreciate that many modifications are possible without materially departing from the novel teachings and advantages of the subject matter described in this disclosure. Other substitutions, modifications, changes and omissions may be made in the design, operating conditions and arrangement of the exemplary embodiments without departing from the spirit of the present invention.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>1. A method of producing a polyaminofunctional alkoxy polysiloxane comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>reacting a polyhydrosiloxane with an alcohol reactant in the presence of a dehydrogenative coupling catalyst to form a polyaminofunctional alkoxy polysiloxane; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein the alcohol reactant includes an polyaminofunctional alcohol. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>2. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein the dehydrogenative coupling catalyst includes a rhodium compound.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>3. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein the dehydrogenative coupling catalyst includes ((C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>P)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>RhCl.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00152" LVL="0"><PTEXT><PDAT>4. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein the polyhydrosiloxane is reacted with the polyaminofunctional alcohol in a solvent which includes a hydrocarbon solvent, a halogenated hydrocarbon solvent, an ether or a mixture thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00153" LVL="0"><PTEXT><PDAT>5. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein the polyhydrosiloxane is reacted with the polyaminofunctional alcohol under substantially anhydrous or deoxygenated conditions.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00154" LVL="0"><PTEXT><PDAT>6. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein the polyhydrosiloxane is reacted with the polyaminofunctional alcohol at a temperature of about 0&deg; C. to 200&deg; C.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00155" LVL="0"><PTEXT><PDAT>7. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> comprising reacting a cyclic polyhydrosiloxane with the polyaminofunctional alcohol to form a cyclic polyaminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00156" LVL="0"><PTEXT><PDAT>8. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> comprising reacting a linear polyhydrosiloxane with the polyaminofunctional alcohol to form a linear polyaminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00157" LVL="0"><PTEXT><PDAT>9. A method of producing an aminofunctional alkoxy polysiloxane comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>reacting a polyhydrosiloxane with an alcohol reactant in the presence of a dehydrogenative coupling catalyst to form an aminofunctional alkoxy polysiloxane; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein the aminofunctional alkoxy polysiloxane includes an aromatic amino group. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>10. The method of producing the aminofunctional alkoxy polysiloxane of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein the aromatic amino group includes a pyridyl group, a pyrimidyl group or a pyrazinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>11. The method of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> comprising reacting a cyclic polyhydrosiloxane with the aminofunctional alcohol to form a cyclic aminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>12. The method of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> comprising reacting a linear polyhydrosiloxane with the aminofunctional alcohol to form a linear aminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>13. The method of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> wherein the dehydrogenative coupling catalyst includes a rhodium compound.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00162" LVL="0"><PTEXT><PDAT>14. A linear polyaminofunctional alkoxy polysiloxane having the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00020">
<CHEMCDX ID="CHEMCDX-00020" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00020.CDX"/>
<CHEMMOL ID="CHEMMOL-00020" ALT="chemistry mol file" FILE="US06482912-20021119-C00020.MOL"/>
<EMI ID="EMI-C00020" ALT="embedded image" HE="44.87805" WI="141.1263" FILE="US06482912-20021119-C00020.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00163" LVL="7"><PTEXT><PDAT>wherein n is an integer from 2 to 1,000 and m is an integer from 0 to 1,000;</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is a polyaminofunctional alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00164" LVL="0"><PTEXT><PDAT>15. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently lower alkyl.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00165" LVL="0"><PTEXT><PDAT>16. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is methyl.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00166" LVL="0"><PTEXT><PDAT>17. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes an aliphatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00167" LVL="0"><PTEXT><PDAT>18. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a cycloaliphatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00168" LVL="0"><PTEXT><PDAT>19. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a primary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00169" LVL="0"><PTEXT><PDAT>20. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a secondary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>21. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a tertiary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00022">
<PARA ID="P-00171" LVL="0"><PTEXT><PDAT>22. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes an aminophenyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00023">
<PARA ID="P-00172" LVL="0"><PTEXT><PDAT>23. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a piperidinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00024">
<PARA ID="P-00173" LVL="0"><PTEXT><PDAT>24. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a piperazinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00025">
<PARA ID="P-00174" LVL="0"><PTEXT><PDAT>25. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a pyrrolidinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00026">
<PARA ID="P-00175" LVL="0"><PTEXT><PDAT>26. The polysiloxane of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein n is an integer of 2 and m is an integer of 0.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00027">
<PARA ID="P-00176" LVL="0"><PTEXT><PDAT>27. A linear aminofunctional alkoxy polysiloxane having the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00021">
<CHEMCDX ID="CHEMCDX-00021" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00021.CDX"/>
<CHEMMOL ID="CHEMMOL-00021" ALT="chemistry mol file" FILE="US06482912-20021119-C00021.MOL"/>
<EMI ID="EMI-C00021" ALT="embedded image" HE="44.87805" WI="141.1263" FILE="US06482912-20021119-C00021.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00177" LVL="7"><PTEXT><PDAT>wherein n is an integer from 2 to 1,000 and m is an integer from 0 to 1,000;</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is an aminofunctional alkoxy group that includes an aromatic amino group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00028">
<PARA ID="P-00178" LVL="0"><PTEXT><PDAT>28. The polysiloxane of </PDAT><CLREF ID="CLM-00027"><PDAT>claim 27</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyridyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00029">
<PARA ID="P-00179" LVL="0"><PTEXT><PDAT>29. The polysiloxane of </PDAT><CLREF ID="CLM-00027"><PDAT>claim 27</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyrimidyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00030">
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>30. The polysiloxane of </PDAT><CLREF ID="CLM-00027"><PDAT>claim 27</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyrazinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00031">
<PARA ID="P-00181" LVL="0"><PTEXT><PDAT>31. The polysiloxane of </PDAT><CLREF ID="CLM-00027"><PDAT>claim 27</PDAT></CLREF><PDAT> wherein n is an integer of 2 and m is an integer of 0.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00032">
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>32. A cyclic polyaminofunctional alkoxy polysiloxane having the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00022">
<CHEMCDX ID="CHEMCDX-00022" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00022.CDX"/>
<CHEMMOL ID="CHEMMOL-00022" ALT="chemistry mol file" FILE="US06482912-20021119-C00022.MOL"/>
<EMI ID="EMI-C00022" ALT="embedded image" HE="78.246" WI="57.6072" FILE="US06482912-20021119-C00022.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00183" LVL="7"><PTEXT><PDAT>wherein q is an integer from 1 to 12; z is an integer from 0 to 11; and q&plus;z&equals;an integer from 3 to 12;</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is a polyaminofunctional alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00033">
<PARA ID="P-00184" LVL="0"><PTEXT><PDAT>33. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes an aliphatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00034">
<PARA ID="P-00185" LVL="0"><PTEXT><PDAT>34. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a cycloaliphatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00035">
<PARA ID="P-00186" LVL="0"><PTEXT><PDAT>35. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a primary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00036">
<PARA ID="P-00187" LVL="0"><PTEXT><PDAT>36. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a secondary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00037">
<PARA ID="P-00188" LVL="0"><PTEXT><PDAT>37. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a tertiary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00038">
<PARA ID="P-00189" LVL="0"><PTEXT><PDAT>38. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes an aminophenyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00039">
<PARA ID="P-00190" LVL="0"><PTEXT><PDAT>39. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a piperidinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00040">
<PARA ID="P-00191" LVL="0"><PTEXT><PDAT>40. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a piperazinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00041">
<PARA ID="P-00192" LVL="0"><PTEXT><PDAT>41. The polysiloxane of </PDAT><CLREF ID="CLM-00032"><PDAT>claim 32</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy group includes a pyrrolidinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00042">
<PARA ID="P-00193" LVL="0"><PTEXT><PDAT>42. A cyclic aminofunctional alkoxy polysiloxane having the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00023">
<CHEMCDX ID="CHEMCDX-00023" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00023.CDX"/>
<CHEMMOL ID="CHEMMOL-00023" ALT="chemistry mol file" FILE="US06482912-20021119-C00023.MOL"/>
<EMI ID="EMI-C00023" ALT="embedded image" HE="78.246" WI="57.6072" FILE="US06482912-20021119-C00023.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00194" LVL="7"><PTEXT><PDAT>wherein q is an integer from 1 to 12; z is an integer from 0 to 11; and q&plus;z&equals;an integer from 3 to 12;</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is an aminofunctional alkoxy group that includes an aromatic amino group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00043">
<PARA ID="P-00195" LVL="0"><PTEXT><PDAT>43. The polysiloxane of </PDAT><CLREF ID="CLM-00042"><PDAT>claim 42</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyridyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00044">
<PARA ID="P-00196" LVL="0"><PTEXT><PDAT>44. The polysiloxane of </PDAT><CLREF ID="CLM-00042"><PDAT>claim 42</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyrimidyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00045">
<PARA ID="P-00197" LVL="0"><PTEXT><PDAT>45. The polysiloxane of </PDAT><CLREF ID="CLM-00042"><PDAT>claim 42</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyrazinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00046">
<PARA ID="P-00198" LVL="0"><PTEXT><PDAT>46. A coating composition comprising a polyaminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00047">
<PARA ID="P-00199" LVL="0"><PTEXT><PDAT>47. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes an aliphatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00048">
<PARA ID="P-00200" LVL="0"><PTEXT><PDAT>48. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a cycloaliphatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00049">
<PARA ID="P-00201" LVL="0"><PTEXT><PDAT>49. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a primary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00050">
<PARA ID="P-00202" LVL="0"><PTEXT><PDAT>50. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a secondary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00051">
<PARA ID="P-00203" LVL="0"><PTEXT><PDAT>51. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a tertiary amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00052">
<PARA ID="P-00204" LVL="0"><PTEXT><PDAT>52. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes an aminophenyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00053">
<PARA ID="P-00205" LVL="0"><PTEXT><PDAT>53. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a piperidinyl group, a piperazinyl group or a pyrrolidinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00054">
<PARA ID="P-00206" LVL="0"><PTEXT><PDAT>54. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a cyclic polyaminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00055">
<PARA ID="P-00207" LVL="0"><PTEXT><PDAT>55. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polyaminofunctional alkoxy polysiloxane includes a linear polyaminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00056">
<PARA ID="P-00208" LVL="0"><PTEXT><PDAT>56. The coating composition of </PDAT><CLREF ID="CLM-00046"><PDAT>claim 46</PDAT></CLREF><PDAT> wherein the polysiloxane includes a compound of the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00024">
<CHEMCDX ID="CHEMCDX-00024" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00024.CDX"/>
<CHEMMOL ID="CHEMMOL-00024" ALT="chemistry mol file" FILE="US06482912-20021119-C00024.MOL"/>
<EMI ID="EMI-C00024" ALT="embedded image" HE="44.87805" WI="141.1263" FILE="US06482912-20021119-C00024.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00209" LVL="7"><PTEXT><PDAT>wherein n is an integer from 2 to 1,000 and m is an integer from 0 to 1,000;</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is a polyaminofunctional alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00057">
<PARA ID="P-00210" LVL="0"><PTEXT><PDAT>57. A coating composition comprising an aminofunctional alkoxy polysiloxane that includes an aromatic amino group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00058">
<PARA ID="P-00211" LVL="0"><PTEXT><PDAT>58. The coating composition of </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyridyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00059">
<PARA ID="P-00212" LVL="0"><PTEXT><PDAT>59. The coating composition of </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyrimidyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00060">
<PARA ID="P-00213" LVL="0"><PTEXT><PDAT>60. The coating composition of </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT> wherein the aromatic amino group includes a pyrazinyl group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00061">
<PARA ID="P-00214" LVL="0"><PTEXT><PDAT>61. The coating composition of </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT> wherein the aminofunctional alkoxy polysiloxane includes a cyclic aminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00062">
<PARA ID="P-00215" LVL="0"><PTEXT><PDAT>62. The coating composition of </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT> wherein the aminofunctional alkoxy polysiloxane includes a linear aminofunctional alkoxy polysiloxane.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00063">
<PARA ID="P-00216" LVL="0"><PTEXT><PDAT>63. The coating composition of </PDAT><CLREF ID="CLM-00057"><PDAT>claim 57</PDAT></CLREF><PDAT> wherein the polysiloxane includes a compound of the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00025">
<CHEMCDX ID="CHEMCDX-00025" ALT="chemistry chemdraw file" FILE="US06482912-20021119-C00025.CDX"/>
<CHEMMOL ID="CHEMMOL-00025" ALT="chemistry mol file" FILE="US06482912-20021119-C00025.MOL"/>
<EMI ID="EMI-C00025" ALT="embedded image" HE="44.87805" WI="141.1263" FILE="US06482912-20021119-C00025.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00217" LVL="7"><PTEXT><PDAT>wherein n is an integer from 2 to 1,000 and m is an integer from 0 to 1,000;</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and R</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>are independently C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>is an aminofunctional alkoxy group that includes an aromatic amino group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl or an alkoxy group; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>is hydrogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group.</PDAT></PTEXT></CLMSTEP>
</CLM>
</CL>
</SDOCL>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06482949-20021119-C00001.CDX SYSTEM "US06482949-20021119-C00001.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00001.MOL SYSTEM "US06482949-20021119-C00001.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00001.TIF SYSTEM "US06482949-20021119-C00001.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00002.CDX SYSTEM "US06482949-20021119-C00002.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00002.MOL SYSTEM "US06482949-20021119-C00002.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00002.TIF SYSTEM "US06482949-20021119-C00002.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00003.CDX SYSTEM "US06482949-20021119-C00003.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00003.MOL SYSTEM "US06482949-20021119-C00003.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00003.TIF SYSTEM "US06482949-20021119-C00003.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00004.CDX SYSTEM "US06482949-20021119-C00004.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00004.MOL SYSTEM "US06482949-20021119-C00004.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00004.TIF SYSTEM "US06482949-20021119-C00004.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00005.CDX SYSTEM "US06482949-20021119-C00005.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00005.MOL SYSTEM "US06482949-20021119-C00005.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00005.TIF SYSTEM "US06482949-20021119-C00005.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00006.CDX SYSTEM "US06482949-20021119-C00006.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00006.MOL SYSTEM "US06482949-20021119-C00006.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00006.TIF SYSTEM "US06482949-20021119-C00006.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00007.CDX SYSTEM "US06482949-20021119-C00007.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00007.MOL SYSTEM "US06482949-20021119-C00007.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00007.TIF SYSTEM "US06482949-20021119-C00007.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00008.CDX SYSTEM "US06482949-20021119-C00008.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00008.MOL SYSTEM "US06482949-20021119-C00008.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00008.TIF SYSTEM "US06482949-20021119-C00008.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00009.CDX SYSTEM "US06482949-20021119-C00009.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00009.MOL SYSTEM "US06482949-20021119-C00009.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00009.TIF SYSTEM "US06482949-20021119-C00009.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00010.CDX SYSTEM "US06482949-20021119-C00010.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00010.MOL SYSTEM "US06482949-20021119-C00010.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00010.TIF SYSTEM "US06482949-20021119-C00010.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00011.CDX SYSTEM "US06482949-20021119-C00011.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00011.MOL SYSTEM "US06482949-20021119-C00011.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00011.TIF SYSTEM "US06482949-20021119-C00011.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00012.CDX SYSTEM "US06482949-20021119-C00012.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00012.MOL SYSTEM "US06482949-20021119-C00012.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00012.TIF SYSTEM "US06482949-20021119-C00012.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00013.CDX SYSTEM "US06482949-20021119-C00013.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00013.MOL SYSTEM "US06482949-20021119-C00013.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00013.TIF SYSTEM "US06482949-20021119-C00013.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00014.CDX SYSTEM "US06482949-20021119-C00014.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00014.MOL SYSTEM "US06482949-20021119-C00014.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00014.TIF SYSTEM "US06482949-20021119-C00014.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00015.CDX SYSTEM "US06482949-20021119-C00015.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00015.MOL SYSTEM "US06482949-20021119-C00015.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00015.TIF SYSTEM "US06482949-20021119-C00015.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00016.CDX SYSTEM "US06482949-20021119-C00016.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00016.MOL SYSTEM "US06482949-20021119-C00016.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00016.TIF SYSTEM "US06482949-20021119-C00016.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00017.CDX SYSTEM "US06482949-20021119-C00017.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00017.MOL SYSTEM "US06482949-20021119-C00017.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00017.TIF SYSTEM "US06482949-20021119-C00017.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00018.CDX SYSTEM "US06482949-20021119-C00018.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00018.MOL SYSTEM "US06482949-20021119-C00018.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00018.TIF SYSTEM "US06482949-20021119-C00018.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00019.CDX SYSTEM "US06482949-20021119-C00019.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00019.MOL SYSTEM "US06482949-20021119-C00019.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00019.TIF SYSTEM "US06482949-20021119-C00019.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00020.CDX SYSTEM "US06482949-20021119-C00020.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00020.MOL SYSTEM "US06482949-20021119-C00020.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00020.TIF SYSTEM "US06482949-20021119-C00020.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00021.CDX SYSTEM "US06482949-20021119-C00021.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00021.MOL SYSTEM "US06482949-20021119-C00021.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00021.TIF SYSTEM "US06482949-20021119-C00021.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00022.CDX SYSTEM "US06482949-20021119-C00022.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00022.MOL SYSTEM "US06482949-20021119-C00022.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00022.TIF SYSTEM "US06482949-20021119-C00022.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00023.CDX SYSTEM "US06482949-20021119-C00023.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00023.MOL SYSTEM "US06482949-20021119-C00023.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00023.TIF SYSTEM "US06482949-20021119-C00023.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00024.CDX SYSTEM "US06482949-20021119-C00024.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00024.MOL SYSTEM "US06482949-20021119-C00024.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00024.TIF SYSTEM "US06482949-20021119-C00024.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00025.CDX SYSTEM "US06482949-20021119-C00025.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00025.MOL SYSTEM "US06482949-20021119-C00025.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00025.TIF SYSTEM "US06482949-20021119-C00025.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00026.CDX SYSTEM "US06482949-20021119-C00026.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00026.MOL SYSTEM "US06482949-20021119-C00026.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00026.TIF SYSTEM "US06482949-20021119-C00026.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00027.CDX SYSTEM "US06482949-20021119-C00027.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00027.MOL SYSTEM "US06482949-20021119-C00027.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00027.TIF SYSTEM "US06482949-20021119-C00027.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00028.CDX SYSTEM "US06482949-20021119-C00028.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00028.MOL SYSTEM "US06482949-20021119-C00028.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00028.TIF SYSTEM "US06482949-20021119-C00028.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00029.CDX SYSTEM "US06482949-20021119-C00029.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00029.MOL SYSTEM "US06482949-20021119-C00029.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00029.TIF SYSTEM "US06482949-20021119-C00029.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00030.CDX SYSTEM "US06482949-20021119-C00030.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00030.MOL SYSTEM "US06482949-20021119-C00030.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00030.TIF SYSTEM "US06482949-20021119-C00030.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00031.CDX SYSTEM "US06482949-20021119-C00031.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00031.MOL SYSTEM "US06482949-20021119-C00031.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00031.TIF SYSTEM "US06482949-20021119-C00031.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00032.CDX SYSTEM "US06482949-20021119-C00032.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00032.MOL SYSTEM "US06482949-20021119-C00032.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00032.TIF SYSTEM "US06482949-20021119-C00032.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00033.CDX SYSTEM "US06482949-20021119-C00033.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00033.MOL SYSTEM "US06482949-20021119-C00033.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00033.TIF SYSTEM "US06482949-20021119-C00033.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-C00034.CDX SYSTEM "US06482949-20021119-C00034.CDX" NDATA CDX>
<!ENTITY US06482949-20021119-C00034.MOL SYSTEM "US06482949-20021119-C00034.MOL" NDATA MOL>
<!ENTITY US06482949-20021119-C00034.TIF SYSTEM "US06482949-20021119-C00034.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-D00000.TIF SYSTEM "US06482949-20021119-D00000.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-D00001.TIF SYSTEM "US06482949-20021119-D00001.TIF" NDATA TIF>
<!ENTITY US06482949-20021119-D00002.TIF SYSTEM "US06482949-20021119-D00002.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06482949</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021119</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09579040</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20000526</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C07D40314</PDAT></B511>
<B512><PDAT>C07D47114</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>544343</PDAT></B521>
<B522><PDAT>544344</PDAT></B522>
<B522><PDAT>544353</PDAT></B522>
<B522><PDAT>544354</PDAT></B522>
<B522><PDAT>544355</PDAT></B522>
<B522><PDAT>544356</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Colormetric sensor compositions and methods</PDAT></STEXT></B540>
<B560>
<B562><NCIT><STEXT><PDAT>Hawley, Gessner, &ldquo;The condensed Chemical Dictonary&rdquo;, 1977, Van Nostrand, New York, pp. 419 and 436.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cram, D.J. and Hammond, G.S. &ldquo;Organic Chemistry, 2nd Ed.&rdquo;, McGraw-Hill, New York, 1964, p. 18 and .* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>John D. Roberts and Marjorie C. Caserio, &ldquo;Basic Principles of Organic Chemistry&rdquo;, Benjamin, New York, 1964, pp. 18-19 and 966-967.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Streitwieser, A. and Heathcock, C.H., &ldquo;Introduction to Organic Chemistry, 2nd Ed.&rdquo;, Macmillan, New York, 1981, p. 1061.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Fessenden, R.J. and Fessenden, J.S., &ldquo;Organic Chemistry&rdquo;, 1982, Willard Grant Press, Boston, p. 451.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kurapov et al, Chemical Abstract 108:96635 for SU 1348335.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Black et al J. Am. Chem. Soc. 121 (1999) 10438-10439.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Gale et al. </PDAT><HIL><ITALIC><PDAT>Chem. Commun</PDAT></ITALIC></HIL><PDAT>. 1998, 1-8. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bianchi, A. et al. Dietrich, B.; Hosseini, M.W. in </PDAT><HIL><ITALIC><PDAT>Supramolecular Chemistry of Anions</PDAT></ITALIC></HIL><PDAT>; Wiley-VCH: New York, 1997, pp 45-62. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Schmidtchen, F.P. </PDAT><HIL><ITALIC><PDAT>Nachr. Chem, Tech. Lab</PDAT></ITALIC></HIL><PDAT>. 1988, 36, 8-17. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>K.L. Kirk </PDAT><HIL><ITALIC><PDAT>Biochemistry of the Halogens and Inorganic Halides </PDAT></ITALIC></HIL><PDAT>Plenum Press: New York, 1991, p 58. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B.L. Riggs </PDAT><HIL><ITALIC><PDAT>Bone and Mineral Research, Annual 2 </PDAT></ITALIC></HIL><PDAT>Elsevier: Amsterdam, 1984, pp 366-393. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>M. Kleerekoper </PDAT><HIL><ITALIC><PDAT>Endocrinol. Metab. Clinic</PDAT></ITALIC></HIL><PDAT>. North Am. 1998, 27, 441-452. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>A. Wiseman </PDAT><HIL><ITALIC><PDAT>Handbook of Experimental Pharmacology </PDAT></ITALIC></HIL><PDAT>XX/2:.; Part 2, Springer-Verlag: Berlin, 1970, pp 48-97. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sessler, J.L. et al. </PDAT><HIL><ITALIC><PDAT>Anion Advances in Supramolecular Chemistry</PDAT></ITALIC></HIL><PDAT>; Lehn, J.M., Ed; JAI Press Inc., 1997; vol. 4, pp 97-142. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Gale, P.A., et al. J. Am. Chem. Soc. 1996, 118, 5140-5141. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sessler, J.L., et al. Chem. Eur. J. 1998, 4, 1095-1099. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Dietrich, B.; et al. J. Am. Chem. Soc. 1981, 103, 1282-1283. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hosseini, M.W., et al. Helvetica Chimica Acta 1988,, 71, 789-756. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Dietrich, B., et al. Helvetica Chimica Acta 1979, 62, 2763-2787. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Metzger, A. et al. Chem. Int. Ed. Engl. 1997, 36, 862-865. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Oddo, B. Gazz Chim. Ital. 1911, 41, 248-255. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Behr, D.; et al. Acta Chem. Scand. 1973, 27, 2411-2414. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sessler, J. L., et al. New J. Chem. 1992, 16, 541-544. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cheeseman, G. W. H. 1962, J. Chem. Soc., 1170-1176. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>H. Fischer; H. Orth in &ldquo;</PDAT><HIL><ITALIC><PDAT>Die Chemie Des Pyrrols</PDAT></ITALIC></HIL><PDAT>,&rdquo; p. 381; I. Band, Ed., Akademische Verlagsgesellschaft, M.B.H., Leipzig, 1934.</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>22</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>544343</PDAT></B582>
<B582><PDAT>544344</PDAT></B582>
<B582><PDAT>544354</PDAT></B582>
<B582><PDAT>544355</PDAT></B582>
<B582><PDAT>544356</PDAT></B582>
<B582><PDAT>544353</PDAT></B582>
</B580>
<B590><B595><PDAT>2</PDAT></B595><B596><PDAT>2</PDAT></B596><B597US/>
</B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/136467</PDAT></DNUM><DATE><PDAT>19990528</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Jonathan</PDAT></FNM><SNM><STEXT><PDAT>Sessler</PDAT></STEXT></SNM></NAM>
<ADR>
<STR><PDAT>5005 Crestway Dr.</PDAT></STR>
<CITY><PDAT>Austin</PDAT></CITY>
<STATE><PDAT>TX</PDAT></STATE>
<PCODE><PDAT>78731</PDAT></PCODE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Bruno</PDAT></FNM><SNM><STEXT><PDAT>Andrioletti</PDAT></STEXT></SNM></NAM>
<ADR>
<STR><PDAT>44, Rue Ren&eacute; Hamon</PDAT></STR>
<CITY><PDAT>94800 Villejuif</PDAT></CITY>
<CTRY><PDAT>FR</PDAT></CTRY>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Andrew Carl</PDAT></FNM><SNM><STEXT><PDAT>Try</PDAT></STEXT></SNM></NAM>
<ADR>
<STR><PDAT>4/141 Croydon Road</PDAT></STR>
<CITY><PDAT>Croydon, NSW, 2132</PDAT></CITY>
<CTRY><PDAT>AU</PDAT></CTRY>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Christopher</PDAT></FNM><SNM><STEXT><PDAT>Black</PDAT></STEXT></SNM></NAM>
<ADR>
<STR><PDAT>1214 Lacey Oak Loop</PDAT></STR>
<CITY><PDAT>Round Rock</PDAT></CITY>
<STATE><PDAT>TX</PDAT></STATE>
<PCODE><PDAT>78681</PDAT></PCODE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Mukund J.</PDAT></FNM><SNM><STEXT><PDAT>Shah</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1624</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention provides novel compounds exemplified by pyrrolic nitrogens used as anion and neutral species recognition elements with an aromatic core as a signal group. Described are methods for the synthesis of various pyrrole aryl compounds as well as various applications for these compounds. Methods of use include the binding and detection of specific analytes in a mixture and, in some examples, the separation of the analyte from the mixture. Additional methods of use include the transport of therapeutic agents and the sensing of components, degradants, and impurities in foodstuffs.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application claims priority to U.S. Provisional Application No. 60/136,467 filed May 28, 1999.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>The government owns rights in the present invention pursuant to National Institutes of Health (grant no. GM 58907 to Jonathon L. Sessler), the National Science Foundation (CHE-9725399 to Jonathan L. Sessler), the Texas ARP (grant 003658-102 to JLS) and a NIH Postdoctoral Fellowship to Christopher B. Black.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>1. Field of the Invention</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>The invention relates generally to compositions and methods for binding and optically sensing anions, cations, and neutral species. Analytical methods for such species is the primary goal of optical sensing. These methods may be qualitative or quantitative. In particular, compositions containing pyrroles as the key recognition element and a quinoxaline backbone as part of the compound, are shown to provide a system with a built-in optical probe for selective sensing.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>2. Description of Related Art</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>In the recent decades, supramolecular chemists have devoted considerable effort to developing systems capable of recognizing, sensing, and transporting anions (Dietrich, et al., 1997). This is an area of effort that is considered both timely and important. Indeed, some 70 to 75% of all natural biological processes are thought to involve a negatively charged species (Schmidtchen, 1988).</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>Anion recognition constitutes an important problem area within the generalized field of supramolecular chemistry. Not surprisingly, therefore, it has been pursued extensively, particularly within the calixarene domain. Indeed, most attention has focused on calixarene systems that have been modified, via attachment to, or reaction with, electron deficient metal centers, so as to make more electrophilic the normally &pgr;-electron rich calixarene moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>Anions constitute key components in food stuffs (e.g., fluoride, citrate and benzoate) and are products for, and pollutants from, modern agriculture (e.g., phosphate and nitrate) and can also act as potent toxins (e.g. cyanide). One anion, pertechnetate, is critical to radio-diagnostic and therapy procedures and, in a different isotopic form, is a major radioactive pollutant. Given these few examples, it is clearly important that we have a means to readily monitor the presence of these species in our everyday environment.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Among the range of biologically important anions, fluoride is of particular interest due to its established role in preventing dental caries (Kirk, 1991). Fluoride anion is also being explored extensively as a treatment for osteoporosis, (Riggs, 1984 and Kleerekoper, 1998) and, on a less salubrious level, can lead to fluorosis, (Wiseman, 1970 and Gale, et al., 1996) a type of fluoride toxicity that generally manifests itself clinically in terms of increasing bone density. This diversity of function, both beneficial and otherwise, makes the problem of fluoride anion detection one of considerable current interest. Thus, while traditional methods of fluoride anion analysis, involving, e.g., ion selective electrodes and </PDAT><HIL><SP><PDAT>19</PDAT></SP></HIL><PDAT>F-NMR spectroscopy remain important, there is an increasing incentive to find alternative means of analysis, including those based on the use of specific chemosensors. Particularly useful would be systems that can recognize fluoride anion in solution and signal its presence via an easy-to-detect optical signature.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>In the past few years, a wide range of anion sensors have been proposed (sapphyrins, Sessler, et al. 1997; calixpyrroles, Gale, et al. 1996 and Sessler, et al., 1998; cyclic polyamines, Dietrich, et al., 1981; Hoseini and Lehn, 1988) guanidinium (Dietrich, et al., 1981 and Metzger, et al., 1997)) that present varying degrees of affinity (and selectivity) toward anions such as F</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, Cl</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> and/or carboxylates. Unfortunately, and in spite of considerable effort, a need for good anion sensors remains. The number of anion sensors which can select for one biological anion over a range of anions present in vivo (phosphate, chloride, fluoride, etc.) remains at best, very limited. While there exists small molecule sensors which can bind anions relatively well, they do so with little or no specificity. This is particularly true in the case of fluoride anion where few, if any, easy-to-use signaling agents exist.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>In addition to anion sensing, it is also desirable to develop sensing elements capable of sensing cations and neutral species. The presence or absence, as well as the level of, various neutral molecular species is a useful diagnostic tool that can signal chemical decomposition. One example is the sensing of cis-3-hexenal (or chemical derivatives thereof), a metabolite of the bacterial </PDAT><HIL><ITALIC><PDAT>E. Coli</PDAT></ITALIC></HIL><PDAT>, Salmonela, and Lysteria. Such sensors would find applicability in the food industry as detectors of food contamination and spoilage. They could, for instance, be incorporated into food packaging materials.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>Therefore, a need exists to develop methods and compositions for the selective detection of anions, cations, and neutral species in general, and for fluoride in particular. A motivation for the preparation of new sensors is to obtain sensor compounds designed to recognize selectively a particular analyte within a range of species and produce an easily detected signal.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>The present invention provides novel compounds containing both pyrrole-derived anion and neutral species recognition subunits and an aromatic core as the optical or visual signaling group to provide chemosensors that allow for the convenient, color-based sensing of anions. Most commonly, the aromatic core will be a quinoxaline moiety, but may be any aryl system having two pyrroles covalently bound to neighboring (but not necessarily directly ajacent) carbons on an aryl moiety through a C&mdash;C single bond connecting pyrroles and the aromatic moiety.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>Formula I illustrates the general pyrrole-aryl systems (&agr;,&agr; and &bgr;,&bgr; substitution on the pyrrole rings) along with the specific pyrrole-quinoxaline analog shown directly below. Note that the pyrrole substitution may also be mixed, i.e, &agr;,&bgr; or &bgr;,&agr;. As used herein, &ldquo;aryl&rdquo; means any aromatic system consisting of one or more rings which may be homonuclear or heteronuclear, and which may or may not contain aromatic or non-aromatic side groups (substitution), and which may be further complexed to one or more metals. The present invention further provides methods of use and synthetic schemes for these novel compounds. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00001">
<CHEMCDX ID="CHEMCDX-00001" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00001.CDX"/>
<CHEMMOL ID="CHEMMOL-00001" ALT="chemistry mol file" FILE="US06482949-20021119-C00001.MOL"/>
<EMI ID="EMI-C00001" ALT="embedded image" HE="282.50775" WI="216.027" FILE="US06482949-20021119-C00001.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>The present invention provides novel compounds exemplified by the pyrrolic nitrogens used as anion recognition elements with an aromatic core as a signal group. The compounds of the present invention are termed pyrrole-aryls, and as used herein, the compounds of the present invention which, at least, combine these two elements will be referred to as such. Although not shown above, the pyrrole carbon atoms may also be substituted. The aryls may or may not contain heteroatoms. Subsituents may include, but are not limited to, hydrogen, alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl, or carboxy and may be the same or different at each occurrence.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>Compounds of the present invention may be prepared by a condensation between a 1,2-diamine and a 2,3-dipyrryl ethanedione as shown in Scheme 1. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00002">
<CHEMCDX ID="CHEMCDX-00002" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00002.CDX"/>
<CHEMMOL ID="CHEMMOL-00002" ALT="chemistry mol file" FILE="US06482949-20021119-C00002.MOL"/>
<EMI ID="EMI-C00002" ALT="embedded image" HE="345.16125" WI="216.027" FILE="US06482949-20021119-C00002.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>While specific substituents are listed above, the quinoxaline analogs may have a wider variability of substituent groups. R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>may be, individually at each occurrence, hydrogen, alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl, or carboxy. Although not shown above, any or all of these possible substitutions may be present on the remaining available carbon atoms of the quinoxaline. Additionally, any or all of these same possible substitution combinations may also be present on the &agr; or &bgr; positions, or on both the &agr; and &bgr; positions (relative to nitrogen) of the pyrrole rings.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>Oxalyl chloride, o-phenylenediamine, 4-nitro-1,2-diaminobenzene were purchased from Aldrich and used without further purification. 4,5-Diamino-1,2-dimethoxybenzene was prepared according to the method of Sessler, 1992. 4,5-Dinitro-1,2-diaminobenzene was prepared according to the method of Cheeseman, 1962.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>Thus, in a second respect, the present invention is the 2,3-dipyrryl-ethanediones used to produce the pyrrole-aryls. In this aspect of the invention the dipyrryl-ethanediones are of Formula II: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00003">
<CHEMCDX ID="CHEMCDX-00003" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00003.CDX"/>
<CHEMMOL ID="CHEMMOL-00003" ALT="chemistry mol file" FILE="US06482949-20021119-C00003.MOL"/>
<EMI ID="EMI-C00003" ALT="embedded image" HE="63.8442" WI="123.3792" FILE="US06482949-20021119-C00003.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00021" LVL="7"><PTEXT><PDAT>wherein individually at each occurrence, each of R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>are the same or different and are hydrogen, alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl, or carboxy. Though not shown the di-&bgr;-linked diketone (bridging group attached to pyrroles in position &bgr; to nitrogen atoms) is within this family, as is the mixed &agr;, &bgr;-linked diketone.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>These dipyrryl-ethanediones may be produced by reaction of a pyrrol either commercially available or obtainable through synthetic methods known to one of skill in the art, with oxalyl chloride as represented in Scheme 1 to generate a variety of dipyrryl-ethanediones.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>Further to this, the present invention provides a new set of novel dione compounds generated from the reaction of bipyrroles, terpyrroles etc. with oxalyl chloride to generate the compounds of Formula III: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00004">
<CHEMCDX ID="CHEMCDX-00004" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00004.CDX"/>
<CHEMMOL ID="CHEMMOL-00004" ALT="chemistry mol file" FILE="US06482949-20021119-C00004.MOL"/>
<EMI ID="EMI-C00004" ALT="embedded image" HE="143.0541" WI="183.62295" FILE="US06482949-20021119-C00004.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00024" LVL="7"><PTEXT><PDAT>wherein individually at each occurrence, each of R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>are the same or different and are hydrogen, alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl, or carboxy and n&equals;0-10. The analogous R</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>groups on either side of the diketone bond may be the same or different (i.e., R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, . . . R</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>on one side of the diketone bond may be the same or different from the corresponding R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, . . . R</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>on the opposite side, etc.; additionally, the R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>groups may have variability amongst individual pyrrole subunits; e.g. R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>on any given subunit may be the same or different from a corresponding R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>on any other subunit). Symmetry in substitution along the axis bisecting the diketone bond or among any pyrrole subunit is not required and maximum variability in substitution is possible so long as the general formula is followed.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>These novel diones may then be used to generate novel pyrrole-aryl compounds such as 2,3-di(bipyrryl)quinoxalines (n&equals;0), 2,3-di(terpyrrylquinoxalines (n&equals;1), 2,3-di(tetrapyrrylquinoxaline (n&equals;2) etc. The preferred route is via a condensation reaction involving the two ketones with an aryl compound.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>It is further contemplated that the 2,3-dipyrryl-ethanediones may undergo reaction with any 1,2-diamine under conditions outlined in Scheme 1 to generate a variety of new compounds for anion sensing as represented by Formula IV (functionalized quinoxaline analogs) and Formula V (functionalized pyrrole, functionalized quinoxaline analogs), respectively. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00005">
<CHEMCDX ID="CHEMCDX-00005" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00005.CDX"/>
<CHEMMOL ID="CHEMMOL-00005" ALT="chemistry mol file" FILE="US06482949-20021119-C00005.MOL"/>
<EMI ID="EMI-C00005" ALT="embedded image" HE="296.4276" WI="179.0586" FILE="US06482949-20021119-C00005.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>In Formula IV and V, respectively, individually at each occurrence, each of R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>are the same or different and are hyrdogen, alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl or carboxy. Note that the quinoxaline analogs are used for illustrative purposes in the above examples. It is readily apparent to one of ordinary skill in the art that an appropriate aryl or substituted aryl may be used in place of quinoxaline for the more generalized pyrrole-aryl compounds. As earlier discussed, the only requirement is orbital overlap of the ring systems comprising the aryl and pyrrole groups which are altered by bond rotation upon binding of substrate (anion, cation, or neutral atom or molecule): </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00006">
<CHEMCDX ID="CHEMCDX-00006" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00006.CDX"/>
<CHEMMOL ID="CHEMMOL-00006" ALT="chemistry mol file" FILE="US06482949-20021119-C00006.MOL"/>
<EMI ID="EMI-C00006" ALT="embedded image" HE="112.0959" WI="156.492" FILE="US06482949-20021119-C00006.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00028" LVL="7"><PTEXT><PDAT>The pyrrole groups are preferably on, but need not be on, adjacent carbons of the aryl moiety. Note that the nitrogen atoms may be deprotonated to afford cation-binding systems.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>2,3-dipyrrol-2&prime;yl-5,6-dicyanopyrazine (Example 30) is an example of an analogous pyrrole-aryl sensing compound that does not contain the quinoxaline moiety. The present invention provides a solution to the needs described herein above by producing compounds and methods for selective sensing. In particular, the preferred pyrrole-aryl compounds of the present invention have the ability to selectively bind fluoride anion over biologically important competitors such as chloride and phosphate and in doing so, produce a color change from yellow to orange in the case of 1 and from orange to purple for 3 and 8 which is, in some circumstances, visible to the naked-eye. It was further found that for these particular analogues, organic solvents encourage fluoride binding while polar solvents, such as methanol or water, lead to fluoride dissociation. This property would allow for the original sensor to be regenerated by changing solvents once the sensing is complete.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>The compounds of the present invention are particularly contemplated for use in fluoride sensing, especially in the presence of other biologically common anion species. While analogues such as 3 may display other anion sensitivities, the ability to selectively sense fluoride anion would be particularly useful for many purposes as further discussed in Examples 40 and 42.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>Therefore, an aspect of the present invention is the development of analytical methods for species which are selectively bound by the pyrrole-aryl compounds. As used herein, &ldquo;analysis&rdquo; means both quantitative and qualitative analysis. As used herein, optical methods included instrumental spectroscopic methods as well as visual observation. While the focus is on optical and visual analytical methods, electrochemical methods employing the pyrrole-aryls as sensing elements are also envisioned. Time-based analytical methods, such as those monitoring changes in fluorescence lifetimes (as well as other photophysical temporal phenomena) measurements are also envisioned. Either of these analytical examples would be sensitive to the modification of the molecular electronic structure of the sensing compound which would be caused upon substrate binding. Many other analytical measurements sensitive to such changes in electronic structure and which are known to those of skill in the art would be applicable in the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>It is contemplated that the pyrrole-aryls of the present invention have a wide variety of uses. A range of compounds with a large number of substituents fall within the scope of the present invention. The precursor molecules, the starting pyrrole or dione, may be derivatized as desired or the pyrrole-aryl may be modified post synthetically to yield compounds with desired substituents. Therefore, it is contemplated that the selectivity of the pyrrole-aryl compounds of the present invention will have a number of different selectivities achieved by variation of substituents within the structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>It is also envisioned that the binding and sensing capabilities of the pyrrole-aryls can be further exploited by surface immobilization. Functionalization of the pyrrole-aryl with reactive groups would afford the ability to attach them to solid phases. Polymer phases, silica and polystyrene, among others, are solid surfaces which find applicability in this embodiment of the invention. Surface immobilization is useful in the separation sciences, in the fabrication of sensors such as fiber optic probes, as well as other applications. In the field of separation science, surface immobilization can be used to fabricate novel stationary phases. In fiber optic sensing application, immobilization of the sensing element on the distal end of a fiber optic tip can be used to construct sensors useful for remote analyses. Fiber optic sensors are known to be amenable to remote sensing, such as in vivo, in vitro or in-situ sensing. In vivo applications would involve miniaturization of the fiber optic tip, thus the high sensitivity achievable with the pyrrole-aryls is particularly advantageous. In the area of foodstuff analysis, surface immobilization of the pyrrole-aryls onto fiber optic sensors, or alternatively, onto packaging components of foodstuffs is envisioned to afford a quick, convenient way to monitor spoilage.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>Additionally, the pyrrole-aryls of the present invention may be modified to increase aqueous solubility for use analytically or as therapeutic agents. In sensing applications, modification of solubility may be used to optimize a sensing element for the particular environment to be interrogated. This is performed through functionalization of the pyrrole-aryl compounds with groups that impart water solubility. Polar groups, especially those which readily carry a charge under various conditions, are candidates for such functionalization. Carboxy, hydroxy, and amine groups are most obvious but others are possible. Enhancing water solubility is useful therapeutically by enhancing bioavailability.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>Additional modifications are envisioned in which the pyrrole-aryls may be incorporated into macrocyclic compound. Porphyrin-type complexes are but one example further described below. By incorporating the binding site into a macrocyclic compound, novel compounds may be made to optimize transport of therapeutic agents, or to tailor the sensing element for a specific application. Metal-linked systems of pyrrole-aryls are another aspect of the present invention. These may be prepared by first preparing silyl derivatives having, for example, TMS groups appended. Subsequent deprotection and reaction with a metal salt will afford metal linked systems.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>Therapeutic uses of the compounds of the invention are also described. The binding capabilities may be exploited for uses as transporting agents. Anionic, cationic, and neutral species, through binding to the appropriate pyrrole-aryl, can be directed in vivo to areas where their therapeutic effect is optimally realized. The high affinity for a number of these species for chloride ion has potential applicability in the treatment of cystic fibrosis. Cystic fibrosis is characterized by a reduced ability to effect chloride ion transport at the cellular level involves the localized introduction of chloride ion. A means for enhancing the transport of chloride ion is therefore useful in such treatments. While this is one specific example, the ability to transport therapeutically active agents is expected to have wider applicability. This has the beneficial advantages of allowing for more efficient and lower dosages, which minimizes side and toxicity effects.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The compounds of the present invention provide a further advantage in the ease with which the pyrrole-aryls can, in light of the present disclosure, be modified. The synthetic steps are relatively simple and inexpensive to carry out. As the optical and binding properties can be controlled by the types of substituents present, this allows enough flexibility to accommodate a number of applications as well as the fine tuning of desired properties, for application in a specific environment.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>The following drawings form part of the present specification and are included to further demonstrate certain aspects of the present invention. The invention may be better understood by reference to one or more of these drawings in combination with the detailed description of specific embodiments presented herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> provides a view of the hydrogen bonded complex of &lsqb;1.F&rsqb;</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>as it extends along the a axis. Hydrogen bonding interactions are indicated by dashed lines. The relevant geometry for these interactions are: N1&mdash;H1N . . . F1 (related by x&minus;1, y, z), N . . . F 2.629(2) &angst;, H . . . F 1.63(3) &angst;, N&mdash;H . . . F 169(2)&deg;; N17&mdash;H17 . . . F1, N . . . F 2.640(2) &angst;, H . . . F 1.69(3) &angst;, N&mdash;H . . . F 168(2)&deg;; O1w&mdash;H1w . . . F1, O . . . F 2.590(2) &angst;, H . . . F 1.70(3) &angst;, N&mdash;H . . . O 177(3)&deg;.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is a view of the 2,3-dipyrrylquinoxaline unit 1 in its anion-free water complex.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS</PDAT></STEXT></H>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>The present invention generally relates to methods and compositions for anion and neutral species binding, analysis and recognition. As used herein, &ldquo;analysis&rdquo; encompasses both quantitative or qualitative analysis. In particular, the compounds and methods of the present invention utilize pyrroles as the key recognition-inducing component and aryl groups as optical reporting group. Many of the disclosed compounds contain quinoxalines as the aryl as part of the backbone structure to provide systems with built in chromophores and/or fluorophores for optical sensing. While quinoxaline is preferred, the invention is not limited to sensing compounds with this aryl component.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>With reference to the substituents contemplated for use in accordance with the present invention, alkyl may be of the repeating unit &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. The number of repeating units within an alkyl substituent may be up to fifty, preferably up to 20 and more preferably from 0-10. Representative examples of alkanes include methane, ethane, straight chain branched or cyclic isomers of propane, butane pentane hexane, octane, nonane and decane. Representative examples of substituted alkyls include alkyls substituted by two or more functional groups as described herein. Hydroxyalkyls includes alcohols of alkyl groups as defined previously. Representative examples of hydroxyalkyls include alcohols of methane, ethane, straight chain branched or cyclic isomers of propane, butane, pentane hexane, octane, nonane and decane. Hydroxyalkyl is meant to include glycols and polyglycols. Representative examples of glycols include diols of ethane, straight-chain, branched or cyclic isomers of propane, butane, pentane hexane, octane, nonane and decane. Representative examples of polyglycols include polyethylene glycol, polypropylene glycol, polypropylene diol and polybutylene diol. Representative examples of oxyalkyls include the alkyl groups defined herein above having ether linkages.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Representative examples of thioalkyls include thiols of an alkyl as described herein above including thiols of ethane, thiols of straight-chain, branched or cyclic isomers of propane, butane, pentane, hexane, heptane, octane, nonane and decane. Sulfate substituted alkyls include alkyls as described above substituted by one or more sulfate groups, a representative example of which is diethyl sulfate ((C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>); they also include simple anionic sulfate or sulfonate substituents such as &mdash;C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>As used herein, aryl refers to a compound whose molecules having either the pi-conjugated ring of benzene or the condensed rings of the other aromatic derivatives including heteroatom-containing aromatic derivatives (heteroaryls). They may additionally contain non-aromatic subsituents as side groups or be linked to metals. Representative examples include benzene, naphthalene, phenanthrene, phenanthroline, and anthracene. A heteroaryl compound, as used herein, refers to a compound which contains more than one kind of atom in an aromatic ring. Representative examples include pyridine, pyrimidine, furan, thiophene, pyrrole and imidazole.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>Representative examples of amines include primary, secondary and tertiary amines of an alkyl as described herein above.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>Representative examples of carboxy groups include carboxylic acids of the alkyls described above as well as aryl carboxylic acids such as benzoic acid. Carboxy groups also include derivatives of carboxylic acids such as esters, amides, acyl halides, anhydides, and nitriles. Representative examples of carboxyamides include primary carboxyamides (RCONH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), secondary (RCONHR) and tertiary (RCONR&prime;R&Prime;) carboxyamides where each of R&prime; and R&Prime; is a functional group as described herein and the carboxy group is as defined herein above.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>Representative examples of ester groups include compounds of the form RCOR&prime; where the R group is an alkyl as described herein above and where R&prime; is a functional group as described herein. Representative examples of acyl groups include acyl derivatives RCO&mdash; or ArCO&mdash;, wherein R is an alkyl as described herein above and Ar is an aryl group as defined herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>The choice of metal ion for complexing to analogues of the present invention will generally be dependent on the use or intended use of the analogue. For example, representative metals for the porphyrin derivative include Zn, Cu, Pd, Ni, Fe, Co, Ru, Rh, and Os.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>In one embodiment a method for anion sensing is disclosed using compounds of general Formula I shown herein above. Importantly, the general structures may possess substituent (R) groups at any carbon capable of accommodating such substituents (i.e., those bound to at least one hydrogen atom in the general structures) each R being defined as above.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>The synthesis of compounds represented in Formula I is outlined in Scheme 1. In this embodiment the substituents R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>are introduced during the synthesis on the aryl 1,2-diamine as shown. It would be well appreciated by one of skill in the art, in light of the present disclosure, that a wide variety of aryl 1,2-diamines may be condensed with a 1,2-dipyrryl ethanedione to provide a vast array of different compounds and that any or all of the remaining positions on the 1,2-diamine may bear substituents as exemplified by Formula IV.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>Additionally, compounds derived from those represented by Formula I are contemplated for the formation of metal complexes. For example, structure 9 may be condensed with 1,10-phenanthroline-5,6-dione to form compound 13. An alternate condensation of structure 9 with 5,6-diamino-1,10-phenanthroline affords structure 14. Both of these examples are shown in Example 34 where the metal binds through the phenanthroline nitrogens. Furthermore, compounds with altered fluorescence, represented by 15 and 16, may be synthesized using conditions similar to those provided in Example 34. Additionally, those syntheses detailed in other Examples could be effected using the appropriate dione.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>Further variants may be produced by using a porphyrin dione in the condensation to form a compound exemplified by structure 17 (Example 34), bearing a range of substituents at the meso and &bgr;-pyrrolic positions. The porphyrin may be metallated using standard techniques to generate a range of compounds containing various metals (for example Zn, Cu, Pd, Ni, Fe, Co, Ru, Rh, Os). For the substituents shown in structure 17, individually at each occurrence, each of R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>7</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>, is a hydrogen atom, alkyl, aryl or heteroaryl and individually at each occurrence, each of R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>is a hydrogen atom, alkyl, aryl or heteroaryl, halo, cyano, acyl, carboxyl, carboxy ester, carboxyamide, nitro or amino. While these are the preferred substituents, a wider range of substitution is possible and may even be desirable for given applications. One of skill in the art can appreciate the wide range of substitution possible. These porphyrin containing compounds are contemplated for analytical applications, particularly as redox-based and/or optical sensors.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>Other possible metal-containing analogs include pyrrole-aryl tethered metallocenes such as ferrocene. Additionally, crown ether-derivatized pyrrole-aryls can be used as metal bearing agents. Other host-guest species such as cyclodextrins may be coupled covalently to the pyrrole-aryls. Metallocenes, crown-ethers, and cyclodextrins act as substrate binders and catalysts in their own distinctive chemistries. Binding to the pyrrole-aryls will produce novel, synergistic binding effects. These are expected to further extend the usefulness of these novel species to electrochemical applications, particularly for analytical sensing. It is envisioned that the metal-complexed derivatives will be useful as ion channels. The selective binding and transport capabilities of such &ldquo;pore-forming&rdquo; species will have application as transport agents therapeutically and as sensors analytically.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>The dipyrrole quinoxalines of the present invention may also be modified post-synthetically to introduce a variety of substituents at the &agr; and/or &bgr; pyrrolic positions, R</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, as shown in compound 18 (Example 35). The substituents R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>are as previously described, R</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>may be the same or different, and may be halides, including, iodo and bromo, alkyl, aryl, heteroaryl, acyl, nitrile, carboxy amide, carboxy ester or sulfide. The introduction of these substituents allows for further modification of properties for a given compound. Using protocols well known in the art, the dibromo or diiodo compounds may be used to generate a further range of a substituted compounds such as those provided by structure 19. Compounds such as 20, may be used in subsequent reaction with a metal salt, such as &lsqb;PdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(PEt</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rsqb;, &lcub;i.e., bis(triethylphosphine)palladium(II) dichloride, or phosphino-platinum dichloride complexes, following removal of the TMS groups to afford metal linked systems.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>The pyrroles used in accordance with the present invention to prepare the pyrryl-quinoxalines, may be derivatized as represented in Scheme 5, structure 21 (Example 36). The pyrrole units with R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>substituents may, in some cases, be commercially available or in other instances may be prepared through synthetic methods well known to one of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>The 1,2-dipyrryl-ethanediones used in the present invention may be generated using the above-described pyrroles in a reaction with oxalyl chloride to provide many different 1,2 dipyrryl-ethanediones as shown in Scheme 5. Substituents R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>are alkyls, hydroxyalkyls, substituted alkyls, amines, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl and carboxy. Representative examples include those described previously with the preferred substituents as listed in Example 36 for compound 22.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>Additionally, several other compounds are contemplated for use in the reaction with oxalyl chloride to generate a series of diones. In particular, many different polypyrroles, bipyrroles (n&equals;0), terpyrroles (n&equals;1), up to and including n&equals;10 may be employed as shown in Scheme 6 (Example 36) to generate compounds exemplified by structure 24. R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>through R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>are alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, aryl, heteroaryl, acyl, halo, carboxy ester, carboxy amide and carboxy as previously described, such that R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>may be the same or different at each occurrence and n is 0-10, with R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>through R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>as H and n&equals;0 being preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>It is further contemplated that quinoxaline compounds of the present invention with a free &agr;-position may undergo further reaction as shown in Schemes 7A-7D (Example 37) for incorporation into macrocycles for use as sensing/transporting agents, and optical display devices. A wide variety of conditions known to one of skill in the art, may be employed to promote reaction of the remaining &agr;-free position on the pyrrole rings as shown in Example 37. These compounds are as represented by structures 25-32, and thus fall within the scope of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>Further sources of synthetic variation may be generated using diones comprised of various heterocyclic rings as shown in Example 38. These compounds may provide alternate selectivity for a variety of other analytes, such as metal ions in the case of the furan, thiophene, pyridine and pyridine N-oxide derived systems.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>Another source of variation involves the use of dianions of either the 1,2-di-pyrrylethanedione or the 2,3-di-pyrrylquinoxalines, as represented in Example 39, in accordance with the present invention. These dianions are contemplated for use as ligands for the generation of metal complexes. Such compounds would find use in the areas of molecular wires and display devices.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>It is particularly contemplated that the pyrrole quinoxaline compounds of the present invention will be of use as anion sensors. Example 40 provides a further discussion. It is further contemplated that the preferred compounds will find utility as novel fluoride anion sensors and receptors, and other examples wil find use as chloride and phosphate sensors and receptors. The unsubstituted pyrrolic nitrogens provide anion binding sites as detailed in Examples 31-33. Furthermore, the pyrrole quinoxaline compounds of the present invention provide a quinoxaline core as a chromophoric signal group for the color-based sensing of anions.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>Any one of a wide variety of anions may be detected using the pyrrole-aryls or alternate heterocyclic quinoxalines in accordance herewith. These anions include, but are not limited to, cyanide anion, phenolate anion, carboxylate anion, sulfate anion, sulfonate anion, nitrate anion, nitrite anion, bromide anion, pertechnetate anion, perrhenate anion, chloride anion, phosphates and phosphonates.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>Additionally, the disclosed methods are contemplated for binding or complexing a range of analytes, including anion, cations and neutral species, but particularly anions and neutrals. Therefore, also contemplated are phosphate-containing compounds, including simple alkyl or aryl phosphates, alkyl phosphonates, nucleotides, oligo- and polynucleotides such as DNA, RNA and anti-sense constructs and nucleotide analogues. Representative examples of phosphates include phosphate or polyphosphate groups. Representative examples of phosphate substituted alkyls include alkyls as described above substituted by one or more phosphate or polyphosphate groups. Representative examples of phosphonate substituted alkyls include alkyls as described above substituted by one or more phosphonate groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>The term nucleotide, as used herein, refers generally to any moiety that includes within its structure a purine, pyrimidine, or nucleic acid with a ribose group and at least one phosphate group, or any derivative of these such as a protected nucleotide. Thus the term nucleotide includes adenosine tri-, di- and monophosphate, guanosine tri-, di- and monophosphate, cytidine tri-, di- and monophosphate, thymidine tri-, di- and monophosphate, uridine tri-, di- and monophosphate and xylo-guanosine monophosphate a well as any nucleotide derivative based upon these or related structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>As discussed previously, the increased specificity and optical analysis makes this class of anion sensors considerably more effective at anion recognition and detection than other classes of molecules. The capacity of pyrrole-aryls and analogues thereof, to effect specific sensing of anions in general, and fluoride in particular, is contemplated to be advantageous for use in vitro and in vivo. For example, the disclosed compounds may be used to effect the construction of electrodes (analogous to pH sensing) or to fiber optic cables for analysis of drinking water, in vitro, or for in vivo fluoride sensing in the analysis of bone density. In addition to optical sensors, other applications are contemplated such as chromatography. Here for example, compounds 1-3 are coupled to a solid support. The pyrryl-quinoxalines can be attached to solid supports, via condensation reaction between complementary functional groups on the quinoxaline and the solid support, e.g., amine on quinoxaline with carboxyl on solid support to yield an amide linkage, or a carboxyl group on the quinoxaline with an amine or hydroxyl on the solid support to give an amide or ester linkage respectively. These coupled compounds may be used to separate various anions from each other and from other species in the mixture.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>Additionally, the binding and/or sensing of fluorinated compounds is also contemplated. It is well established that fluorinated hydrocarbons are damaging to the atmosphere, as well as to humans, and that fluorinated phosphates are extremely toxic when ingested, for instance from chemical weapons. In order to increase solubility in aqueous solutions, derivatives containing additional pyrroles in the pyrrole-aryl system as outlined in Example 41. This would allow for analysis of fluoride levels in blood samples as well as a treatment for any detected fluorosis.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>In the detection of fluoride anion as described in Examples 31-33, the preferred solvent is an aprotic one with dichloromethane particularly preferred. However, other solvents are contemplated for the appropriate analogues as described previously.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="7"><PTEXT><PDAT>Immobilization on Solid Supports</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>The target pyrrole-aryl sensing compound can be covalently attached to a solid support using any of the number of methods commonly employed in the art to immobilize molecular species to solid supports. Covalent attachment of the sensing compound to the solid support may occur by reaction between a reactive site or a binding moiety on the solid support and a reactive site or another binding moiety attached to the sensing compound or via intervening linkers or spacer molecules, where the two binding moieties can react to form a covalent bond. For example, binding of a sensing compound to a solid support can be carried out by reacting a free amino group of an amino-functionalized sensing compound with a reactive carboxy of the solid support. Similarly the reaction of alcohol groups and the derivatized and native SiOH groups of silica can afford immobilization.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>Coupling of a sensing compound to a solid support in this way may be carried out through a variety of covalent attachment functional groups. Any suitable functional group may be used to attach the sensing compound to the solid support, including but not limited to disulfide, carbamate, hydrazone, ester, N-functionalized thiourea, functionalized maleimide, mercuric-sulfide, gold-sulfide, amide, thiolester, azo, ether and amino. The solid support for use in separation science or sensor technologies may be made from a wide variety of materials, such as silica, cellulose, nitrocellulose, nylon membranes, controlled-pore glass beads, acrylamide gels, polystyrene, activated dextran, agarose, polyethylene, functionalized plastics, glass, silicon, brominated Wang resin, Merrifield resin, agarobiose, carboxypolystyrene HL, and TG-amino resin. Some solid support materials may require functionalization prior to attachment of the sensing compound. Solid supports that may require such surface modification include aluminum, steel, iron, copper, nickel, gold, silicon, and nonfunctionalized polymers. In the area of sensing of components, degradants, and impurities in foodstuffs, solid support materials include polyethylenes such as LDPE and ULLDPE, EVA and others. In addition to solid surface immobilization through covalent interactions, noncovalent interactions (such as that of biotin with streptavidin, for example), as well as other similar chemistries that are well-known known to those of skill in the art are applicable in the present invention. Example 43 describes the ability of a surface bound sensing compound to detect fluoride ion.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>While the above examples recite solid support immobilization via covalent interactions, binding moieties may also include functional groups that attach to the solid support via a high-affinity, noncovalent interaction (such as biotin with streptavidin), as well as other means that are well-known to those of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>The selective binding capabilities of the sensing elements described herein may be useful in a number of applications wherein it will be advantageous to have such binding on a solid support. For example, binding to silica-based supports would have utility in the separation sciences. These have additional utility in the area of fiber optic sensing. Functionalization of the sensing element with silyl alcohols groups, among others, will allows for attachment onto silica. Additionally, it will be beneficial for similar purposes to incorporate such sensing elements onto a polymer support. The molecule shown at right in the example below may be incorporated into a polymerizing chemistry known to one of skill in the art to afford a material that has the ability to behave as a sponge toward analytes of interest. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00007">
<CHEMCDX ID="CHEMCDX-00007" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00007.CDX"/>
<CHEMMOL ID="CHEMMOL-00007" ALT="chemistry mol file" FILE="US06482949-20021119-C00007.MOL"/>
<EMI ID="EMI-C00007" ALT="embedded image" HE="404.4411" WI="216.027" FILE="US06482949-20021119-C00007.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>In the above example, R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>is hydrogen, alkyl, hydroxyalkyl, glycol, polyglycol, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amide, ester, acyl, aldehyde, or carboxy.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="7"><PTEXT><PDAT>Enhancement of Water Solubility</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>The unsubstituted pyrrole-aryls have relatively low solubility. In order to enhance further the general utility of these species as sensing compounds, it is desirable to afford one the capability of readily enhancing water solubility. Such solubility characteristics may be tailored through functionalzation. Water solubility is most markedly enhanced through the functionalization of these sensing compounds with groups that readily carry a formal charge in aqueous solutions. Additionally, groups of varying polarity may be used to modify water solubility. Combinations of these groups can be used depending upon the level of water solubility sought to be imparted to the sensing compound.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>Functional groups which find applicability in this regard include carboxy, amino, sulfonate, alcohols. Oxyhydroxyalkyl and oxycarboxy groups such a hydroxypropoxy and carboxyethoxy are useful in this regard. Multiply carboxylated derivatives may be used in their native form or they may be converted to ester or amide products that can be used to further append hydroxylated substituents. Polyether-linked polyhydroxylated alkyl groups, polyethylene glycols and other multi-hydroxy containing groups will also afford enhanced water solubility while allowing the sensing element to retain lipophilicity.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="7"><PTEXT><PDAT>Pharmaceutical Compositions and Routes of Administration</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>Apart from the application of the subject sensing elements as in vivo and in vitro sensors, it is envisioned that they may be used as therapeutic agents. They are particularly useful in applications were anion and neutral molecule transport are necessary. One specific example involves the use of chloride ion transport for the treatment of cystic fibrosis. Cystic fibrosis is a hereditary disease characterized by the production of defective chloride channel proteins in epithelial cells, particularly the lungs. Established treatments target the symptoms of the disease but do not compensate for the poor chloride ion transport. An effective, biocompatible carrier that functions in vivo to augment cell permeability for chloride anion could provide a conceptually simple, potentially new approach to cystic fibrosis treatment. These sensing elements have therapeutic uses in any situation wherein the selective transport of an anion or neutral species is desired. One variation on the class of compounds described herein involves the derivatization with crown ethers. Such compounds would enhance the role of ion or neutral species transport.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>Where clinical application of controlled release compositions is undertaken, it will be necessary to prepare the composition as a pharmaceutical composition appropriate for the intended application. Generally, this will entail preparing a sterile, physiologically compatible pharmaceutical composition that is essentially free of pathogens, as well as any other impurities that could be harmful to humans or animals. One also will generally desire to employ appropriate buffers to render the complex stable and allow for uptake by target cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>Aqueous compositions of the present invention comprise an effective amount of a controlled release composition as discussed above dispersed in a pharmaceutically acceptable carrier or aqueous medium. Such compositions also are referred to as inocula. The phrases &ldquo;pharmaceutically&rdquo; or &ldquo;pharmacologically acceptable&rdquo; refer to compositions that do not produce an adverse, allergic or other untoward reaction when administered to an animal, or a human, as appropriate.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>As used herein, &ldquo;pharmaceutically acceptable carrier&rdquo; includes any and all solvents, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption delaying agents and the like. The use of such media and agents for pharmaceutical active substances is well known in the art. Except insofar as any conventional media or agent is incompatible with the active ingredient, its use in the therapeutic compositions is contemplated. Supplementary active ingredients also can be incorporated into the compositions.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>Solutions of therapeutic compositions can be prepared in water suitably mixed with a surfactant, such as hydroxypropylcellulose. Dispersions also can be prepared in glycerol, liquid polyethylene glycols, mixtures thereof and in oils. Under ordinary conditions of storage and use, these preparations contain a preservative to prevent the growth of microorganisms.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>The therapeutic compositions of the present invention are advantageously administered in the form of injectable compositions either as liquid solutions or suspensions; solid forms suitable for solution in, or suspension in, liquid prior to injection may also be prepared. These preparations also may be emulsified. A typical composition for such purpose comprises a pharmaceutically acceptable carrier. For instance, the composition may contain 10 mg, 25 mg, 50 mg or up to about 100 mg of human serum albumin per milliliter of phosphate buffered saline. Other pharmaceutically acceptable carriers include aqueous solutions, non-toxic excipients, including salts, preservatives, buffers and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>Examples of non-aqueous solvents are propylene glycol, polyethylene glycol, vegetable oil and injectable organic esters such as ethyl oleate. Aqueous carriers include water, alcoholic/aqueous solutions, saline solutions, parenteral vehicles such as sodium chloride, Ringer&apos;s dextrose, etc. Intravenous vehicles include fluid and nutrient replenishers. Preservatives include antimicrobial agents, anti-oxidants, chelating agents and inert gases. The pH and exact concentration of the various components in the pharmaceutical composition are adjusted according to well known parameters.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>Additional formulations are suitable for oral administration. Oral formulations include such typical excipients as, for example, pharmaceutical grades of mannitol, lactose, starch, magnesium stearate, sodium saccharine, cellulose, magnesium carbonate and the like. The compositions take the form of solutions, suspensions, tablets, pills, capsules, sustained release formulations or powders. When the route is topical, the form may be a cream, ointment, salve or spray.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>The therapeutic compositions of the present invention may include classic pharmaceutical preparations. Administration of therapeutic compositions according to the present invention will be via any common route so long as the target tissue is available via that route. This includes oral, nasal, buccal, rectal, vaginal or topical. Topical administration would be particularly advantageous for the treatment of skin cancers, to prevent chemotherapy-induced alopecia or other dermal hyperproliferative disorder. Alternatively, administration may be by orthotopic, intradermal subcutaneous, intramuscular, intraperitoneal or intravenous injection. Such compositions would normally be administered as pharmaceutically acceptable compositions that include physiologically acceptable carriers, buffers or other excipients. For treatment of conditions of the lungs, the preferred route is aerosol delivery to the lung. Volume of the aerosol is between about 0.01 ml and 0.5 ml. Similarly, a preferred method for treatment of colon-associated disease would be via enema. Volume of the enema is between about 1 ml and 100 ml.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>An effective amount of the therapeutic composition is determined based on the intended goal. The term &ldquo;unit dose&rdquo; or &ldquo;dosage&rdquo; refers to physically discrete units suitable for use in a subject, each unit containing a predetermined-quantity of the therapeutic composition calculated to produce the desired responses, discussed above, in association with its administration, i.e., the appropriate route and treatment regimen. The quantity to be administered, both according to number of treatments and unit dose, depends on the protection desired.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>Precise amounts of the therapeutic composition also depend on the judgment of the practitioner and are peculiar to each individual. Factors affecting the dose include the physical and clinical state of the patient, the route of administration, the intended goal of treatment (alleviation of symptoms versus cure) and the potency, stability and toxicity of the particular therapeutic substance. Example 42 discusses anion binding compounds as therapeutic agents.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>The following examples are included to demonstrate preferred embodiments of the invention. It should be appreciated by those of skill in the art that the techniques disclosed in the examples which follow represent techniques discovered by the inventor to function well in the practice of the invention, and thus can be considered to constitute preferred modes for its practice. However, those of skill in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific embodiments which are disclosed and still obtain a like or similar result without departing from the spirit and scope of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>The following examples are merely illustrative and not exhaustive. Examples of compositions useful in the present invention, along with their preparation are given. It is expected that one skilled in the art may appreciate that minor deviations may be incorporated without deviating from the scope of the present invention.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 1</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of 1,2-Dipyrryl ethanedione</PDAT></STEXT></H>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>Oxalyl chloride (6.4 g, 0.05 mol) and dichloromethane (25 mL) were placed together under an argon atmosphere and stirred. Upon cooling to &minus;78&deg; C. in an acetone/CO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>bath, dry pyridine (10 g, 0.12 mol) was added, resulting in the formation of a yellow precipitate. To this cooled suspension was added a solution of freshly distilled pyrrole (6.7 g, 0.1 mol) in dichloromethane (25 mL) by use of a canula. Immediately, the reaction mixture turns from yellow to brown. The reaction was allowed to stir for an additional 15 minutes at &minus;60&deg; C., after which time hydrochloric acid (5 M, 100 mL) was added to quench the reaction. The biphasic system is then separated and the organic phase was collected. The aqueous phase was extracted with dichloromethane (3&times;30 mL), and the combined organic phases were washed with water (100 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. This afforded a green precipitate. The crude product was further purified by silica gel column chromatography (acetone/hexanes (80/20 v/v)) to afford 10 (1.81 g, 38%) as a yellow powder.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="7"><PTEXT><PDAT>Chracterization Data for 10</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.26 (2H, dd, J</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;3.7 Hz, J</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;2.4 Hz, H</PDAT><HIL><SB><PDAT>&bgr;</PDAT></SB></HIL><PDAT>), 6.89 (2H, dd, J</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;3.7 Hz, J</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;0.5 Hz, H</PDAT><HIL><SB><PDAT>&bgr;pyrr</PDAT></SB></HIL><PDAT>), 7.30 (broad s, H</PDAT><HIL><SB><PDAT>&agr;pyrr</PDAT></SB></HIL><PDAT>), 12.27 (2H, s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;111.0, 120.9, 128.4, 128.6, 181.4.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 2</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of 2,3-dypyrrylquinoxaline (1)</PDAT></STEXT></H>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>The synthesis of 2,3-dipyrrylquinoxaline (1) was carried out as follows. The diketone 10 (570 mg, 3.03 mmol) was dissolved in glacial acetic acid (70 mL) and to this was added a solution of ortho-phenylenediamine (715 mg, 6.62 mmol) in acetic acid (30 mL) with stirring. The resultant mixture was then brought to reflux for 90 min under an atmosphere of argon. After this time majority of the acetic acid was removed under vacuum and the residue was taken up in a mixture of water (30 mL) and dichloromethane (30 mL). The organic phase was separated off and the aqueous phase was extracted with further dichloromethane (2&times;20 mL). The organic phases were combined and washed with saturated aqueous sodium bicarbonate solution (50 mL), water and (50 mL) and brine (50 mL). After drying over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue obtained was the purified using silica gel column chromatography (dichloromethane) to afford 1 (730 mg, 94%) as a yellow powder.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>Oxalyl chloride, o-phenylenediamine, 4-nitro-1,2-diaminobenzene were purchased from Aldrich and used without further purification. 4,5-Diamino-1,2-dimethoxybenzene was prepared according to the method of Sessler, 1992. 4-5,-Dinitro-1,2-diaminobenzene was prepared according to the method of Cheeseman, 1962.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="7"><PTEXT><PDAT>Characterization Data for 1</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;6.16 (2H, m, H</PDAT><HIL><SB><PDAT>&bgr;2</PDAT></SB></HIL><PDAT>), 6.82 (2H, m, H</PDAT><HIL><SB><PDAT>&bgr;1</PDAT></SB></HIL><PDAT>), 6.89 (2H, m, H</PDAT><HIL><SB><PDAT>&agr;</PDAT></SB></HIL><PDAT>) 7.46 (2H, dd, J</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>&equals;12.5 Hz, J</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&equals;2.9 Hz, CH</PDAT><HIL><SB><PDAT>benz</PDAT></SB></HIL><PDAT>), 7.78 (2H, dd, J</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>&equals;12.5 Hz, J</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&equals;2.9 Hz, CH</PDAT><HIL><SB><PDAT>benz</PDAT></SB></HIL><PDAT>), 9.54 (2H, broad s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;109.9, 112.8, 121.1, 128.0, 128.8, 129.0, 139.6, 143.6; HRMS (CI&plus;) m/z calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>13</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>: 261.11402, found: 261.11343; Anal. Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>13</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.0.5H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O: C, 71.35; H, 4.87; N, 20.80. Found C, 71.23; H, 4.79; N, 20.48.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 3</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of 2,3-dipyrrol-2&prime;-yl-6,7-dimethoxyquinoxaline (2)</PDAT></STEXT></H>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>4,5-Diamino-1,2-dimethoxybenzene (1.25 g, 7.45 mmol) and 1,2-dipyrrol-2&prime;-ylethanedione (2 g, 10.65 mmol) were dissolved in acetic acid (250 mL) and heated at reflux under an atmosphere of argon overnight. The solvent was removed under vacuum and the residue was taken up in a mixture of water (50 mL) and dichloromethane (100 mL). The organic phase was separated off and the aqueous phase was extracted with further dichloromethane (2&times;40 mL). The organic phases were combined and washed with saturated aqueous sodium bicarbonate solution (50 mL), water (50 mL), then brine (50 mL). After drying over anhydrous sodium sulfate, the solution was filtered and evaporated to dryness. Final purification was then effected using silica gel column chromatography (methanolchloroform, 2:98) to afford 2,3-dipyrrol-2&prime;-yl-6,7-dimethoxyquinoxaline (2.05 g, 86%) as a yellow/green powder: m.p. 196-198&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;3.98 (6H, s), 6.05-6.09 (2H, m), 6.11-6.15 (2H, m), 6.92-6.96 (2H, m), 7.32 (2H, s), 11.35 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;56.7, 106.5, 110.4, 112.1, 120.8, 129.7, 137.3, 142.3, 152.7; HRMS (CI&plus;) m/z (M&plus;1) calcd. for C</PDAT><HIL><SB><PDAT>18</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>: 321.1352, found: 321.1358; UV-vis (CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) &lgr;</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>&lsqb;nm&rsqb; (&egr;): 272 (23 890), 292sh (17 850), 412 (15 900).</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="7"><PTEXT><PDAT>Characterization Data for 2</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>m.p. 196-198&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;3.98 (6H, s), 6.05-6.09 (2H, m), 6.11-6.15 (2H, m), 6.92-6.96 (2H, m), 7.32 (2H, s), 11.35 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;56.7, 106.5, 110.4, 112.1, 120.8, 129.7, 137.3, 142.3, 152.7; HRMS (CI&plus;) m/z (M&plus;1) calcd. for C</PDAT><HIL><SB><PDAT>18</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>: 321.1352, found: 321.1358.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 4</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of 2,3-dipyrrol-2&prime;-yl-6,7-dinitroquinoxaline (3)</PDAT></STEXT></H>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-ylethanedione (200 mg, 1.06 mmol) and 1,2-diamino-4,5-dinitrobenzene (265 mg, 1.34 mmol) were dissolved in glacial acetic acid (40 mL) and the resultant solution was heated at reflux in the dark for 4 h under an atmosphere of argon. The solution was allowed to cool and evaporated to dryness in vaccuo. The residue was taken up in dichloromethane (50 mL) and washed with sodium hydrogen carbonate solution (sat., 2&times;50 mL), brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue was chromatographed over silica (chloroform) and the front running band was collected to afford 2,3-dipyrrol-2&prime;-yl-6,7-dinitroquinoxaline (297 mg, 80%) as a red powder: m.p. 215-217&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.20-6.28 (2H, m, pyrrole H), 6.68-6.77 (2H, m, pyrrole H), 7.15-7.22 (2H, m, pyrrole H), 8.50 (2H, s, quinoxline H), 11.94 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;109.9, 114.9, 124.6, 125.7, 127.9, 140.0, 140.7, 147.7; HRMS (CI&plus;) m/z (M&plus;1) calcd. for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>351.0842, found 351.0852; UV-vis (CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) &lgr;</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>&lsqb;nm&rsqb; (&egr;): 340 (29 100), 460 (29 200).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 5</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of 6-nitro-2-3-dipyrrylquinoxaline (7)</PDAT></STEXT></H>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-ylethanedione (175 mg, 0.93 mmol) and 4-nitro-1,2-diaminobenzene (245 mg, 1.60 mmol) were dissolved in glacial acetic acid (30 mL) and the resultant solution was heated at reflux in the dark overnight under an atmosphere of argon. The solution was allowed to cool and evaporated to dryness in vaccuo. The residue was taken up in dichloromethane (50 mL) and washed with sodium hydrogen carbonate solution (sat., 2&times;50 mL), brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue was chromatographed over silica (chloroform) and the front running band was collected to afford 2,3-dipyrrol-2&prime;-yl-6-nitroquinoxaline (240 mg, 85%) as a red powder: m.p. 206-208&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.15-6.25 (2H, m, pyrrole H), 6.45-6.60 (2H, m, pyrrole H), 7.07-7.19 (2H, m, pyrrole H), 8.05 (1H, d, J 9.1 Hz, H8 quinoxaline), 8.48 (1H, dd, J 9.1, 2.5 Hz, H7 quinoxaline), 8.65 (1H, d, J 2.5 Hz, H5 quinoxaline), 11.75 (1H, br s, NH), 11.86 (1H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;109.2, 109.6, 112.9, 114.1, 122.3, 122.6, 123.6, 123.7, 128.1, 128.3, 129.2, 137.8, 142.4, 146.3, 146.5, 147.0; HRMS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>306.0991, found 306.0996; UV-vis (CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) &lgr;</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>&lsqb;nm&rsqb; (&egr;): 325 (22 000), 370 (13 650), 450 (18 730); Anal. Calc. for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>: C, 62.95; H, 3.61; N, 22.95. Found C, 62.87; H, 3.67; N, 22.96.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 6</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of Mono-2-(trimethylsilyl)ethoxymethyl (SEM) protected derivative (12)</PDAT></STEXT></H>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>2,3-Dipyrrylquinoxaline (400 mg, 1.54 mmol) was dissolved in N,N-dimethylformamide (30 ml) under an atmosphere of argon. Sodium hydride (60% dispersion in mineral oil, 100 mg) was added and the resultant mixture was allowed to stir at room temperature for 1 h. 2-(trimethylsilyl)ethoxymethyl chloride (SEM-Cl) (205 mg, 1.23 mmol) was then added and the mixture was stirred at room temperature for a further 90 min. The solvent was removed under vacuum and the residue was taken up in dichloromethane (150 ml) and washed with water (2&times;100 ml), and brine (100 ml). The organic phase was dried over sodium sulfate, filtered and evaporated to dryness. Final purification was then effected using silica gel column chromatography (toluene initially, then toluene/ethylacetate, 95/5) to afford 7 (40 mg, 6.6%) as a brown gum: </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (500 MHz, CD</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) &dgr;&minus;0.70 (9H, s), 0.56-0.60 (2H, m), 3.23-3.27 (2H, m), 5.15 (2H, s), 5.78-5.80 (1H, m), 6.12-6.14 (1H, m), 6.34-6.37 (1H, m), 6.48-6.51 (1H, m), 6.96-6.98 (1H, m), 7.02-7.04 (1H, m), 7.63-7.67 (1H, m), 7.71-7.75 (1H, m) 7.98-7.82 (1H, m), 9.90-10.00 (1H, br s); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, CD</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) &dgr;&minus;1.6, 17.8, 30.1, 66.1, 77.0, 109.0, 111.0, 112.3, 113.1, 122.0, 123.4, 128.4, 128.8, 129.4, 130.6, 140.4, 141.2, 145.3, 146.0.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 7</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-di-5&prime;-bromopyrrol-2&prime;-ylquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-ylquinoxaline (1.5 g, 5.77 mmol) was dissolved in carbon tetrachloride (150 ml) and recrystallised N-bromosuccinimde (2.25 mg, 12.64 mmol) and benzoyl peroxide (40 mg) were added and the resultant mixture was heated at reflux under an atmosphere of argon in the dark overnight. The solvent was then removed under vacuum and the residue was chromatographed over silica (ethyl acetate/dichloromethane 5:95) and the major band was collected to afford 2,3-di-5&prime;-bromopyrrol-2&prime;-ylquinoxaline (1.7 g, 70%) as a light brown solid: m.p. 204-206&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.16-6.24 (4H, m, &bgr;-pyrrolic H), 7.73-7.81 (2H, m, aryl H), 7.95-8.03 (2H, m, aryl H), 12.3 (2H, broad s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;101.9, 111.1, 112.8, 128.1, 129.6, 130.4, 139.5, 143.9; HRMS (CI&plus;) m/z calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>Br</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>: 416.93504, found: 416.93557; Anal. Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>Br</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>: C, 45.93; H, 2.39; N, 13.40. Found C, 46.09; H, 2.56; N, 13.49.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 8</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-di-5&prime;-iodopyrrol-2&prime;-ylquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-ylquinoxaline (500 mg, 1.92 mmol) and sodium acetate (1.04 g, 7.68 mmol) were dissloved in acetic acid (100 mL) and cooled to 0&deg; C. in an ice bath. As the acetic acid began to crystallise, a solution of iodine monochloride (592 mg, 3.65 mmol) in acetic acid (10 mL) was added to the quinoxaline solution and the mixture was stirred for 10 min. A saturated solution of sodium thiosulfate (30 mL) was then added and the mixture was stirred at room temperature for 1 h. The mixture was then washed with ethyl acetate (100 mL) and the organic phase was separated off. The organic phase was washed with water (2&times;100 mL) and brine (100 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue ws achromatographed over silica (dichloromethane/hexane 1:1, v/v) to afford 2,3-di-5&prime;-iodopyrrol-2&prime;-ylquinoxaline (830 mg, 84%).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 9</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-di(5&prime;-formylpyrrol-2&prime;-yl)quinoxaline</PDAT></STEXT></H>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>Phosphorus oxychloride (240 &mgr;L, 2.57 mmol) was added to DMF (454 &mgr;L, 5.86 mmol) at 0&deg; C. under an atmosphere of argon. This mixture was then allowed to warm to room temperature and stirred for 10 min before 1,2-dichloroethane (3 mL) was added. To this mixture was then added a solution of 2,3-dipyrrol-2&prime;-ylquinoxaline (260 mg, 1.00 mmol) in 1,2-dichloroethane (3 mL) over a period of 10 min. The resulting mixture was heated at reflux for 30 min before being cooled to 0&deg; C. A saturated aqueous solution of sodium acetate (3 mL) was then added and the mixture was heated at reflux for a further 30 min. Upon cooling, the mixture was washed with chloroform (2&times;50 mL) and the combined organic phases were then washed with water (2&times;50 mL), brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue was then chromatographed over silica (dichloromethane initially, then dichloromethane/methanol, 99.5:0.5 v/v) to afford 2,3-di(5&prime;-formylpyrrol-2&prime;-yl)quinoxaline (216 mg, 68%) as a yellow solid.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 10</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-di(5&prime;-benzoylpyrrol-2&prime;-yl)quinoxaline</PDAT></STEXT></H>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>Under an atmosphere of argon, N,N-dimethylbenzamide (1.20 g, 8.0 mmol) was added to 1,2-dichloroethane (5 mL) followed by the addition of phosphorus oxychloride (368 &mgr;L, 3.96 mmol) and and the mixture was stirred at room temperature for 30 min. To this mixture was added a solution of 2,3-dipyrrol-2&prime;-ylquinoxaline (400 mg, 1.54 mmol) in 1,2-dichloroethane (50 mL) over a period of 20 min. The resulting mixture was heated at reflux for 24 h before being allowed to cool. An aqueous solution of sodium acetate (20 mL) was then added and the mixture was heated at reflux for a further 30 min. Upon cooling, the mixture was washed with dichloromethane (2&times;100 mL) and the combined organic phases were then washed with water (2&times;150 mL), brine (150 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue was then chromatographed over silica (dichloromethane) to afford 2,3-di(5&prime;-benzoylpyrrol-2&prime;-yl)quinoxaline (314 mg, 44%).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 11</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6,7-dipentoxyquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>4,5-Dipentoxy-1,2-diaminobenzene (1.12 g, 4.0 mmol) and 1,2-dipyrrol-2&prime;-ylethanedione (500 mg, 2.66 mmol) were dissolved in acetic acid (80 ml) and the resulting mixture was first evacuated, and then placed under an atmosphere of argon and heated at reflux in the dark overnight. The mixture was allowed to cool and the solvent was removed under vacuum. The residue was then dissolved in dichlormethane (100 ml) and washed with sodium carbonate solution (100 ml), brine (100 ml), dried over anhydrous sodium sulfate and evaporated to dryness. The residue was then chromatographed over silica (dichloromethane) and the front running band was collected to afford 2,3-dipyrrol-2&prime;-yl-6,7-dipentoxyquinoxaline (768 mg, 67%) as a yellow-green powder: m.p. 142-144&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;0.94 (6H, t, J 7.0 Hz, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 1.33-1.56 (8H, m, &ggr; and &dgr; CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 1.84 (4H, app quin., &bgr; CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 4.17 (4H, t, J 6.3 Hz, &agr; CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), 6.03-6.08 (2H, m, pyrrole H), 6.09-6.14 (2H, m, pyrrole H), 6.90-6.95 (2H, m, pyrrole H), 7.25 (2H, s, quinoxaline H), 11.38 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;13.9, 21.9, 27.8, 28.1, 68.4, 106.8, 108.6, 110.1, 120.2, 128.9, 151.4; HRMS (CI&plus;) m/z (M&plus;1) calcd. for C</PDAT><HIL><SB><PDAT>26</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>33</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>433.2603, found 433.2613.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 12</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-di(5&prime;-bromopyrrol-2&prime;-yl)-6-nitroquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-yl-6-nitroquinoxaline (500 mg, 1.64 mmol) was dissolved in carbon tetrachloride (150 mL) and recrystallised NBS (613 mg, 3.44 mmol, 2.1 equiv.) and benzoyl peroxide (10 mg) were added. The resultant mixture was heated at reflux under an atmosphere of argon in the dark overnight. The mixture was allowed to cool and then evaporated to dryess. The residue was chrommatographed over silica (dichloromethane) to afford 2,3-di(5&prime;-bromopyrrol-2&prime;-yl)-6-nitroquinoxaline (226 mg, 30%) as a red solid.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 13</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6-aminoquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-yl-6-nitroquinoxaline (107 mg, 0.35 mmol) was dissolved in ethanol (20 mL) and palladium on carbon (10%, 10 mg) was added. The mixture was placed under an atmosphere of hydrogen and stirred overnight in the dark. The mixture was then filtered through celite and the filtrate was evaporated to dryness to afford 2,3-dipyrrol-2&prime;-yl-6-aminoquinoxaline (90 mg, 93%) as an orange solid.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 14</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6,7-diaminoquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-yl-6,7-dinitroquinoxaline (90 mg, 0.25 mmol) was dissolved in absolute ethanol (40 mL) and 10% palladium on carbon (15 mg) was added. The resulting mixture was stirred under an atmosphere of hydrogen overnight in the dark. The solution was then filtered through celite and evaporated to dryness to afford crude 2,3-dipyrrol-2&prime;-yl-6,7-diaminoquinoxaline (72 mg, 100%) and used without further purification.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 15</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-5-nitroquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-ylethanedione (500 mg, 2.66 mmol) and 3-nitro-1,2-phenylenediamine (680 mg, 4.45 mmol) were dissolved in acetic acid (100 mL) and heated at reflux in the dark under an atmosphere of argon overnight. The solvent was removed under vacuum and the residue was dissolved in dichloromethane (150 mL), washed with sodium carbonate solution (2&times;100 mL) and brine (100 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The crude material was then chromatographed over silica (dichloromethane) and the major front running band was collected to afford 2,3-dipyrrol-2&prime;-yl-5-nitroquinoxaline (480 mg, 59%) as an orange solid: m.p. 183-185&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.15-6.22 (2H, m, pyrrole H), 6.39-6.47 (2H, m, pyrrole H), 7.05-7.10 (2H, m, pyrrole H), 7.76-7.84 (1H, m, quinoxaline H), 8.14-8.22 (2H, m, quinoxaline H), 11.41 (1H, br s, NH), 11.77 (1H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;109.3, 113.0, 113.4, 122.7, 123.0, 123.2, 127.6, 128.0, 128.1, 131.0, 131.9, 139.3, 145.9, 146.2; HRMS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>306.0991, found 306.0995.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 16</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6-bromoquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-ylethanedione (440 mg, 2.34 mmol) and 4-bromo-1,2-phenylenediamine (560 mg, 3.00 mmol) were dissolved in acetic acid (70 mL) and heated at reflux in the dark under an atmosphere of argon overnight. The solvent was removed under vacuum and the residue was dissolved in dichloromethane (150 mL), washed with sodium carbonate solution (2&times;100 mL) and brine (100 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The crude material was then chromatographed over silica (dichloromethane) and the major front running band was collected to afford 2,3-dipyrrol-2&prime;-yl-6-bromoquinoxaline (510 mg, 65%) as a brown/green solid: m.p. 144-146&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (500 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.12-6.15 (2H, m, pyrrole H), 6.28-6.30 (2H, m, pyrrole H), 6.98-7.02 (2H, m, pyrrole H), 7.80 (1H, dd, J 2.1, J 8.8 Hz, quinoxaline H), 7.85 (1H, d, J 8.8 Hz, quinoxaline H), 8.07 (1H, d, J 2.1 Hz, quinoxaline H), 11.57 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;108.9, 109.1, 112.0, 112.2, 121.5, 121.8, 122.0, 128.3, 128.4, 129.1, 130.0, 132.0, 138.2, 140.1, 145.3, 145.7; MS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>Br 339.02453, found 339.02430.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 17</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-diaminonaphthalene adduct</PDAT></STEXT></H>
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-yl ethanedione (200 mg, 1.06 mmol) and 2,3-diaminonaphthalene (252 mg, 1.59 mmol) were dissolved in glacial acetic acid (30 mL) and the resultant solution was heated at reflux under an atmosphere of argon in the dark overnight. The solution was allowed to cool and evaporated to dryness in vaccuo. The residue was taken up in dichloromethane (50 mL) and washed with sodium hydrogen carbonate solution (sat., 2&times;50 mL), brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue was chromatographed over silica (dichloromethane) and the front running band was collected to afford the 2,3-diaminonaphthalene adduct (156 mg, 95%) as a light brown solid: m.p. 184-186&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.15-6.20 (2H, m, pyrrole H), 6.34-6.39 (2H, m, pyrrole H), 7.03-7.08 (2H, m. pyrrole H), 7.55-7.64 (2H, m), 8.15-8.23 (2H, m), 8.54 (2H, s), 11.71 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;108.9, 112.6, 122.0, 125.6, 126.3, 128.2, 129.0, 133.0, 136.7, 145.8; HRMS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>20</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>15</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>311.12967, found 311.12963.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 18</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 9,10-diaminophenanthrene adduct</PDAT></STEXT></H>
<PARA ID="P-00115" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-yl ethanedione (500 mg, 2.66 mmol) and 9,10-diaminophenanthrene (830 mg, 3.99 mmol) were dissolved in glacial acetic acid (150 mL) and the resultant mixture was heated at reflux under an atmosphere of argon in the dark overnight. The mixture was allowed to cool and evaporated to dryness in vaccuo. The residue was chromatographed over silica (diclhoromethane) and the front running band was collected to afford the 9,10-diaminophenanthrene adduct (687 mg, 72%) as a light brown solid. HRMS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>24</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>361.14532, found 361.14525.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 19</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6-carboxyquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>1,2-Dipyrrol-2&prime;-ylethanedione (500 mg, 2.66 mmol) and 3,4-diaminobenzoic acid (404 mg, 2.66 mmol) were dissolved in glacial acetic acid (80 mL) and the resultant solution was heated at reflux in the dark overnight. The solution was allowed to cool and evaporated to dryness in vaccuo. The residue was taken up in ethyl acetate (150 mL) and washed with hydrochloric acid (3 M, 80 mL), brine (80 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The residue was chromatographed over silica (ethyl acetate/dichloromethane, 3:2 v/v) and the major band was collected to afford 2,3-dipyrrol-2&prime;-yl-6-carboxyquinoxaline (270 mg, 33%). </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.14-6.21 (2H, m, pyrrole H), 6.35-6.43 (2H, m, pyrrole H), 7.02-7.09 (2H, m, pyrrole H), 8.00 (1H, d, J 8.7 Hz, H8 quinoxaline), 8.17 (1H, dd, J 8.7, 1.9 Hz, H7 quinoxaline), 8.49 (1H, d, J 2.5 Hz, H5 quinoxaline), 11.66 (1H, br s, NH), 11.73 (1H, br s, NH), 13.40 (1H, br s, CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;109.0, 109.3, 112.1, 112.8, 121.8, 122.5, 128.1, 128.4, 128.5, 129.9, 130.6, 138.5, 141.5, 145.8, 146.3, 166.8, HRMS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>13</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>305.1039, found 305.1035.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 20</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6-carboxyquinoxaline octylester</PDAT></STEXT></H>
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-yl-6-carboxyquinoxaline (100 mg, 0.33 mmol) and octanol (47 mg, 0.36 mmol) were dissolved in dichloromethane (20 mL). To this solution was added DCC (82 mg, 0.40 mmol) and DMAP (2.5 mg, 0.02 mg) in dichloromethane (10 mL) over a 10 min period and the resulting mixture was stirred at room temperature for 4 h. The mixture was then evaporated to dryness and chromographed over silica (dichloromethane) to afford 2,3-dipyrrol-2&prime;-yl-6-carboxyquinoxaline octyl ester (76 mg, 55%) as a yellow/green solid.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 21</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6-carbxyamidoaquinoxaline-4&Prime;-benzo-18-crown-6</PDAT></STEXT></H>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-yl-6-carboxyquinoxaline (100 mg, 0.33 mmol) was dissolved in a mixture of dichloromethane (10 mL) and N,N-diisopropylethylamine (100 mg, 0.724 mmol) and HBTU (137 mg, 0.362 mmol) was added. The resulting mixture was stirred for 5 min prior to the addition of a solution of 4-aminobenzo-18-crown-6 (118 mg, 0.36 mmol) in dichloromethane (6 mL). The reaction mixture was allowed to stir under an atmosphere of argon in the dark overnight. The mixture was then evaporated to dryness and the residue was chromatographed over silica (ethyl acetate initially, then methanol/ethyl acetate, 5:95 v/v) to afford 2,3-dipyrrol-2&prime;-yl-6-carbxyamidoaquinoxaline-4&Prime;-benzo-18-crown-6 (150 mg, 74%).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 22</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;-yl-6-carboxyquinoxaline coupled to a bead</PDAT></STEXT></H>
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>2,3-Dipyrrol-2&prime;-yl-6-carboxyquinoxaline (45 mg, 0.14 mmol), HBTU (62 mg, 0.16 mmol), N,N-diisopropylethylamine (50 mg, 0.36 mmol) and DMF (0.5 mL) were added to dichloromethane (7 mL). This solution was then added to pre-swelled TG-amino resin (the resin was successively rinsed with DMF, then dichloromethane and then methanol several times). The mixture was stirred overnight and then filtered under vacuum and washed successively with dichoromethane, DMF, dichoromethane, DMF, dichloromethane, methanol, dichloromethane, and finally two rinses with methanol. After the third wash the solutions were colourless. The beads were then dried under vacuum for 4 days without further purification.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 23</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>1,2-Di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)ethanedione</PDAT></STEXT></H>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>Oxalyl chloride (800 &mgr;L, 8.64 mmol) and dichloromethane (15 mL) were placed together under an argon atmosphere and stirred. Upon cooling to &minus;78&deg; C. in an acetone/CO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>bath, dry pyridine (1.28 mL, 15.8 mmol) was added, resulting in the formation of a yellow precipitate. To this cooled suspension was added a solution of 3,4-difluoropyrrole (1.49 g, 14.4 mmol) in dichloromethane (3 mL) via syringe. The reaction was allowed to stir for 3 h at &minus;60&deg; C., and then warmed to 0&deg; C. over a 4 h period. The solution was then diluted with dichloromethane (20 mL) and washed with hydrochloric acid (3 M, 2&times;50 mL). The biphasic system was separated off and the organic phase was collected and washed with water (50 mL) and brine (50 mL). The organic phase was then dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The acidic aqueous phase from the initial extraction was extracted with ethyl acetate (50 mL). The organic phase was separated off and washed with brine (100 ml), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. This afforded a green precipitate which was purified by silica gel column chromatography (dichloromethane/ethyl acetate, 95:5 to 90:10 (v/v) as eluent) to afford 1,2-di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)ethanedione (405 mg, 21%) as a yellow powder: m.p. 260-263&deg; C. decomposed; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (500 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;7.43-7.46 (2H, m), 12.36 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, </PDAT><HIL><SP><PDAT>19</PDAT></SP></HIL><PDAT>F decoupled) &dgr;110.7 (m), 113.3 (d, J 192 Hz),136.8 (dd, J 9.1, 1.5 Hz), 141.0 (t, J 8.2 Hz), 178.8; </PDAT><HIL><SP><PDAT>19</PDAT></SP></HIL><PDAT>F NMR (470 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;&minus;164.1, &minus;177.9; HRMS (CI&plus;) m/z (M&plus;1) calcd for C</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>F</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>: 261.0287, found: 261.0288.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 24</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>2,3-Di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)quinoxaline</PDAT></STEXT></H>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>1,2-Di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)ethanedione (112 mg, 0.43 mmol) and ortho-phenylenediamine (125 mg, 1.15 mmol) were dissolved in glacial acetic acid (20 mL). The resultant mixture was then heated at reflux under an atmosphere of argon in the dark overnight. The reaction mixture was evaporated to dryness under vacuum and the residue obtained was purified using silica gel column chromatography (dichloromethane eluent) to afford 2,3-di(340 ,4&prime;-difluoropyrrol-2&prime;-yl)quinoxaline (133 mg, 93%) as a yellow-green powder: m.p. 188-192&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (500 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;6.94-6.98 (2H, m, pyrrole H), 7.80-7.94 (2H, m, quinoxaline H), 8.01-8.05 (2H, m, quinoxaline H), 11.47 (2H, broad s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>, </PDAT><HIL><SP><PDAT>19</PDAT></SP></HIL><PDAT>F decoupled) &dgr;104.0 (d, J 22 Hz), 111.1 (d, J 16 Hz), 128.3, 130.3, 136.3 (dd, J 244, 11 Hz), 137.6 (dd, J 235, 11 Hz), 139.7, 142.4; </PDAT><HIL><SP><PDAT>19</PDAT></SP></HIL><PDAT>F NMR (470 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;&minus;172.6 (dt, J 12.2, 3.3 Hz), &minus;180.5 (dt, J 12.6, 3.3 Hz); HRMS (CI&plus;) m/z (M&plus;1) calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>F</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>: 333.0763, found: 333.0754; Anal. Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>F</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>: C, 57.84; H, 2.43; N, 16.86. Found C, 57.71; H, 2.50; N, 16.81.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 25</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>2,3-Di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)-6-nitroquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>1,2-Di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)ethanedione (98 mg, 0.38 mmol) and 4-nitro-1,2-diaminobenzene (115 mg, 0.75 mmol) were dissolved in glacial acetic acid (30 mL) and the resultant solution was heated at reflux in the dark overnight under an atmosphere of argon. The solution was allowed to cool and evaporated to dryness in vaccuo. The residue was chromatographed over silica (chloroform) and the front running band was collected to afford 2,3-di(3&prime;,4&prime;-difluoropyrrol-2&prime;-yl)-6-nitroquinoxaline (120 mg, 84%) as a red powder: m.p. 217-219&deg; C. with decomposition; HRMS (CI&plus;) m/z (M&plus;1) Calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>7</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>F</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>378.06141, found 378.06206.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 26</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 1,2-di(5&prime;-ethoxycarbonyl-3&prime;,4&prime;-dimethylpyrrol-2&prime;-yl)ethanedione</PDAT></STEXT></H>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>A solution of 5&prime;-ethoxycarbonyl-3&prime;,4&prime;-dimethylpyrrole (500 mg, 2.99 mmol) in dry dichloromethane (10 mL) was cooled in an ice bath under an atmosphere of argon. To this solution was added oxalyl chloride (220 mg, 1.79 mmol) and the solution was allowed to cool prior to the addition of tin(IV) chloride (857 mg, 380 &mgr;L, 3.29 mmol). The resultant mixture was stirred at 0&deg; C. for 1 h and then allowed to warm to room temperature over 1 h. The solution was then washed with water (2&times;50 mL), brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The crude residue was then recrystallised from a mixture of ethyl acetate/hexane, 1:9 v/v to afford 1,2-di(5&prime;-ethoxycarbonyl-3&prime;,4&prime;-dimethylpyrrol-2&prime;-yl)ethanedione as a light green powder (128 mg, 22%): m.p. 210-212&deg; C.; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (500 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;1.39 (6H, t, J 7.1 Hz), 2.27 (6H, s), 2.34 (6H, s), 4.38 (4H, q, J 7.1 Hz), 10.93 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;9.7, 11.2, 14.4, 61.0, 125.1, 126.9, 127.6, 133.4, 160.7, 179.5; HRMS (CI&plus;) m/z (M&plus;1) calcd for C</PDAT><HIL><SB><PDAT>20</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>25</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>: 389.17126, found: 389.17092.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 27</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 1,2-di(4&prime;-acetyl-3&prime;,5&prime;-dimethylpyrrol-2&prime;-yl)ethanedione</PDAT></STEXT></H>
<PARA ID="P-00124" LVL="0"><PTEXT><PDAT>A solution of 2,4-dimethyl-3-acetylpyrrole (1.48 g, 10.8 mmol) in dry ether (180 mL) was cooled in an ice bath under an atmosphere of argon. To this solution was added oxalyl chloride (720 &mgr;L, 8.1 mmol) and the solution was then stirred at 0&deg; C. for 1 h, then allowed to warm to room temperature. The resultant dark-red-purple precipitate was then collected on a frit and the filtrate was removed and the precipitate was then washed with dichloromethane (30 mL). Mass spectral analysis revealed that the initial filtrate contained very little of the desired compound, however peaks at m/z (M&plus;1) 210 and 228 can be attributed to mono-condensation with oxalyl chloride, followed by hydrolysis of the acid chloride to the acid, and mono-condensation product with oxalyl chloride respectively. The dichloromethane washings of the precipitate contained essentially only the desired product. The precipitate itself also contained essentially only the desired 1,2-di(4&prime;-acetyl-3&prime;,5&prime;-dimethylpyrrol-2&prime;-yl)ethanedione (420 mg, 24%) as a purple solid. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;2.28 (3H, s), 2.40 (3H, s), 2.53 (3H, s), 11.74 (2H, br s, NH); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (125 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) &dgr;12.3, 14.5, 31.3, 123.5, 124.9, 132.0, 143.1, 183.4, 194.6, HRMS (CI&plus;) m/z (M&plus;1) calcd for C</PDAT><HIL><SB><PDAT>18</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>21</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>: 329.15013, found: 329.15075.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 28</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>2,3-Di(3&prime;,5&prime;-dimethyl-4&prime;acetylpyrrol-2&prime;-yl)-6-nitroquinoxaline</PDAT></STEXT></H>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>1,2-Di(4&prime;-acetyl-3&prime;,5&prime;-dimethylpyrrol-2&prime;-yl)ethanedione (100 mg, 0.30 mmol) and 4-nitro-1,2-diaminobenzene (79 mg, 0.52 mmol) were dissolved in glacial acetic acid (15 mL) and the resultant solution was heated at reflux in the dark overnight under an atmosphere of argon. The solution was allowed to cool and the evaporated to dryness in vaccuo. The residue was then taken up in chloroform (70 mL) and washed with hydrochloric acid (3 M, 3&times;40 mL), water (50 mL), sodium bicarbonate solution (60 mL), brine (70 mL). The organic phase was then dried over anhydrous sodium sulfate, filtered and evaporated to dryness to afford 34 mg of crude material.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 29</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 1,2-di(4&prime;-heptanoyl-3&prime;,5&prime;-dimethylpyrrol-2&prime;-yl)ethanedione</PDAT></STEXT></H>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>A solution of 2,4-dimethyl-3-heptanoylpyrrole (500 mg, 2.41 mmol) in dry dichloromethane (10 mL) was cooled in an ice bath under an atmosphere of argon. To this solution was added oxalyl chloride (183 mg, 1.44 mmol, 125 &mgr;L) and the solution was then stirred at 0&deg; C. for 1 h, then at r.t. for 2 h. The reaction mixture was diluted with dichloromethane (50 mL), and then washed with water (2&times;30 mL), brine (30 mL), dried over anhydrous sodium sulfate, filtered, and evaporated to dryness. Mass spec analysis of the crude product indicated the presence of the desired compound, 1,2-di(4&prime;-heptanoyl-3&prime;,5&prime;-dimethylpyrrol-2&prime;-yl)ethanedione. No further purification was attempted. (CI&plus;) m/z (M&plus;1) C</PDAT><HIL><SB><PDAT>28</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>41</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>requires 469; 208 (70), 252 (40), 280 (100), 298 (45), 469 (45). (CI&minus;) m/z C</PDAT><HIL><SB><PDAT>28</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>40</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>requires 468; 278 (28), 468 (100).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 30</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Preparation of 2,3-dipyrrol-2&prime;yl-5,6-dicyanopyrazine</PDAT></STEXT></H>
<PARA ID="P-00127" LVL="0"><PTEXT><PDAT>Diaminomaleonitrile (348 mg, 3.22 mmol) and 1,2-dipyrrol-2&prime;-yl ethanedione (500 g, 2.66 mmol) were dissolved in acetic acid (70 mL) and heated at reflux under an atmosphere of argon for overnight in the dark. The solvent was removed under vacuum and the residue was taken up in a mixture of water (50 mL) and dichloromethane (100 mL). The organic phase was separated off and the aqueous phase was extracted with further dichloromethane (2&times;40 mL). The organic phases were combined and washed with saturated aqueous sodium bicarbonate solution (50 mL), water (50 mL), then brine (50 mL). After drying over anhydrous sodium sulfate, the organic phase was filtered and evaporated to dryness. Final purification was then effected using silica gel column chromatography (dichloromethane) to afford 2,3-dipyrrol-2&prime;yl-5,6-dicyanopyrazine (65 mg. 10%). </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (250 MHz, DMSO d</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>) 6.17&dgr;-6.25 (2H, m), 6.82-6.88 *2H, m), 7.12-7.18 (2H, m), 11.96 (2H, br s, NH; </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (62.5 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr;110.2, 114.5, 114.7m, 125.4, 126.3, 144.0; HRMS (CI&plus;) m/z (M&plus;1) calcd. For C</PDAT><HIL><SB><PDAT>14</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>: 261.08887, found: 261.08869.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 31</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Structure Determination of Fluoride Complexes</PDAT></STEXT></H>
<PARA ID="P-00128" LVL="7"><PTEXT><PDAT>X-ray Structure Analysis</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>The molecular structure of compound 1 as well as its corresponding tetrabutylammonium fluoride complex (&lsqb;1.F&rsqb;</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>) were deduced from single crystal X-ray diffraction analyses. The requisite single crystals were obtained from the slow evaporation of dichloromethane/methanol (90/10: v/v) and neat dichloromethane solutions of 1 and &lsqb;1.F&rsqb;</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>.(Bu)</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SP><PDAT>&plus; </PDAT></SP></HIL><PDAT>respectively. In both cases, the quinoxaline moiety was found to possess the expected planar structure. As shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT> and </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>, the two pyrrole subunits were found to be rotated in such a way that they point out, in opposite directions, towards the exterior of the system.</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>While the structures of the fluoride complex and anion-free receptor are quite similar, a major difference involves the hydrogen bonding network. The fluoride complex &lsqb;1.F&rsqb;</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>presents a network that involves 1) two pyrrolic NH subunits derived from two distinct dipyrrylquinoxaline units, 2) a fluoride anion and 3) a molecule of water. The net result is a planar network, wherein two identical planes are separated by a layer of tetrabulammonium cations, as shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>. By contrast, the structure of the fluoride-free system reveals a hydrogen bonding network that serves to arrange the dipyrrylquinoxaline moieties into layers wherein a molecule of water bridges two pyrrolic NH groups from two distinct molecules. In this instance, it is also worth noting that, in addition to the conventional N . . . O hydrogen bonding interactions, one hydrogen atom of the bridging water molecule is directed at the centroid of a pyrrole ring. The result of this interaction is that the molecules from two different planes are related by a two-fold screw axis.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>In the case of the fluoride complex &lsqb;1.F&rsqb;</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, the tightness of the hydrogen bonds is highlighted by the short F . . . N distance: These distances are 2.629(2) and 2.640(2) &angst; respectively, and are, in fact, shorter than the corresponding F . . . N distances (2.790(2) &angst;) observed in the case of calixpyrrole fluoride anion complex (Dietrich, et al., 1981).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 32</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Spectroscopic Studies-Colormetric Assay for Anion Binding</PDAT></STEXT></H>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>The conclusion that 1 binds fluoride anion in dichloromethane solution was further supported by mass spectrometric analyses and titration experiments made using UV-visible absorption and fluorescence emission methods (Tables 1 and 2). The latter studies, which provided K</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>values (Tables 1 and 2), were complemented by molar ratio analyses (Job plots) with 1:1 binding stoichiometries observed in all cases.</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>In order to analyze compounds having only one pyrrolic nitrogen, a mono SEM protected analogue (12) was prepared as described in Example 6. Additionally, quinoxaline (11) was used in the analysis. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00008">
<CHEMCDX ID="CHEMCDX-00008" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00008.CDX"/>
<CHEMMOL ID="CHEMMOL-00008" ALT="chemistry mol file" FILE="US06482949-20021119-C00008.MOL"/>
<EMI ID="EMI-C00008" ALT="embedded image" HE="44.3961" WI="140.19075" FILE="US06482949-20021119-C00008.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>The results are as shown in the following tables:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="350pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE 1</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Spectroscopic properties of 2,3-dipyrrylquinoxaline 1, dipyrryl ethanedione</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>10, 6,7-dimethoxy-2,3-dipyrrylquinoxaline 2, 6,7-dinitro-2,3-</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>dipyrrylquinoxaline 3, 6-nitro-2,3-dipyrrylquinoxaline 7, and quinoxaline</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>11. All values measured in dichloromethane.</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="offset" colwidth="35pt" align="left"/>
<colspec colname="1" colwidth="56pt" align="center"/>
<colspec colname="2" colwidth="35pt" align="center"/>
<colspec colname="3" colwidth="49pt" align="center"/>
<colspec colname="4" colwidth="35pt" align="center"/>
<colspec colname="5" colwidth="49pt" align="center"/>
<colspec colname="6" colwidth="42pt" align="center"/>
<colspec colname="7" colwidth="49pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>MonoSE</PDAT></PTEXT></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>2,3-di-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Dipyrryl</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>M-2,3-di-</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>pyrryl</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>ethane-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Di-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Mono-</PDAT></PTEXT></entry>
<entry></entry>
<entry><PTEXT><PDAT>pyrrylquin-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Quin-</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>quinoxaline</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>dione</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>methoxy</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nitro</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Dinitro</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>oxaline</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>oxaline</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>10</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>7</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>12</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>11</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="7" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="35pt" align="left"/>
<colspec colname="2" colwidth="56pt" align="center"/>
<colspec colname="3" colwidth="35pt" align="center"/>
<colspec colname="4" colwidth="49pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="center"/>
<colspec colname="6" colwidth="49pt" align="center"/>
<colspec colname="7" colwidth="42pt" align="center"/>
<colspec colname="8" colwidth="49pt" align="center"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>&lgr;</PDAT><HIL><SB><PDAT>max</PDAT></SB></HIL><PDAT>(ex)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>412 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>341 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>414 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>450 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>460 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>396 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>315 nm</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lgr;</PDAT><HIL><SB><PDAT>max</PDAT></SB></HIL><PDAT>(em)</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>490 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>458 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>475 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>600 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>620 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>492 nm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>403 nm</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&egr;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>17,110</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>16,200</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>15,900</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>18,730</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>29,200</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>14860</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>6,222</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>(at &lgr;</PDAT><HIL><SB><PDAT>max</PDAT></SB></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><PTEXT><FOO ID="FOO-00001"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>Fluorescence emission scan parameters: excitation at &lgr;</PDAT><HIL><SB><PDAT>max</PDAT></SB></HIL><PDAT>, 240 nm/min., emission slit width &equals; 5 &mgr;m, excitation slit width &equals; 5 &mgr;m. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<CWU>
<TABLE-US ID="TABLE-US-00002">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="329pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE 2</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Anion binding constants (K</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>) for 2,3-dipyrrylquinoxalines 2, 3 and 7 and</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>control compounds 1, 10 and 11.</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="35pt" align="left"/>
<colspec colname="2" colwidth="42pt" align="right"/>
<colspec colname="3" colwidth="56pt" align="right"/>
<colspec colname="4" colwidth="42pt" align="right"/>
<colspec colname="5" colwidth="56pt" align="right"/>
<colspec colname="6" colwidth="42pt" align="right"/>
<colspec colname="7" colwidth="56pt" align="right"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>2-3</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>Mono SEM-</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>dipyrrylquin-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Dipyrryl</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>2,3-dipyrryl</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>oxaline</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>ethanedione</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Dimethoxy</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Mononitro</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Dinitro</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>quinoxaline</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Anion</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1</PDAT><HIL><SP><PDAT>b</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>10</PDAT><HIL><SP><PDAT>c</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>7</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>12</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>F</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>18,200 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>23,000 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>2,300 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>118,000 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>117,000 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>2,300 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>60 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>170 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>&lt;50 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>80 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>55 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>&lt;50 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Cl</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>50 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>&lt;50 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>&lt;50 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>45 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>45 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>&lt;50 M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00002"><PTEXT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>All errors are &plusmn; 10%. All binding constants are reported as the average of 2-4 trials. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00003"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>Binding constants determined by fluorescence quenching: &lgr;</PDAT><HIL><SB><PDAT>ex </PDAT></SB></HIL><PDAT>&equals; 412 nm, &lgr;</PDAT><HIL><SB><PDAT>em </PDAT></SB></HIL><PDAT>&equals; 420-750 nm, 240 nm/min, emission slit width &equals; 5 &mgr;m, excitation slit width &equals; 5 &mgr;m. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00004"><PTEXT><HIL><SP><PDAT>c</PDAT></SP></HIL><PDAT>Binding constants were determined from UV-vis absorbance titration measurements monitoring the spectral changes occurring at 341 nm. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00135" LVL="0"><PTEXT><PDAT>In terms of specifics, we found that in dichloromethane solution, the diketone precursor, 10, displays a relatively large extinction coefficient whereas its fluorescence emission is minimal. Under the same conditions, quinoxaline itself, 11, displays a relatively low extinction coefficient. Nonetheless, even with these control systems the addition of tetrabutylammonium salts of various anions (F</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, Cl</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>and H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>), gave rise to results that were quite interesting. In the case of 11 (in dichloromethane), the addition of F</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, Cl</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>and H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>did not induce any significant change in the absorbance or emission spectra. By contrast, in the case of 10 remarkable changes were noticed in the emission spectra when either F</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>or H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>were added. As a matter of fact, in the presence of F</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, a significant decrease and a shift in the absorbance intensity could be observed visually with the color of the solution changing from yellow-green to orange. Such effects can be rationalized in terms of the electron withdrawing nature of the two carbonyl groups, which serve to pull the electrons from the pyrrole units and thus act to increase the acidity of the pyrrolic NH protons. As a result, hydrogen bonding interactions with F</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>are favored. In the particular case of inorganic phosphate, we speculate that the two carbonyl groups may also be involved in binding, stabilizing the complex via ancillary hydrogen bonding interactions involving the two HOP-phosphate protons.</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>Unfortunately, the fluorescence quantum yield of 10 is low. Thus we considered that 2,3-dipyrrylquinoxaline system 1 derived from it as well as its analogues 2, 3, and 7 might prove to be far better sensors. Not only should they display high affinities toward fluoride anion in dichloromethane solution, but they were expected to exhibit even more dramatic fluoride anion induced color changes as measured by absorption and emission spectroscopy, as well as naked eye color detection. As summarized in Table 2, this expectation is indeed realized in the case of 1, 3, and 7, with the latter two systems showing very dramatic yellow to purple fluoride anion-induced colorimetric responses.</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>The greater &ldquo;success&rdquo; of 3 and 7 relative to 1 and 2, a system that hardly &ldquo;works&rdquo; at all in terms of colorimetric F</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>signaling, is not really surprising considering that the relative electron deficiency of the mono- and dinitro derivatives should lead to increase in their hydrogen bonding donating character. Indeed, both 3 and 7 display affinity constants (K</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>), for F</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>binding in dichloromethane (ca 10</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>), that are quite high. By contrast, 1 (K</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>&equals;2&times;10</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>) and 2 (K</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>&equals;2&times;10</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>M</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>) display affinity constant that are much lower. Interestingly, even in the case of the high affinity systems 3 and 7 an excellent selectivity for fluoride anion is maintained; indeed, the selectivity ratio for F</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>over Cl</PDAT><HIL><SP><PDAT>&minus; </PDAT></SP></HIL><PDAT>is more than 360.</PDAT></PTEXT></PARA>
<PARA ID="P-00138" LVL="0"><PTEXT><PDAT>In addition to the specific pyrrole-quinoxalines, the usefulness of the general pyrrole-aryl structures as sensing compounds has been demonstrated. Using 2,3-dipyrrol-2&prime;yl-5,6dicyanopyrazine (preparation is described in Example 30) as a sensing compound, a vivid yellow-to-red color change in solution observed upon addition of fluoride ion verifies that the quinoxaline backbone is not essential for chemical sensing in this family of compounds. This is consistent with the theory that changes in orbital overlap between the pi systems of conjugated bridging unit and the pyrrole rings account for the sensitivity of the sensing elements to analyte species.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 33</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Mechanistic Studies of Fluoride Anion Binding</PDAT></STEXT></H>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>In order to understand more fully the above results, studies were performed to map out the mode of fluoride anion binding. Firstly, it was verified that two pyrrolic nitrogens are required to observe the anion-induced color change. Toward this end, the mono protected 2,3-dipyrrylquinoxaline 12 was prepared by reacting 0.8 equivalents of SEMCl with one equivalent of 2,3-dipyrrylquinoxaline. (See Scheme 2 illustrating mono SEM protection of 2,3-dipyrrylquinoxaline.) In dichloromethane, this mono-protected adduct showed no color change when treated with tetrabutyl ammonium fluoride. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00009">
<CHEMCDX ID="CHEMCDX-00009" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00009.CDX"/>
<CHEMMOL ID="CHEMMOL-00009" ALT="chemistry mol file" FILE="US06482949-20021119-C00009.MOL"/>
<EMI ID="EMI-C00009" ALT="embedded image" HE="250.58565" WI="216.027" FILE="US06482949-20021119-C00009.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>The next series of mechanistic studies involved carrying out temperature dependent NMR measurements (room temperature to &minus;80&deg; C.). These revealed little out of the ordinary (i.e., no temperature dependent chemical shift changes were observed) and are consistent with a single atropisomer of 1 being present in solution. Further studies involve X-ray diffraction analysis with the realties as shown in Table 3.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00003">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE 3</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Selected bond distances (&angst;) and bond angles from X-ray</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="offset" colwidth="112pt" align="left"/>
<colspec colname="1" colwidth="21pt" align="center"/>
<colspec colname="2" colwidth="84pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&lsqb;1 &middot; F&rsqb;</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="offset" colwidth="28pt" align="left"/>
<colspec colname="1" colwidth="84pt" align="left"/>
<colspec colname="2" colwidth="21pt" align="center"/>
<colspec colname="3" colwidth="84pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>N-H . . . H-N</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>6.562</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>6.892</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>N . . . N</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>5.766</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>5.763</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>&agr;</PDAT></SB></HIL><PDAT> . . . H</PDAT><HIL><SB><PDAT>&agr;</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>8.795</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>8.746</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>&bgr;2 </PDAT></SB></HIL><PDAT>. . . H</PDAT><HIL><SB><PDAT>&bgr;2</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>2.607</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2.612</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>F . . . H-N1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&mdash;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.639</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>F . . . H-N2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&mdash;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>8.196</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<H LVL="1"><STEXT><PDAT>EXAMPLE 34</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Analogues of Pyrrole-Aryls for Metal Binding and Altered Fluorescence Properties</PDAT></STEXT></H>
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>Analogues of the pyrrole-aryls may be prepared to form metal complexes as shown below. By reaction of 9 with a 1,10-phenanthroline-5,6-dione, a compound represented by 13 may be synthesized. Compounds exemplified by 13 and 14 are contemplated for the ability to complex a metal through the phenanthroline unit. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00010">
<CHEMCDX ID="CHEMCDX-00010" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00010.CDX"/>
<CHEMMOL ID="CHEMMOL-00010" ALT="chemistry mol file" FILE="US06482949-20021119-C00010.MOL"/>
<EMI ID="EMI-C00010" ALT="embedded image" HE="309.6387" WI="216.027" FILE="US06482949-20021119-C00010.TIF"/>
</CHEM-US>
</CWU>
<PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00011">
<CHEMCDX ID="CHEMCDX-00011" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00011.CDX"/>
<CHEMMOL ID="CHEMMOL-00011" ALT="chemistry mol file" FILE="US06482949-20021119-C00011.MOL"/>
<EMI ID="EMI-C00011" ALT="embedded image" HE="235.95705" WI="216.027" FILE="US06482949-20021119-C00011.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>Similar analogues may be synthesized using the appropriate 1,2-diamines to produce compounds such as 15 and 16 for altered fluorescence /binding properties. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00012">
<CHEMCDX ID="CHEMCDX-00012" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00012.CDX"/>
<CHEMMOL ID="CHEMMOL-00012" ALT="chemistry mol file" FILE="US06482949-20021119-C00012.MOL"/>
<EMI ID="EMI-C00012" ALT="embedded image" HE="233.5473" WI="154.59255" FILE="US06482949-20021119-C00012.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>Additionally, using a porphyrin 1,2-diones, compounds exemplified by structure 17 can be generated as shown below: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00013">
<CHEMCDX ID="CHEMCDX-00013" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00013.CDX"/>
<CHEMMOL ID="CHEMMOL-00013" ALT="chemistry mol file" FILE="US06482949-20021119-C00013.MOL"/>
<EMI ID="EMI-C00013" ALT="embedded image" HE="139.45365" WI="214.0992" FILE="US06482949-20021119-C00013.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00144" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>are as described previously and representative metals include Li, B, Na, Mg, Al, Si, K&mdash;As, Rb&mdash;Sb, Cs&mdash;La, Hf&mdash;Bi, pr, Eu, Yb and Th.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 35</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Post-Synthetic Modification of the &lsquo;Parent&rsquo; 2,3-Dipyrrol-2&prime;-yl-quinoxaline</PDAT></STEXT></H>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>A wide variety of substituents may be introduced to the pyrrole quinoxaline post-synthetically at the &agr;-pyrrolic positions as shown with the following selected examples. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00014">
<CHEMCDX ID="CHEMCDX-00014" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00014.CDX"/>
<CHEMMOL ID="CHEMMOL-00014" ALT="chemistry mol file" FILE="US06482949-20021119-C00014.MOL"/>
<EMI ID="EMI-C00014" ALT="embedded image" HE="126.24255" WI="156.97395" FILE="US06482949-20021119-C00014.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00146" LVL="2"><PTEXT><PDAT>1:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;H</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="2"><PTEXT><PDAT>2:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;OMe</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="2"><PTEXT><PDAT>3:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00149" LVL="2"><PTEXT><PDAT>4:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00150" LVL="2"><PTEXT><PDAT>5:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00151" LVL="2"><PTEXT><PDAT>6:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00152" LVL="2"><PTEXT><PDAT>7:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;H, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00153" LVL="2"><PTEXT><PDAT>8:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00154" LVL="2"><PTEXT><PDAT>9:R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00155" LVL="2"><PTEXT><PDAT>n&equals;1-10</PDAT></PTEXT></PARA>
<PARA ID="P-00156" LVL="7"><PTEXT><PDAT>with any of R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>may be as follows:</PDAT></PTEXT></PARA>
<PARA ID="P-00157" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&equals;I, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&equals;Br, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&equals;COCH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&equals;CHO</PDAT></PTEXT></PARA>
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>As shown in Scheme 4 below. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00015">
<CHEMCDX ID="CHEMCDX-00015" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00015.CDX"/>
<CHEMMOL ID="CHEMMOL-00015" ALT="chemistry mol file" FILE="US06482949-20021119-C00015.MOL"/>
<EMI ID="EMI-C00015" ALT="embedded image" HE="503.0991" WI="449.09235" FILE="US06482949-20021119-C00015.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>One of skill in the art will further recognize that the diiodo or the dibromo compounds may be modified through known synthetic means to generate a range of &agr;-substituted compounds as exemplified by structures 19. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00016">
<CHEMCDX ID="CHEMCDX-00016" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00016.CDX"/>
<CHEMMOL ID="CHEMMOL-00016" ALT="chemistry mol file" FILE="US06482949-20021119-C00016.MOL"/>
<EMI ID="EMI-C00016" ALT="embedded image" HE="188.89605" WI="180.0225" FILE="US06482949-20021119-C00016.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00160" LVL="2"><PTEXT><PDAT>X&equals;CHO, Y&equals;Z&equals;H</PDAT></PTEXT></PARA>
<PARA ID="P-00161" LVL="2"><PTEXT><PDAT>X&equals;Z&equals;H, Y&equals;CHO</PDAT></PTEXT></PARA>
<PARA ID="P-00162" LVL="2"><PTEXT><PDAT>X&equals;Y&equals;H, Z&equals;CHO</PDAT></PTEXT></PARA>
<PARA ID="P-00163" LVL="2"><PTEXT><PDAT>X&equals;NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Y&equals;Z&equals;H</PDAT></PTEXT></PARA>
<PARA ID="P-00164" LVL="2"><PTEXT><PDAT>X&equals;Z&equals;H, Y&equals;NO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00165" LVL="2"><PTEXT><PDAT>X&equals;Y&equals;H, ZNO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00166" LVL="2"><PTEXT><PDAT>X&equals;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Y&equals;Z&equals;H</PDAT></PTEXT></PARA>
<PARA ID="P-00167" LVL="2"><PTEXT><PDAT>X&equals;Z&equals;H, Y&equals;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00168" LVL="2"><PTEXT><PDAT>X&equals;Y&equals;H, Z&equals;NH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00169" LVL="0"><PTEXT><PDAT>Methods are also available for the synthesis of a TMS derivative as shown below: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00017">
<CHEMCDX ID="CHEMCDX-00017" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00017.CDX"/>
<CHEMMOL ID="CHEMMOL-00017" ALT="chemistry mol file" FILE="US06482949-20021119-C00017.MOL"/>
<EMI ID="EMI-C00017" ALT="embedded image" HE="152.1828" WI="181.46835" FILE="US06482949-20021119-C00017.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>Removal of the TMS group and subsequent reaction with a metal salt, as described previously, will afford metal linked systems.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 36</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>The Starting Pyrrole Unit as a Source of Variation</PDAT></STEXT></H>
<PARA ID="P-00171" LVL="0"><PTEXT><PDAT>It will be apparent to one of skill in the art that many pyrrolylquinoxalines may be obtained within the context of the present invention. For example, as shown below, various substituents may be introduced on the starting pyrrole to generate a series of diones. These diones are then used in the synthesis of pyrrole-aryls to effect desired properties, such as a particular anion specificity, or increased solubility in a specific solvent. Accordingly it is contemplated that variety of approaches may be employed, in accordance with the present invention, to prepare an array of diones with a wide variety of substituents as represented in Scheme 5 below. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00018">
<CHEMCDX ID="CHEMCDX-00018" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00018.CDX"/>
<CHEMMOL ID="CHEMMOL-00018" ALT="chemistry mol file" FILE="US06482949-20021119-C00018.MOL"/>
<EMI ID="EMI-C00018" ALT="embedded image" HE="165.6207" WI="216.027" FILE="US06482949-20021119-C00018.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00172" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00173" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00174" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;COCH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00175" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CO(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00176" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;H, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00177" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;H, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00178" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>H, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL></PTEXT></PARA>
<PARA ID="P-00179" LVL="2"><PTEXT><PDAT>n&equals;1-10</PDAT></PTEXT></PARA>
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>It is further envisioned that different combinations of polypyrroles, in particular bipyrroles and terpyrroles, may be employed in the reaction with oxalyl chloride to produce various dione analogues as represented below. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00019">
<CHEMCDX ID="CHEMCDX-00019" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00019.CDX"/>
<CHEMMOL ID="CHEMMOL-00019" ALT="chemistry mol file" FILE="US06482949-20021119-C00019.MOL"/>
<EMI ID="EMI-C00019" ALT="embedded image" HE="316.6128" WI="216.027" FILE="US06482949-20021119-C00019.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00181" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>are as described previously, n&equals;1-10 with n&equals;0, R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>7</PDAT></SB></HIL><PDAT>&equals;H preferred</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 37</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Incorporation into Macrocycles</PDAT></STEXT></H>
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>It is contemplated that the remaining &agr;-free position on the pyrrole rings may react under a variety of conditions as shown below, to provide a number of novel compounds with a pyrrole-aryl and a macrocyclic component. These macrocycles may be used in fields such as anion binding (26), cation binding (28, 31, 32) and in optical devices (26, 28, 31, 32) and molecular wires (28, 31, 32).</PDAT></PTEXT></PARA>
<PARA ID="P-00183" LVL="0"><PTEXT><PDAT>In the following examples, R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>are as previously described, n&equals;0-10 with the preferred compound(s) as indicated within the synthetic scheme. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00020">
<CHEMCDX ID="CHEMCDX-00020" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00020.CDX"/>
<CHEMMOL ID="CHEMMOL-00020" ALT="chemistry mol file" FILE="US06482949-20021119-C00020.MOL"/>
<EMI ID="EMI-C00020" ALT="embedded image" HE="641.1069" WI="319.47615" FILE="US06482949-20021119-C00020.TIF"/>
</CHEM-US>
</CWU>
<PDAT>
</PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00021">
<CHEMCDX ID="CHEMCDX-00021" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00021.CDX"/>
<CHEMMOL ID="CHEMMOL-00021" ALT="chemistry mol file" FILE="US06482949-20021119-C00021.MOL"/>
<EMI ID="EMI-C00021" ALT="embedded image" HE="576.55395" WI="319.9581" FILE="US06482949-20021119-C00021.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00184" LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&equals;H, n&equals;1</PDAT></PTEXT></PARA>
<PARA ID="P-00185" LVL="0"><PTEXT><PDAT>It should again be stressed that although not shown above, all of the reaction schemes can be applied to analogues having widely substituted pyrrole rings. The pyrroles may be substituted both &agr; and &bgr;, or in both ways to the pyrrole nitrogen atoms. The above reaction schemes are not intended to be limited to unsubstituted pyrroles or to the substitutions shown.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 38</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Alternate Heterocycles in the Starting Diketone</PDAT></STEXT></H>
<PARA ID="P-00186" LVL="0"><PTEXT><PDAT>It is contemplated that alternate heterocyclic diones may be used in a condensation reaction with aryl 1,2-diamines, as outlined in previous examples, to produce 2,3-heteroaryl quinoxaline analogues. It is believed that these compounds will act as effective sensors for a variety of cations or neutrals. Compounds 33-38 below represent some proposed alternative diones contemplated for use in accordance with the present invention. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00022">
<CHEMCDX ID="CHEMCDX-00022" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00022.CDX"/>
<CHEMMOL ID="CHEMMOL-00022" ALT="chemistry mol file" FILE="US06482949-20021119-C00022.MOL"/>
<EMI ID="EMI-C00022" ALT="embedded image" HE="558.29655" WI="162.02025" FILE="US06482949-20021119-C00022.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 39</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Dianions as Ligands</PDAT></STEXT></H>
<PARA ID="P-00187" LVL="0"><PTEXT><PDAT>The pyrrole-aryls of the present invention may be used as sensors for anions, cations or neutral molecules provided the compound is of the appropriate charge of polarization. For instance, pyrrole-aryls of the present invention are contemplated for use as metal cation chelants by removing protons from the pyrrolic nitrogens as shown below. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00023">
<CHEMCDX ID="CHEMCDX-00023" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00023.CDX"/>
<CHEMMOL ID="CHEMMOL-00023" ALT="chemistry mol file" FILE="US06482949-20021119-C00023.MOL"/>
<EMI ID="EMI-C00023" ALT="embedded image" HE="225.3825" WI="178.34985" FILE="US06482949-20021119-C00023.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 40</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Pyrrole-Aryls As Anion Sensing Agents</PDAT></STEXT></H>
<PARA ID="P-00188" LVL="0"><PTEXT><PDAT>The compounds of the present invention are used as anion sensors in a variety of applications including, chromatography, anion quantification, ion-selective electrodes and fiber-optics. A preferred example for use of the present compounds is for selective anion sensing, in particular fluoride sensing. Fluoride sensing has largely been complicated by competition from other biologically common species such as hydroxide, chloride and phosphate. The ability to sense fluoride is important for the analysis of drinking water, as well as ground water, in biological systems such as teeth and bones and in certain disease states such as fluorosis. In vitro sensing for fluoride is also important, for example to determine the amount of damaging fluorocarbons in the atmosphere and even the presence of fluorinated phosphates which can be used as chemical weapons due to their toxicity when ingested. The compounds of the present invention provide a distinct advantage over other sensors due to the selectivity for fluoride ion as demonstrated in Examples 7-9 and the dramatic color change produced upon binding. This makes the compounds particularly amenable for use in paper based sensing such as litmus paper, solid support sensing and as a coating on either fiber optic wires or electrodes. Selective sensing and separation are also contemplated using chromatographic methods. For example the present compounds may be coupled to a solid support and used to separate various anions from each other and from other species in the mixture. In certain circumstances a desired anion may even be collected as the system is entirely reversible based on the environment. Washing under appropriate conditions completely removes fluoride anion and returns the molecule to its original state.</PDAT></PTEXT></PARA>
<PARA ID="P-00189" LVL="0"><PTEXT><PDAT>It will also be apparent to one of skill in the art that many derivatives and analogues may be obtained within the context of the disclosed methods and compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00190" LVL="0"><PTEXT><PDAT>Once a range of pyrrole-aryl or alternate heterocyclic analogues have been generated, as described herein in the foregoing detailed examples, the specificity, kinetics and thermodynamics of anion binding under a range of conditions and with an array of different anions may be determined. The structure and function of the most promising compounds may then be optimized so that they bind the desired anion under the appropriate conditions, solvent, temperature, affinity pH etc., to function as an efficient sensor.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 41</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Synthesis of Water Soluble Pyrrole-Aryl Analogues</PDAT></STEXT></H>
<PARA ID="P-00191" LVL="0"><PTEXT><PDAT>It is contemplated that the addition of charged groups and/or polar groups such as glycols or polyglycols to the 2,3-dipyrrylquinoxaline core will impart solubility in aqueous solutions. The synthesis of such a compound is outlined in the scheme below. The compound is that of 5 from Example 1. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00024">
<CHEMCDX ID="CHEMCDX-00024" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00024.CDX"/>
<CHEMMOL ID="CHEMMOL-00024" ALT="chemistry mol file" FILE="US06482949-20021119-C00024.MOL"/>
<EMI ID="EMI-C00024" ALT="embedded image" HE="227.05515" WI="216.027" FILE="US06482949-20021119-C00024.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00192" LVL="0"><PTEXT><PDAT>It is further contemplated that the addition of further pyrroles to the quinoxaline subunit will result in the increase of solubility in aqueous solutions. The synthesis of such compounds is illustrated in the following schemes.</PDAT></PTEXT></PARA>
<PARA ID="P-00193" LVL="0"><PTEXT><PDAT>It is expected that these compounds will serve as sensors and therapeutic agents in aqueous solutions as described in the next example. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00025">
<CHEMCDX ID="CHEMCDX-00025" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00025.CDX"/>
<CHEMMOL ID="CHEMMOL-00025" ALT="chemistry mol file" FILE="US06482949-20021119-C00025.MOL"/>
<EMI ID="EMI-C00025" ALT="embedded image" HE="573.43545" WI="214.58115" FILE="US06482949-20021119-C00025.TIF"/>
</CHEM-US>
</CWU>
<PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00026">
<CHEMCDX ID="CHEMCDX-00026" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00026.CDX"/>
<CHEMMOL ID="CHEMMOL-00026" ALT="chemistry mol file" FILE="US06482949-20021119-C00026.MOL"/>
<EMI ID="EMI-C00026" ALT="embedded image" HE="427.7448" WI="215.8002" FILE="US06482949-20021119-C00026.TIF"/>
</CHEM-US>
</CWU>
<PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00027">
<CHEMCDX ID="CHEMCDX-00027" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00027.CDX"/>
<CHEMMOL ID="CHEMMOL-00027" ALT="chemistry mol file" FILE="US06482949-20021119-C00027.MOL"/>
<EMI ID="EMI-C00027" ALT="embedded image" HE="375.89265" WI="216.027" FILE="US06482949-20021119-C00027.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 42</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Anion Binding Compounds as Therapeutic Agents</PDAT></STEXT></H>
<PARA ID="P-00194" LVL="0"><PTEXT><PDAT>The compounds of the present invention, in particular those compounds with increased solubility in aqueous solutions are contemplated to be of use as in vivo anion sensors, for example blood samples, and as therapeutic agents to bind excess anion in certain disease states such as fluorosis.</PDAT></PTEXT></PARA>
<PARA ID="P-00195" LVL="0"><PTEXT><PDAT>To develop pyrrole-aryl compounds of the present invention for use as therapeutic agents, in vitro tests will be first conducted to determine the efficiency of binding, retention and selectivity in aqueous solutions. These will follow similar protocols as previously described for screening in organic solvents.</PDAT></PTEXT></PARA>
<PARA ID="P-00196" LVL="0"><PTEXT><PDAT>Following such in vitro tests, the binding activity of promising compounds will be followed up, in for example biological fluids such as blood, and then in in vivo animal studies. These studies will be conducted according to the standard practice for such animal trials, the execution of which will be ell known to one of skill in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00197" LVL="0"><PTEXT><PDAT>During the animal trials, the compounds may be further modified if required. They may be modified to increase solubility or to overcome in vivo degradation. Alternatively, if such problems occur, the compounds may be enveloped within a bio-compatible liposome and then administered intravenously.</PDAT></PTEXT></PARA>
<PARA ID="P-00198" LVL="0"><PTEXT><PDAT>Toxicity studies will also be carried out at this stage. The methods for determining both acute and chronic toxicity will be well known to one of skill in the art. Toxicity can be investigated in relation to solubility, net charge at physiological pH and changes in substituents.</PDAT></PTEXT></PARA>
<PARA ID="P-00199" LVL="0"><PTEXT><PDAT>All of the compositions and methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the compositions and methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain agents which are both chemically and physiologically related may be substituted for the agents described herein while the same or similar results would be achieved. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 43</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Sensing Compound Immobilized on a Solid Support</PDAT></STEXT></H>
<PARA ID="P-00200" LVL="0"><PTEXT><PDAT>The usefulness of the pyrrole-aryl compounds as sensing agents when bound to solid supports was demonstrated by visual color change in the presence of tetrabutylammonium fluoride. 2,3-Dipyrrol-2&prime;-yl-6-carboxyquinoxaline (preparation is described in Example 19) was immobilized on a polystyrene beads functionalized with polyethylene glycol groups that terminate in an amine. The quinoxaline is linked to TG-amino resin through an amide bond through a condensation reaction. An acetyl derivatized bead was used a blank.</PDAT></PTEXT></PARA>
<PARA ID="P-00201" LVL="0"><PTEXT><PDAT>The presence of fluoride ion was signaled by a dramatic visual color change from yellow to red for the 2,3-dipyrrol-2&prime;-yl-6-carboxyquinoxaline-fuctionalized bead. The blank bead was initially colorless and remained so upon addition of fluoride ion.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>REFERENCES</PDAT></STEXT></H>
<PARA ID="P-00202" LVL="0"><PTEXT><PDAT>The following references, to the extent that they provide exemplary procedural or other details supplementary to those set forth herein, are specifically incorporated herein by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00203" LVL="1"><PTEXT><PDAT>Gale et al. Chem. Commun. 1998, 1-8.</PDAT></PTEXT></PARA>
<PARA ID="P-00204" LVL="1"><PTEXT><PDAT>Dietrich, B.; Hosseini, M. W. in Supramolecular Chemistry of Anions; Bianchi, A., Bowman-James, K. and Garcia-Espa&ntilde;a, E., Ed.; Wiley-VCH: New York, 1997, pp 45-62.</PDAT></PTEXT></PARA>
<PARA ID="P-00205" LVL="1"><PTEXT><PDAT>Schmidtchen, F. P. Nachr. Chem, Tech. Lab. 1988, 36, 8-17.</PDAT></PTEXT></PARA>
<PARA ID="P-00206" LVL="1"><PTEXT><PDAT>K. L. Kirk Biochemistry of the Halogens and Inorganic HalidesPlenum Press: New York, 1991, p 58.</PDAT></PTEXT></PARA>
<PARA ID="P-00207" LVL="1"><PTEXT><PDAT>B. L. Riggs Bone and Mineral Research, Annual 2 Elsevier: Amsterdam, 1984, pp 366-393.</PDAT></PTEXT></PARA>
<PARA ID="P-00208" LVL="1"><PTEXT><PDAT>M. Kleerekoper Endocrinol. Metab. Clin. North Am. 1998, 27, 441-452.</PDAT></PTEXT></PARA>
<PARA ID="P-00209" LVL="1"><PTEXT><PDAT>A. Wiseman Handbook of Experimental Pharmacology XX/2.; Part. 2, Springer-Verlag: Berlin, 1970, pp 48-97.</PDAT></PTEXT></PARA>
<PARA ID="P-00210" LVL="1"><PTEXT><PDAT>Sessler, J. L.; Andrievsky, A.; Genge, J. W. in Advances in Supramolecular Chemistry; Lehn, J. M., Ed.; JAI Press Inc., 1997; Vol. 4, pp 97-142.</PDAT></PTEXT></PARA>
<PARA ID="P-00211" LVL="1"><PTEXT><PDAT>Gale, P. A.; Sessler, J. L.; Kr&aacute;l, V. K.; Lynch, V. M. J. Am. Chem. Soc. 1996, 118, 5140-5141.</PDAT></PTEXT></PARA>
<PARA ID="P-00212" LVL="1"><PTEXT><PDAT>Sessler, J. L.; Gale, P. A.; Genge, J. W. Chem. Eur. J. 1998, 4, 1095-1099.</PDAT></PTEXT></PARA>
<PARA ID="P-00213" LVL="1"><PTEXT><PDAT>Dietrich, B.; Hosseini, M. W.; Lehn, J. M.; Sessions, R. B. J. Am. Chem. Soc. 1981, 103, 1282-1283.</PDAT></PTEXT></PARA>
<PARA ID="P-00214" LVL="1"><PTEXT><PDAT>Hosseini, M. W.; Lehn, J. M. Helvetica Chimica Acta 1988, 71, 749-756.</PDAT></PTEXT></PARA>
<PARA ID="P-00215" LVL="1"><PTEXT><PDAT>Dietrich, B.; Fyles, D. L.; Fyles, T. M.; Lehn, J. -M. Helvetica Chimica Acta 1979, 62, 2763-2787.</PDAT></PTEXT></PARA>
<PARA ID="P-00216" LVL="1"><PTEXT><PDAT>Metzger, A.; Lynch, V. M.; Anslyn, E. V. Angew. Chem. Int. Ed. Engl. 1997, 36, 862-865.</PDAT></PTEXT></PARA>
<PARA ID="P-00217" LVL="1"><PTEXT><PDAT>Oddo, B. Gazz. Chim. Ital. 1911, 41, 248-255.</PDAT></PTEXT></PARA>
<PARA ID="P-00218" LVL="1"><PTEXT><PDAT>Behr, D.; Brand&auml;nge, S.; Lindstr&ouml;m, B. Acta Chem. Scand. 1973, 27, 2411-2414.</PDAT></PTEXT></PARA>
<PARA ID="P-00219" LVL="1"><PTEXT><PDAT>Sessler, J. L.; Mody, T. D.; Ramasamy, R.; Sherry, A. D. New J. Chem. 1992, 16, 541-544.</PDAT></PTEXT></PARA>
<PARA ID="P-00220" LVL="1"><PTEXT><PDAT>Cheeseman, G. W. H. 1962, J. Chem. Soc., 1170-1176.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00221" LVL="0"><PTEXT><PDAT>1. A pyrrole-aryl compound of the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00028">
<CHEMCDX ID="CHEMCDX-00028" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00028.CDX"/>
<CHEMMOL ID="CHEMMOL-00028" ALT="chemistry mol file" FILE="US06482949-20021119-C00028.MOL"/>
<EMI ID="EMI-C00028" ALT="embedded image" HE="130.5801" WI="111.84075" FILE="US06482949-20021119-C00028.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>, individually at each occurrence, are the same or different and are selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, glycolyl, polyglycol ether, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amido, ester, acyl, aldo, and carboxy; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-10, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein aryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>phenyl and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings of carbon only, the individual rings being of 5-7 carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein heteroaryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>one 5 or 6 membered aromatic ring, said ring containing at least one carbon atom and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings, said rings each containing 5 or 6 members and each ring having at least one carbon atom; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein ester is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>are alkyl and may consist of up to twenty carbon atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole aryl, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein acyl is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms, and wherein R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may consist of up to twenty atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole aryl, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein carboxy is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOH wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms; </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00222" LVL="7"><PTEXT><PDAT>and salts thereof,</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>provided, however, that R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>cannot all be hydrogen. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00223" LVL="0"><PTEXT><PDAT>2. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;OCH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00224" LVL="0"><PTEXT><PDAT>3. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00225" LVL="0"><PTEXT><PDAT>4. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00226" LVL="0"><PTEXT><PDAT>5. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00227" LVL="0"><PTEXT><PDAT>6. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, and wherein n is 0-20.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00228" LVL="0"><PTEXT><PDAT>7. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;H, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00229" LVL="0"><PTEXT><PDAT>8. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00230" LVL="0"><PTEXT><PDAT>9. The compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00231" LVL="0"><PTEXT><PDAT>10. A compound selected from the group consisting of: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00029">
<CHEMCDX ID="CHEMCDX-00029" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00029.CDX"/>
<CHEMMOL ID="CHEMMOL-00029" ALT="chemistry mol file" FILE="US06482949-20021119-C00029.MOL"/>
<EMI ID="EMI-C00029" ALT="embedded image" HE="319.7313" WI="215.0631" FILE="US06482949-20021119-C00029.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00232" LVL="0"><PTEXT><PDAT>11. A compound of the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00030">
<CHEMCDX ID="CHEMCDX-00030" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00030.CDX"/>
<CHEMMOL ID="CHEMMOL-00030" ALT="chemistry mol file" FILE="US06482949-20021119-C00030.MOL"/>
<EMI ID="EMI-C00030" ALT="embedded image" HE="192.4965" WI="194.6511" FILE="US06482949-20021119-C00030.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>11</PDAT></SB></HIL><PDAT>, individually at each occurrence, are the same or different and are selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, glycolyl, polyglycol ether, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amido, ester, acyl, aldo, and carboxy; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where m&equals;1-10, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein aryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>phenyl and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings of carbon only, the individual rings being of 5-7 carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein heteroaryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>one 5 or 6 membered aromatic ring, said ring containing at least one carbon atom and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings, said rings each containing 5 or 6 members and each ring having at least one carbon atom; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein ester is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>are alkyl and may consist of up to twenty carbon atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to rings of the compound, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein acyl is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms, and wherein R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may consist of up to twenty atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to rings of the compound, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein carboxy is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOH wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>and n&equals;0-10, and further wherein each of R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>on either side of the axis of the quinoxaline bridge may be the same or different from the corresponding R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>7 </PDAT></SB></HIL><PDAT>on the opposite side of the quinoxaline bridge and further wherein each R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>of the n subunits of pyrrole may be the same or different from corresponding R</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>of any other subunits of pyrrole; </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00233" LVL="7"><PTEXT><PDAT>and salts thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00234" LVL="0"><PTEXT><PDAT>12. The compound of </PDAT><CLREF ID="CLM-00011"><PDAT>claim 11</PDAT></CLREF><PDAT> wherein n&equals;1.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00235" LVL="0"><PTEXT><PDAT>13. The compound of </PDAT><CLREF ID="CLM-00011"><PDAT>claim 11</PDAT></CLREF><PDAT> wherein n&equals;2.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00236" LVL="0"><PTEXT><PDAT>14. A pyrrole-aryl compound of the general structure: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00031">
<CHEMCDX ID="CHEMCDX-00031" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00031.CDX"/>
<CHEMMOL ID="CHEMMOL-00031" ALT="chemistry mol file" FILE="US06482949-20021119-C00031.MOL"/>
<EMI ID="EMI-C00031" ALT="embedded image" HE="126.7245" WI="116.1783" FILE="US06482949-20021119-C00031.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, individually at each occurrence, are the same or different and are selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, glycolyl, polyglycol ether, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amido, ester, acyl, aldo, and carboxy; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-10, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein aryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>phenyl and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings of carbon only, the individual rings being of 5-7 carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein heteroaryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>one 5 or 6 membered aromatic ring, said ring containing at least one carbon atom and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings, said rings each containing 5 or 6 members and each ring having at least one carbon atom; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein ester is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>are alkyl and may consist of up to twenty carbon atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole aryl, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein acyl is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms, and wherein R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may consist of up to twenty atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole aryl, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein carboxy is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOH wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>and further wherein Ar is selected from the group consisting of: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00032">
<CHEMCDX ID="CHEMCDX-00032" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00032.CDX"/>
<CHEMMOL ID="CHEMMOL-00032" ALT="chemistry mol file" FILE="US06482949-20021119-C00032.MOL"/>
<EMI ID="EMI-C00032" ALT="embedded image" HE="117.85095" WI="156.97395" FILE="US06482949-20021119-C00032.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>&emsp;and further wherein X, Y, and Z are selected from the group consisting of hydrogen, aldehyde, nitro, and amino; </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00237" LVL="7"><PTEXT><PDAT>and salts thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00238" LVL="0"><PTEXT><PDAT>15. A pyrrole-quinoxaline compound of the general structure: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00033">
<CHEMCDX ID="CHEMCDX-00033" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00033.CDX"/>
<CHEMMOL ID="CHEMMOL-00033" ALT="chemistry mol file" FILE="US06482949-20021119-C00033.MOL"/>
<EMI ID="EMI-C00033" ALT="embedded image" HE="154.59255" WI="111.84075" FILE="US06482949-20021119-C00033.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, individually at each occurrence, are the same or different and are selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, glycolyl, polyglycol ether, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amido, ester, acyl, aldo, and carboxy; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-10, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein aryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>phenyl and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings of carbon only, the individual rings being of 5-7 carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein heteroaryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>one 5 or 6 membered aromatic ring, said ring containing at least one carbon atom and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings, said rings each containing 5 or 6 members and each ring having at least one carbon atom; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein ester is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>are alkyl and may consist of up to twenty carbon atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole-quinoxaline, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein acyl is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms, and wherein R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may consist of up to twenty atoms and fuirther wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole-quinoxaline, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein carboxy is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOH wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>and wherein TAS is a trialkylylsilyl group; </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00239" LVL="7"><PTEXT><PDAT>and salts thereof.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00240" LVL="0"><PTEXT><PDAT>16. A pyrrole-aryl compound of the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00034">
<CHEMCDX ID="CHEMCDX-00034" ALT="chemistry chemdraw file" FILE="US06482949-20021119-C00034.CDX"/>
<CHEMMOL ID="CHEMMOL-00034" ALT="chemistry mol file" FILE="US06482949-20021119-C00034.MOL"/>
<EMI ID="EMI-C00034" ALT="embedded image" HE="130.5801" WI="111.84075" FILE="US06482949-20021119-C00034.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>form part of a cyclic group said cyclic group selected from the group consisting of aryl or heteroaryl wherein aryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>phenyl and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings of carbon only, the individual rings being of 5-7 carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>and wherein heteroaryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>one 5 or 6 membered aromatic ring, said ring containing at least one carbon atom and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings, said rings each containing 5 or 6 members and each ring having at least one carbon atom; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>and further wherein R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>, individually at each occurrence, are the same or different and are selected from the group consisting hydrogen, alkyl, hydroxyalkyl, glycolyl, polyglycol ether, amino, nitro, halo, cyano, aryl, heteroaryl, thio, thioalkyl, amido, ester, acyl, aldo, and carboxy; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-10, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein aryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>phenyl and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings of carbon only, the individual rings being of 5-7 carbon atoms; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein heteroaryl is selected from the group consisting of </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>one 5 or 6 membered aromatic ring, said ring containing at least one carbon atom and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>a radical having 2-10 aromatic rings, said rings each containing 5 or 6 members and each ring having at least one carbon atom; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein ester is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>are alkyl and may consist of up to twenty carbon atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole-aryl, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein acyl is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COR</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms, and wherein R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may consist of up to twenty atoms and further wherein either R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>b </PDAT></SB></HIL><PDAT>may be directly attached to the pyrrole-aryl, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="3"><PTEXT><PDAT>wherein carboxy is R</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>COOH wherein R</PDAT><HIL><SB><PDAT>a </PDAT></SB></HIL><PDAT>is alkyl and may consist of up to twenty carbon atoms; </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00241" LVL="7"><PTEXT><PDAT>and salts thereof,</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>provided, however, that R</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>cannot all be hydrogen. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00242" LVL="0"><PTEXT><PDAT>17. The pyrrole-aryl compound of </PDAT><CLREF ID="CLM-00016"><PDAT>claim 16</PDAT></CLREF><PDAT> wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-5.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00243" LVL="0"><PTEXT><PDAT>18. The pyrrole-aryl compound of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-5.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00244" LVL="0"><PTEXT><PDAT>19. The compound of </PDAT><CLREF ID="CLM-00011"><PDAT>claim 11</PDAT></CLREF><PDAT> wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where m&equals;1-5.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00245" LVL="0"><PTEXT><PDAT>20. The pyrrole-aryl compound of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT> wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-5.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00246" LVL="0"><PTEXT><PDAT>21. The pyrrole-quinoxaline compound of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT> wherein polyglycol ether is O(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>CH</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and where n&equals;1-5.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00022">
<PARA ID="P-00247" LVL="0"><PTEXT><PDAT>22. The compound of any of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>11</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT>, or </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> existing as a salt of one or more counterions selected from the group consisting of:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>Group IA metals, Group IIA metals, ammonium, alkylammonium, and any combination thereof; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>wherein one or more of the pyrrole nitrogens posses formal negative charge.</PDAT></PTEXT></CLMSTEP>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06482949-20021119-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06482949-20021119-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06482949-20021119-D00002.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06483956-20021119-D00000.TIF SYSTEM "US06483956-20021119-D00000.TIF" NDATA TIF>
<!ENTITY US06483956-20021119-D00001.TIF SYSTEM "US06483956-20021119-D00001.TIF" NDATA TIF>
<!ENTITY US06483956-20021119-D00002.TIF SYSTEM "US06483956-20021119-D00002.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06483956</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021119</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09637480</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20000811</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>G02B  600</PDAT></B511>
<B512><PDAT>H01S  313</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>385 11</PDAT></B521>
<B522><PDAT>372 29011</PDAT></B522>
<B522><PDAT>372 2902</PDAT></B522>
<B522><PDAT>372 32</PDAT></B522>
<B522><PDAT>372 20</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Fiber frequency locker</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4547664</PDAT></DNUM>
<DATE><PDAT>19851000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Vogt et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>250205</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5107512</PDAT></DNUM>
<DATE><PDAT>19920400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Shibutani</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>372 32</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5396361</PDAT></DNUM>
<DATE><PDAT>19950300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Sasaki et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5428700</PDAT></DNUM>
<DATE><PDAT>19950600</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Hall</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5511083</PDAT></DNUM>
<DATE><PDAT>19960400</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>D&apos;Amato et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5561675</PDAT></DNUM>
<DATE><PDAT>19961000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Bayon et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>372  6</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>6009111</PDAT></DNUM>
<DATE><PDAT>19991200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Corwin et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
</B560>
<B570>
<B577><PDAT>24</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>372  6</PDAT></B582>
<B582><PDAT>372 20</PDAT></B582>
<B582><PDAT>372 29011</PDAT></B582>
<B582><PDAT>372 32</PDAT></B582>
<B582><PDAT>372 2902</PDAT></B582>
<B582><PDAT>385 10</PDAT></B582>
<B582><PDAT>385 11</PDAT></B582>
<B582><PDAT>385 16</PDAT></B582>
<B582><PDAT>385 37</PDAT></B582>
<B582><PDAT>359156</PDAT></B582>
<B582><PDAT>359157</PDAT></B582>
<B582><PDAT>359187</PDAT></B582>
<B582><PDAT>359188</PDAT></B582>
</B580>
<B590><B595><PDAT>2</PDAT></B595><B596><PDAT>6</PDAT></B596><B597US/>
</B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/149004</PDAT></DNUM><DATE><PDAT>19990813</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Yaakov</PDAT></FNM><SNM><STEXT><PDAT>Shevy</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Pasadena</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Amnon</PDAT></FNM><SNM><STEXT><PDAT>Yariv</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Pasadena</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Dan</PDAT></FNM><SNM><STEXT><PDAT>Provenzano</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Los Angeles</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>California Institute of Technology</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Pasadena</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Fish &amp; Richardson P.C.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Hemang</PDAT></FNM><SNM><STEXT><PDAT>Sanghavi</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Omar</PDAT></FNM><SNM><STEXT><PDAT>Rojas</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>2874</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>Techniques and devices using a fiber cavity formed of two spaced fiber gratings to construct a laser frequency locker.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>RELATED PATENT APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application claims the benefit of U.S. Provisional Application No. 60/149,004, filed Aug. 13, 1999.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>ORIGIN OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>The U.S. Government has certain rights in this invention pursuant to Grant No. ESC 9806922 awarded by the National Science Foundation.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>This application relates to optical fiber devices and lasers.</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>The output frequency of a laser can drift or fluctuate due to various internal processes (e.g., shot noise and other fluctuations) or environmental factors (e.g., a change in temperature or vibrations). The frequency of a semiconductor laser, for example, can change with the electric driving current and temperature. Such variations in the laser frequency are undesirable in certain applications where the frequency stability is required.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>For example, wavelength-division-multiplexing (WDM) has been used to expand the capacity of a fiber communication link by simultaneously transmitting different optical waves at different wavelengths. It is critically important to specify and standardize the wavelengths in WDM signals so that WDM devices, modules, and subsystems from different manufactures are compatible and can be integrated and deployed in commercial WDM networks. One commonly-used WDM wavelength standard is the International Telecommunication Union (ITU) standard, where the WDM wavelengths of different optical waves are required to match ITU grid frequencies. Hence, the laser transmitters for the different WDM channels need be stabilized against wavelength instability caused by either internal or external fluctuations.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>Other applications, such as precision spectroscopic measurements and nonlinear optical processes, may also require frequency stabilization of lasers.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY</PDAT></STEXT></H>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>This application includes techniques and devices that use optical fibers and fiber devices to stabilize the frequency of a laser.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DESCRIPTION OF DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00009" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> shows one embodiment of a laser frequency locker based on polarization mode dispersion in a fiber cavity formed of two sets of fiber gratings in a fiber.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2A</PDAT></FGREF><PDAT> shows transmission spectrum of a fiber Fabry-Perot resonator with two spaced fiber gratings in absence of polarization mode dispersion, where a single transmission peak appears near 1535 nm within the reflective bandwidth from about 1534.5 nm to about 1535.6 nm.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2B</PDAT></FGREF><PDAT> shows an example of two closed spaced transmission peaks within the reflective bandwidth of a fiber Fabry-Perot resonator caused by splitting a single transmission peak due to the polarization mode dispersion in the system shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> shows an exemplary error signal produced by an implementation of the system shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> shows measured laser frequency as a function of injection current to a diode laser with and without a frequency control shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> shows another example of a laser frequency locker based on two fiber cavities formed in two separate fibers.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>Like reference symbols in the various drawings indicate like elements.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION</PDAT></STEXT></H>
<PARA ID="P-00016" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> shows one embodiment of a fiber-based frequency locker </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT>. A laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is optically coupled to a fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> so that the output laser beam </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> is confined and guided within the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>. The fiber </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> is designed to be anisotropic so that the index of refraction for an optical polarization along a selected direction perpendicular to the fiber core is different from that for another optical polarization perpendicular to the selected direction. For example, a polarization-preserving fiber with such anisotropy in the index can be used as the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>. One way to achieve this anisotropy in the index of refraction is to mechanically stress the fiber </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> along the selected direction that is substantially perpendicular to the fiber axis. In another method, the fiber core is exposed to UV light to create the desired birefringence in the fiber core. Furthermore, a birefringent dielectric material may be used to form the fiber core.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>The fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> includes a segment </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> in which two sets of Bragg gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> with substantially the same grating period are formed in the fiber and are spaced from each other by a gap </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT>. Each fiber grating operates as a reflector to selectively reflect light at a Bragg wavelength that satisfies the Bragg phase matching condition and to transmit other spectral components. This Bragg wavelength is equal to twice of the product of the effective index of the refraction of the fiber and grating period. Since both gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> have the same grating period, they are reflective at the same wavelength. The reflection of the gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> is not limited to a single wavelength but rather has a reflection bandwidth where each grating is reflective to light at any wavelength within the bandwidth. The reflection bandwidth of each grating is a function of the grating strength which depends on the depth of the periodic modulation on the fiber&apos;s index of refraction and the number of periods in each grating. Hence, the two spaced gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> form a Fabry-Perot cavity only for light at the Bragg wavelength.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>Light at the Bragg wavelength in such a Fabry-Perot cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> will be reflected by the gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> to bounce back and forth to cause light interference. A constructive interference occurs to create a transmission peak at a resonance when the round-trip phase delay is 360 degrees or any multiple of 360 degrees. The optical transmission of the Fabry-Perot cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> decays as the phase delay deviates from the resonance and becomes zero when the phase delay deviates from the resonance exactly by 180 degrees. As the phase delay continues to change, the optical transmission begins to increase and reaches the peak value when another resonance condition is met. This behavior is periodic with respect to the round-trip phase delay. This round-trip phase delay is essentially determined by the product of the effective index of refraction of the fiber and the gap </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT> and a resonance peak occurs when the product is equals to one half of the wavelength. When expressed in frequency, the round-trip phase delay represents the frequency difference between two adjacent resonant peaks and is called the free spectral range (FSR) of the Fabry-Perot cavity.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>The Fabry-Perot cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> can be configured to have only a single transmission peak within the reflection bandwidth by making the reflection bandwidth of the fiber gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> less than FSR. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2A</PDAT></FGREF><PDAT> shows the transmission spectrum of an exemplary fiber Fabry-Perot cavity where each fiber grating is designed to be reflective in the bandwidth from about 1534.5 nm to about 1535.6 nm. In absence of the polarization mode dispersion, a single transmission peak </PDAT><HIL><BOLD><PDAT>200</PDAT></BOLD></HIL><PDAT> appears in the reflective bandwidth when the frequency of input light matches one of the resonance peaks of the fiber Fabry-Perot cavity.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>When the finesse of the fiber Fabry-Perot cavity </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> is relatively high, e.g., by increasing each grating&apos;s strength, the linewidth of each transmission peak is narrow and thus the resonance frequency of the transmission peak is a well-defined frequency. Therefore, this resonance frequency can be used as a frequency reference or marker. Since the transmission of the input light changes when the input frequency drifts relative to the resonance frequency, a variation in the transmission intensity of the input light can be used to indicate the frequency shift of the input light with respect to the resonance frequency.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>Notably, the index of the refraction of the fiber </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> is anisotropic. For input light at a fixed input frequency, the optical polarization parallel to the selected direction experiences one value for the index of refraction and the optical polarization perpendicular to the selected direction experiences a different value for the index of refraction. These two different index values along two orthogonal directions create a polarization mode dispersion between two orthogonal polarizations and respectively produce two closely spaced resonance peaks, one for each polarization. The frequency spacing between the two peaks is determined by the index difference in the gap </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2B</PDAT></FGREF><PDAT> shows an example of two transmission peaks </PDAT><HIL><BOLD><PDAT>210</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>220</PDAT></BOLD></HIL><PDAT> near 1541.41 nm from the fiber cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> formed of a polarization-preserving silicon glass fiber. The index difference between the two orthogonal polarizations makes the two polarizations to match the same resonance mode of the cavity at two different frequencies </PDAT><HIL><BOLD><PDAT>210</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>220</PDAT></BOLD></HIL><PDAT> that is about 2.18 GHz apart.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>The system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> is designed to use these two peaks along two orthogonal polarizations at the same resonance mode to create an error signal that indicates a variation in the laser frequency and to use a feedback mechanism to correct the laser frequency based on the error signal.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>The fiber gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> are designed so that their reflective bandwidth covers a spectral range in which the frequency of the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is to be stabilized. The polarization of the output laser beam </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> and the selected direction of the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> are oriented at about 45 degrees relative to each other so that the input laser power is essentially equally divided between two orthogonal polarizations, one parallel to the selected axis and another perpendicular to the selected axis. A polarization device </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> is coupled to the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> to receive the transmission from the fiber cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>. Examples of such device </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> include, among others, a polarization beam splitter and a polarizing fiber coupler. In operation, the device </PDAT><HIL><BOLD><PDAT>140</PDAT></BOLD></HIL><PDAT> is oriented to separate the polarization along the selected direction to be a first output signal </PDAT><HIL><BOLD><PDAT>141</PDAT></BOLD></HIL><PDAT> from another polarization perpendicular to the selected direction which is a second output signal </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><PDAT>. Two light detectors </PDAT><HIL><BOLD><PDAT>151</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>152</PDAT></BOLD></HIL><PDAT> are used to respectively receive and convert the signals </PDAT><HIL><BOLD><PDAT>141</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>142</PDAT></BOLD></HIL><PDAT> into electrical output signals.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>An electronic circuit </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> is coupled to receive the output signals from the detectors </PDAT><HIL><BOLD><PDAT>151</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>152</PDAT></BOLD></HIL><PDAT>. One of the two signals </PDAT><HIL><BOLD><PDAT>151</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>152</PDAT></BOLD></HIL><PDAT> (e.g., </PDAT><HIL><BOLD><PDAT>152</PDAT></BOLD></HIL><PDAT> which representing the peak </PDAT><HIL><BOLD><PDAT>220</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>) is inverted by the circuit </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> and is then added to another signal to produce a sum signal. The sum signal may be subsequently amplified for further processing. As illustrated, the circuit </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> may include an operational amplifier to perform the inverting, summing, and amplifying steps.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> shows one example of the above sum signal as a spectral dispersive line shape for a laser wavelength at about 1544.78 nm. The two peaks from the fiber Fabry-Perot cavity due to the anisotropy along two orthogonal polarizations are about 1.84 GHz apart from each other. When the polarization of the laser beam </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> is exactly 45 degrees with respect to the selected direction of the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>, the two peaks are essentially identical in spectral profile and strength but are spectrally shifted from each other. Hence, the sum signal goes to zero at the center frequency between the two peaks and becomes either positive or negative when the laser frequency deviates from that center frequency. This center frequency can be used as a frequency reference (f</PDAT><HIL><SB><PDAT>ref</PDAT></SB></HIL><PDAT>) to which the laser frequency is locked.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>The fiber cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> can be designed to set the frequency reference at a desired value by controlling, e.g., anisotropy in the index of the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>, the structure of the gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> and the gap </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT>. For WDM applications, for example, the frequency reference may be one of the WDM wavelengths specified by the ITU standard.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>Referring back to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, an error signal </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> may be a voltage or current signal from the circuit </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> that represents the sign and magnitude of the sum signal. The error signal </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> is then fed back to the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> to form a servo control feedback loop. The servo loop, in response to the error signal </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT>, operates to adjust the frequency of the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> towards the frequency reference so that the magnitude of the error signal </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> is reduced within an acceptable range and hence the laser frequency stays &ldquo;locked&rdquo; at the frequency reference. The sign of the error signal </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> dictates the direction of the correction to the laser frequency and the magnitude determines the amount of the correction to the laser frequency.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>The laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> in general may be any tunable laser whose output frequency can be controlled by a signal </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT> from a frequency control unit </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT>. For example, the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> may include a semiconductor laser, a fiber laser with either a linear or ring cavity, or a laser based on a semiconductor or fiber laser. The frequency control unit </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT> may be an internal part of the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> or a device external to the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>. For example, if the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is a semiconductor diode laser, the frequency control </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT> may be the driving circuit and the control signal </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT> may be the driving current to the diode. Alternatively, the frequency control </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT> may be a temperature controller that controls the temperature of the diode. If the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> includes a fiber as part of the optical path, the frequency control unit </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT> may include a fiber stretcher that controls the fiber length and hence the laser frequency.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> shows measured laser wavelength as a function of the injection current to a laser diode with and without the servo control as shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>. Curve </PDAT><HIL><BOLD><PDAT>410</PDAT></BOLD></HIL><PDAT> shows the measured data when the frequency servo control is in operation. In comparison, curve </PDAT><HIL><BOLD><PDAT>420</PDAT></BOLD></HIL><PDAT> shows the measured data when the frequency servo control is turned off. The measurements indicate that the servo control improves the frequency stability of the diode laser by one order of magnitude. Higher stability can be obtained with higher servo loop gain.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> shows another frequency servo control system </PDAT><HIL><BOLD><PDAT>500</PDAT></BOLD></HIL><PDAT> by using two fiber cavities </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>B in two separate fibers </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>B, respectively. A fiber coupler </PDAT><HIL><BOLD><PDAT>510</PDAT></BOLD></HIL><PDAT> may be used to divide the laser beam </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT> into two equal beams and respectively couple the two beams into the fibers </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>B. Unlike the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> used in the single fiber system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT>, the two fibers </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>B are not required to have two different indices for two orthogonal polarizations to create the closely spaced resonance peaks to match the same resonance cavity mode due to polarization mode dispersion. Instead, the two fiber cavities </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>B are designed so that their resonance frequencies for the same order of the resonance are slightly shifted from each other by a desired amount. This may be achieved by, for example, configuring their gaps between the two gratings, or the grating periods, or both, to be different. In one implementation, the two fibers </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>B may be placed under slightly different tensions to achieve the frequency shift between the two peaks.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>The gap between the two fiber gratings in each fiber cavity is set sufficiently small that the FSR of the cavity is greater than the reflective bandwidth. Hence, only a single transmission resonance peak can appear within the reflective bandwidth for each fiber cavity. Like the polarization dispersion in the system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, the center frequency between the two different transmission peaks from the two fiber cavities </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>B can be used as a frequency reference to lock the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>. Detectors </PDAT><HIL><BOLD><PDAT>151</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>152</PDAT></BOLD></HIL><PDAT> are used to receive the signals for the two transmission peaks and the circuit </PDAT><HIL><BOLD><PDAT>160</PDAT></BOLD></HIL><PDAT> is used to invert one of the signals to produce the sum signal </PDAT><HIL><BOLD><PDAT>170</PDAT></BOLD></HIL><PDAT> as a feedback control.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>In both systems </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1 and 500</PDAT></FGREF><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT>, the frequency reference may be made adjustable so that the laser frequency, while being locked to the reference, can be tunable. For example, the two shifted resonance peaks in both systems may be shifted to change the center frequency. As long as the servo control operates properly, the laser </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> can be adjusted in response to the signal </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT> to make the laser frequency to follow the center frequency.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>In the system </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, this may be achieved by changing the grating spacing and the gap </PDAT><HIL><BOLD><PDAT>133</PDAT></BOLD></HIL><PDAT> between the two fiber gratings </PDAT><HIL><BOLD><PDAT>131</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> so that both peaks shift by the same amount toward the same direction. A fiber stretcher may be engaged to the fiber </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT> at the position of the cavity </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT> to implement the tuning. In the system </PDAT><HIL><BOLD><PDAT>500</PDAT></BOLD></HIL><PDAT> in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT>, one or both fibers </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>B may be stretched to shift the center frequency between the two resonance peaks.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>A number of embodiments have been described. Nevertheless, it will be understood that various modifications and enhancements may be made without departing from the spirit and scope of the following claims.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>1. A device, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a fiber, coupled to receive a laser beam at a laser frequency, having a fiber cavity formed of two sets of Bragg gratings that are spaced from each other and are reflective at said laser frequency, said fiber having a first index of refraction for an optical polarization along a first direction perpendicular to the fiber core and a second different index of refraction for an optical polarization along a second direction orthogonal to said first direction; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a polarization element coupled to said fiber to receive a transmitted laser beam from said fiber cavity and to produce a first beam polarized along said first direction and a second polarized beam along said second direction; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first light detector to receive said first laser beam to produce a first detector signal; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second light detector to receive said second laser beam to produce a second detector signal; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>an electronic circuit operable to combine said first and said second detector signals to produce an error signal indicative of a deviation of said laser frequency with respect to a reference frequency defined by said fiber cavity. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>2. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said laser beam is polarized along a direction that forms an angle of 45 degrees with respect to the first direction.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>3. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said fiber is a polarization-preserving fiber.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>4. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said fiber is mechanically stressed along one of said first and said second directions.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>5. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said fiber includes a birefringent dielectric material.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>6. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said electronic circuit includes a circuit element which inverts said first detector signal and then adds the inverted first detector signal to said second detector signal to produce said error signal.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>7. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said polarization element includes a polarization beam splitter.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>8. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said polarization element includes a polarizing fiber coupler.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>9. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, further comprising a laser operable to produce said laser beam.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>10. The device as in </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein said laser includes a semiconductor laser.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>11. The device as in </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein said laser includes a fiber as a port of a laser cavity of said laser.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>12. The device as in </PDAT><CLREF ID="CLM-00011"><PDAT>claim 11</PDAT></CLREF><PDAT>, wherein said laser includes a ring cavity formed of said fiber.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>13. The device as in </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein said laser is operable to adjust said laser frequency of said laser beam in response to said error signal to stabilize said laser frequency relative to said reference frequency.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>14. The device as in </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, further comprising an element engaged to control said fiber cavity so as to vary said reference frequency.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>15. A device, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a fiber coupler to receive a laser beam at a laser frequency and to split said laser beam into a first laser beam and a second laser beam; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first fiber, coupled to receive said first laser beam, having a first fiber cavity formed of two sets of Bragg gratings that are spaced from each other and are reflective at said laser frequency; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second fiber, coupled to receive said second laser beam, having a second fiber cavity formed of two sets of Bragg gratings that are spaced from each other and are reflective at said laser frequency; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a first light detector to receive a first transmission from said first fiber cavity to produce a first detector signal; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>a second light detector to receive a second transmission from said second fiber cavity to produce a second detector signal; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>an electronic circuit operable to combine said first and said second detector signals to produce an error signal indicative of a deviation of said laser frequency with respect to a reference frequency defined by said fiber cavity. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>16. The device as in </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, further comprising an element coupled to at least one of said first and said second fiber cavities to control and vary said reference frequency.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>17. The device as in </PDAT><CLREF ID="CLM-00016"><PDAT>claim 16</PDAT></CLREF><PDAT>, wherein said element includes a fiber stretcher.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>18. A method, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>forming a fiber cavity in a fiber by fabricating two sets of Bragg gratings in the fiber that are spaced from each other; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>making the fiber to have a first index of refraction for an optical polarization along a first direction perpendicular to the fiber core and a second different index of refraction for an optical polarization along a second direction orthogonal to said first direction; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>coupling a laser beam at a laser frequency that falls within a reflection bandwidth of said Bragg gratings; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>aligning the polarization of said laser beam to form an angle of 45 degrees with respect to said first direction; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>producing two transmission peaks at two frequencies from the fiber cavity; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>separately converting the transmission peaks into two signals; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>inverting one of the two signals and adding the inverted signal to another signal to form an error signal that indicates a deviation of the laser frequency from a frequency reference centered between the two transmission peaks; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>adjusting the laser frequency to reduce the error signal so that the laser frequency is stabilized relative to the frequency reference. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>19. The method as in </PDAT><CLREF ID="CLM-00018"><PDAT>claim 18</PDAT></CLREF><PDAT>, further comprising changing the frequency reference, while maintaining the laser frequency relative to the frequency reference, to tune the laser frequency.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>20. The method as in </PDAT><CLREF ID="CLM-00019"><PDAT>claim 19</PDAT></CLREF><PDAT>, wherein the frequency reference is changed by controlling the fiber cavity.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>21. The method as in </PDAT><CLREF ID="CLM-00018"><PDAT>claim 18</PDAT></CLREF><PDAT>, wherein the spacing between the Bragg gratings of the fiber cavity is set at a value so that the free spectral range of the fiber cavity is greater than a reflective bandwidth of the Bragg gratings.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00022">
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>22. A method, comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>forming a first fiber cavity by fabricating two sets of Bragg gratings in a first fiber that are spaced from each other to produce a first transmission resonance peak; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>forming a second fiber cavity by fabricating two sets of Bragg gratings in a second fiber that are spaced from each other to produce a second transmission resonance peak different from the first transmission resonance peak; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>coupling a laser beam at a laser frequency that falls within a reflection bandwidth of the Bragg gratings in the first and second cavities; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>separately converting the transmission peaks into two signals; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>inverting one of the two signals and adding the inverted signal to another signal to form an error signal that indicates a deviation of the laser frequency from a frequency reference centered between the two transmission peaks; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>adjusting the laser frequency to reduce the error signal so that the laser frequency is stabilized relative to the frequency reference. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00023">
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>23. The method as in </PDAT><CLREF ID="CLM-00022"><PDAT>claim 22</PDAT></CLREF><PDAT>, wherein each fiber cavity has a free spectral range greater than the reflection bandwidth of the Bragg gratings.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00024">
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>24. The method as in </PDAT><CLREF ID="CLM-00022"><PDAT>claim 22</PDAT></CLREF><PDAT>, further comprising changing the frequency reference, while stabilizing the laser frequency relative to the frequency reference, to tune the laser frequency.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06483956-20021119-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06483956-20021119-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06483956-20021119-D00002.TIF"/>
</SDODR>
</PATDOC>

